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ABSTRACT 
A series of experiments were conducted to examine the effect of dietary protein and 
amino acids (AA) on intestinal Clostridium (C.) perfringens proliferation and necrotic 
enteritis (NE) in broiler chickens.  
The effects of dietary protein level and protein digestibility on the growth 
performance and carcass characteristics of broilers were evaluated first. Low protein 
(LoPro) diets supported growth performance equal to high protein (HiPro) diets when 
highly digestible protein supplements were incorporated. Birds fed HiPro yielded more 
breast meat than those fed LoPro while birds fed diets with highly digestible (HiDig) 
protein supplements accumulated more abdominal fat than those fed diets containing 
low digestible (LoDig) protein ingredients.   
The next experiment focused on the development of a feasible experimental 
model to induce NE experimentally in broilers to investigate potential dietary 
approaches. Different modes of challenge (oral gavage, in-feed and in-water) with 
different doses of C. perfringens inoculums (2 or 4 ml) were tested using 
microbiological, pathological and hematological parameters. The findings suggested the 
possibility to applly any of the evaluated treatments to induce the disease in broilers 
raised on litter.  
The next experiment was conducted to examine the effects of dietary protein 
level and digestibility on the growth performance and intestinal ecosystem of C. 
perfringens challenged and unchallenged broilers. The results of this experiment again 
revealed the ability of LoPro diets to maintain the growth performance of broilers as 
with HiPro diets, when HiDig protein supplements were included. The findings further 
demonstrated significant reduction in the intestinal C. perfringens numbers and severity 
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of intestinal lesions of infected broilers when LoPro diets and HiDig protein 
supplements were fed.   
The last experiment was performed to assess the methionine requirement for 
optimum growth in broiler chickens fed diets supplemented with either DL-methionine 
(DLM) or 2-hydroxy-4-methylthiobutanoic acid (HMB) under C. perfringens infected 
and uninfected situations. None of the methionine sources affected the growth of C. 
perfringens in the broiler GIT, however, infected birds needed more dietary methionine 
to achieve maximum growth when DLM, but not HMB, was included in the diet. 
Based on the overall findings it can be concluded that the dietary approaches 
tested in this project may support our efforts in the development of nutritional strategies 
to minimize the impact of C. perfringens on broiler production in an antibiotic free 
livestock industry. 
 
 
 
 
 
 
 
 
 
 
 
  
iv 
 
ACKNOWLEDMENTS 
I would first and foremost like to express my sincere gratitude and appreciation to my 
supervisor Dr. M. D. Drew, for all his advice, guidance and encouragement throughout 
the program. I am greatly thankful to Dr. A. G. Van Kessel, who took the time out to 
help me when I was in need. I would also like to thank Drs. B. Laarveld, H. L. Classen, 
M. Chirino-Trejo, and P. Leterme for serving on my advisory committee, and Dr. D. R. 
Korver for serving as my external examiner.    
I would like to acknowledge the Department of Animal and Poultry Science and 
College of Graduate Studies and Research for generous scholarships I received during 
my program. None of this research would have been possible without the financial 
support for this project from Natural Sciences and Engineering Research Council of 
Canada (NSERC) and Evonik-Degussa GmbH. I am very grateful for their involvement. 
I wish to express my sincere thanks to Monique Burmester, Paula Mason and all 
other employees at the Animal Care Unit where I conducted all my animal trials. I 
would also like to acknowledge the excellent technical assistance given to me by Jason 
Marshall. Thanks to my fellow graduate students for their substantial cooperation, 
support and friendship over the past few years. 
I would like to express my sincerest gratitude to my parents, Eddie and 
Somalatha Widyaratne for having sown in me the principles of discipline, respect and 
admiration for life. Finally but most importantly, I would like to thank my wonderful 
wife Dushmanthi, loving daughter Amaya and cute son Dinel. Thank you for your love, 
support and patience! Dushmanthi, you encouraged and convinced me to accept 
challenges I contemplated I would never succeed, and I too will always be there to 
support you in whatever targets you set out to accomplished. 
  
v 
 
 
DEDICATION 
With a great respect and heartfelt gratitude, this work is dedicated to my school Rahula 
College, Matara – Sri Lanka, and all my past teachers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
vi 
 
TABLE OF CONTENT 
 
PERMISSION TO USE ................................................................................................................. I 
ABSTRACT .................................................................................................................................. II 
ACKNOWLEDMENTS ............................................................................................................. IV 
DEDICATION .............................................................................................................................. V 
TABLE OF CONTENT .............................................................................................................. VI 
LIST OF TABLES ....................................................................................................................... X 
LIST OF FIGURES .................................................................................................................. XII 
1. INTRODUCTION ..................................................................................................................... 1 
2. LITERATURE REVIEW ......................................................................................................... 3 
2.1. Necrotic enteritis in broiler chickens....................................................................... 3 
2.1.1. The disease ........................................................................................................... 3 
2.1.2. The pathogen ........................................................................................................ 4 
2.1.3. Pathogenesis ......................................................................................................... 6 
2.1.4. Clostridium perfringens virulence factors ........................................................... 9 
2.2. Experimental induction of necrotic enteritis ........................................................ 14 
2.3. Clostidium perfringens and broiler growth performance .................................... 16 
2.4. Control using antibiotics ........................................................................................ 17 
2.5. Alternative strategies .............................................................................................. 19 
2.6. Predisposing factors ................................................................................................ 20 
  
vii 
 
2.6.1. Cereal type ......................................................................................................... 21 
2.6.2. Exogenous enzymes ........................................................................................... 25 
2.6.3. Non-nutritional ingredients ................................................................................ 28 
2.6.5. Feed processing and feeding .............................................................................. 30 
2.7. Dietary protein, amino acids and necrotic enteritis ............................................. 31 
2.7.1. Low protein diets................................................................................................ 35 
2.7.2. High protein diets ............................................................................................... 40 
2.7.3. Amino acid digestibility and availability ........................................................... 42 
2.8. Digestible amino acid values in broiler ration formulation ................................ 43 
2.9. Summary .................................................................................................................. 44 
3. EFFECTS OF PROTEIN LEVEL AND DIGESTIBILITY ON THE GROWTH 
AND CARCASS CHARACTERISTICS OF BROILER CHICKENS .................................. 47 
3.1. Abstract .................................................................................................................... 47 
3.2. Introduction ............................................................................................................. 48 
3.3. Materials and methods ........................................................................................... 49 
3.3.1. Experiment 1 ...................................................................................................... 50 
3.3.2. Experiment 2 ...................................................................................................... 51 
3.3.3. Chemical analysis............................................................................................... 59 
3.3.4. Calculations and statistical Analysis .................................................................. 59 
3.4. Results ...................................................................................................................... 61 
3.5. Discussion ................................................................................................................. 70 
4. EVALUATION OF MICROBIOLOGICAL, PATHOLOGICAL AND 
HEMATOLOGICAL PARAMETERS IN AN EXPERIMENTAL DISEASE 
MODEL FOR NECROTIC ENTERITIS IN BROILER CHICKENS RAISED ON 
LITTER ........................................................................................................................................ 76 
  
viii 
 
4.1. Abstract .................................................................................................................... 76 
4.2. Introduction ............................................................................................................. 77 
4.3. Materials and methods ........................................................................................... 79 
4.3.1. Birds and management ....................................................................................... 79 
4.3.2. Feed and feeding ................................................................................................ 80 
4.3.3. Preparation of innoculum ................................................................................... 80 
4.3.4. Experimental design and challenge procedure ................................................... 85 
4.3.5. Sample and data collection................................................................................. 87 
4.3.6. Whole-blood chemiluminescence assay ............................................................ 88 
4.3.7. Pathological examination ................................................................................... 89 
4.3.8. Genomic DNA extraction and purification ........................................................ 89 
4.3.9. Bacterial enumeration ........................................................................................ 92 
3.3.10. Statistical analysis ............................................................................................ 94 
4.5. Results ...................................................................................................................... 94 
4.6. Discussion ............................................................................................................... 100 
5. EFFECTS OF DIETARY PROTEIN LEVEL AND PROTEIN DIGESTIBILITY 
ON THE GROWTH PERFORMANCE AND INTESTINAL ECOSYSTEM OF 
BROILER CHICKENS INFECTED WITH CLOSTRIDIUM PERFRINGENS ................ 111 
5.1. Abstract .................................................................................................................. 111 
5.2. Introduction ........................................................................................................... 112 
5.3. Materials and methods ......................................................................................... 115 
5.3.1. Birds and management ..................................................................................... 115 
5.3.2. Experimental design ......................................................................................... 116 
5.3.3. C. perfringens challenge procedure ................................................................. 116 
5.3.4. Sample and data collection............................................................................... 117 
5.3.5. Pathological examination ................................................................................. 117 
  
ix 
 
5.3.6. Genomic DNA extraction and purification ...................................................... 118 
5.3.7. Bacterial enumeration ...................................................................................... 118 
5.3.8. Volatile fatty acid and ammonia analyses ........................................................ 118 
5.3.9. Statistical analysis ............................................................................................ 119 
5.4. Results .................................................................................................................... 120 
5.5. Discussion ............................................................................................................... 133 
6. ORAL CLOSTRIDIUM PERFRINGENS CHALLENGE AFFECTS THE 
METHIONINE REQUIREMENTS OF BROILER CHICKENS ........................................ 144 
6.1 Abstract ................................................................................................................... 144 
6.2. Introduction ........................................................................................................... 145 
6.3. Materials and methods ......................................................................................... 147 
6.3.1. Birds and management ..................................................................................... 147 
6.3.2. Dietary treatments ............................................................................................ 148 
6.3.3. C. perfringens challenge procedure ................................................................. 152 
6.3.4. Experimental design ......................................................................................... 153 
6.3.5. Sample and data collection............................................................................... 153 
6.3.6. Pathological examination ................................................................................. 153 
6.3.7. Genomic DNA extraction and purification ...................................................... 154 
6.3.8. Bacterial enumeration ...................................................................................... 154 
6.3.9. Statistical analysis ............................................................................................ 154 
6.4. Results .................................................................................................................... 154 
6.5. Discussion ............................................................................................................... 156 
7. GENERAL DISCUSSION ................................................................................................... 164 
8. REFERENCES ...................................................................................................................... 169 
 
  
x 
 
LIST OF TABLES  
 
Table 2.1. Characteristics of identified toxins of C. perfringens. .................................................. 7 
Table 2.2. Different methods employed for the experimental induction of necrotic 
enteritis in broiler chickens. .................................................................................................. 15 
Table 2.3. Effect of low crude protein diets on performance of broilers. .................................... 37 
Table 3.1. Ingredient composition of the starter diet used from 0 to 21d of age in Exp. 1. ......... 52 
Table 3.2. Ingredient and nutrient composition of the reference diet used in Exp.1.................... 53 
Table 3.3. Ingredient and nutrient composition of starter diets used in Exp. 2. ........................... 55 
Table 3.4. Ingredient and nutrient composition of grower diets used in Exp. 2. ......................... 57 
Table 3.5. Moisture (%), crude protein, ammonia and amino acid composition (% DM) 
and, apparent (AID) and standardized (SID) ileal digestibility (%) of amino acids in 
the test ingredients measured in 28-d old broiler chickens in Exp. 1. .................................. 62 
Table 3.6. Effect of the interaction between digestible protein level and protein 
digestibility on apparent (AID: DM and CP) and standardized (SID: AA) ileal 
digestibility (%) measured in 35-d old broiler chickens. ...................................................... 64 
Table 3.7. Effect of the interaction between digestible protein level and protein 
digestibility on standardized ileal digestible amino acid contents (%) measured in 
35-d old broiler chickens. ...................................................................................................... 65 
Table 3.8. Effect of the interaction between digestible protein level and protein 
digestibility on growth performance during starter, grower and overall periods of 
broiler chickens. .................................................................................................................... 66 
Table 3.9. Effect of dietary protein level and protein digestibility on breast muscle yield 
and accumulation of abdominal fat in broiler chickens in Exp. 2. ........................................ 69 
Table  4.1. Ingredient and nutrient composition of grower diet used for all birds from d 
14 to 35 of age in Exp. 1(as fed basis). ................................................................................. 81 
Table  4.2. Ingredient and nutrient composition of the grower diet used for all birds from 
d 14 to 28 of age in Exp. 2 (as fed basis). ............................................................................. 83 
Table 4.3. Experimental designs. ................................................................................................. 86 
Table 4.4. Intestinal gross lesion scoring system for necrotic enteritis. ....................................... 90 
Table 4.5. Effect of Clostridium perfringens challenge and mode of inoculation (oral 
gavage vs feed) on growth performance of broiler chickens in Exp. 1. ............................... 95 
  
xi 
 
Table 4.6. Effect of mode (water and feed) and dose of administration of Clostridium 
perfringens on growth performance of broiler chickens in Exp. 2. ...................................... 97 
Table 4.7. Effect of Closrtidium perfringens challenge and mode of pathogen 
administration on organism proliferation in the ileum and the cecum of broiler 
chickens at 28 and 35 d of age in Exp. 1. ............................................................................ 101 
Table 4.8. Effect of mode (water and feed) and dose of administration of Closrtidium 
perfringens on organism proliferation in the intestinal contents of broiler chickens 
at 28 d of age in Exp. 2. ...................................................................................................... 102 
Table 5.1. Effect of dietary protein level, protein digestibility and Clostridium 
perfringens challenge on growth performance of broiler chickens during a 35 day 
growth trial. ......................................................................................................................... 121 
Table 5.2. Effect of dietary protein level and protein digestibility on ileal Clostridium 
perfringens population and intestinal gross lesion score of broiler chickens on d 35 
of age. .................................................................................................................................. 125 
Table 5.3. Effect of dietary protein level, protein digestibility and Clostridium 
perfringens challenge on volatile fatty acid profile, total volatile fatty acid 
concentration (μmol/g) and ammonia concentration (mmol/g) in the ceca of broiler 
chickens at d 35. .................................................................................................................. 127 
Table 5.4. Effect of dietary protein level, protein digestibility and Clostridium 
perfringens challenge on molar ratio (% of total) of volatile fatty acid in the ceca of 
broiler chickens at d 35. ...................................................................................................... 131 
Table 6.1. Ingredient and nutrient composition of experimental diets to be fed from d8 
to 21 of age (% as-is basis). ................................................................................................ 149 
Table 6.2. Effect of different methionine sources and levels on intestinal lesion score 
and Clostridium perfringens populations in the ceca of broiler chickens on d 21 of 
age. ...................................................................................................................................... 155 
Table 6.3. The effect of methionine source and C. perfringens infection on the quadratic 
regression coefficients and calculated methionine requirements for ADG, ADFI and 
FCR in broiler chickens. ..................................................................................................... 157 
 
  
xii 
 
LIST OF FIGURES 
 
Figure3.1. Effect of dietary protein level and protein digestibility (A) and, growth phase 
(B) on the PER of broiler chickens used in Exp.2. .................................................. 68 
Figure 4.1. Mean intestinal gross lesion scores of NE in broiler chickens challenged 
with C. perfringens in an 8 h cooked meat broth, (A) using two modes (oral gavage 
or feed) at d28 and d35 of age in Exp. 1, and (B) using two modes (water or feed) at 
two dose rates (2 and 4 mL) at d28 of age in Exp. 2. . ............................................. 99 
Figure 4.2. Mean peak whole blood chemiluminesence detected in 28-d-old broiler 
chickens challenged with C. perfringens in an 8 h cooked meat broth, using two 
modes (water or feed) at two dose rates (2 and 4 ml) in Exp. 2. . .......................... 103 
Figure 5.1. Average daily gain (g/d) of broiler chickens during the grower period (Wk 
3: d15 – 21, Wk 4: d22 – 28, Wk 5: d29 – 35). ...................................................... 124 
Figure 5.2. Effect of C. perfringens challenge on the microbial butarate and total VFA 
production in caca of broilers fed different dietary treatments. ............................. 129 
Figure 5.3. Effect of C. perfringens challenge on the final body weight at d35 of broilers 
fed different dietary treatments  ............................................................................. 136 
Figure 6.1. The effect of methionine source and C. perfringens inoculation on the 
requirement of broiler chickens for methionine. .................................................... 158 
 
 
 
 
 
 
 
 
 
  
xiii 
 
LIST OF ABBREVIATIONS 
 
AA  Amino acid/s 
ADFI   Average daily feed intake 
ADG   Average daily gain 
AGP  Antibiotic growth promoter/s 
AI  Auto inducer/s 
AID  Apparent ileal digestibility 
BW  Body weight  
cfu  Colony forming units 
CP  Crude protein 
DLM  DL-methionine 
DM  Dry matter 
FCR  Feed conversion ratio 
FOS   Fructo oligosaccharides 
GIT  Gastrointestinal tract 
hCP  High crude protein 
HiDig  High digestible 
HiPro  High protein 
HMB  2-hydroxy-4-methylthiobutanoic acid 
lCP  Low crude protein 
LoDig  Low digestible 
LoPro  Low protein 
MBM  Meat and bone meal 
ME   Metabolizable energy 
  
xiv 
 
MOS   Mannan oligosaccharides 
MR  Molar ratio  
NE   Necrotic enteritis 
NSP   Non-starch polysaccharides 
PCR  Polymerase chain reaction 
PER  Protein efficiency ratio 
PMN   Polymorphonuclear cells 
PPC   Potato protein concentrates 
QS  Quorum sensing 
RLU  Relative light units 
ROS  Reactive oxygen species 
SID  Standardized ileal digestible/digestibility 
VFA   Volatile fatty acid/s 
WBCL  Whole blood chemiluminesence 
W-DDGS Wheat distiller’s dried grains with solubles 
  
1 
 
1. INTRODUCTION 
The gastrointestinal tract (GIT) of farm animals acts as a reservoir for the maintenance 
and proliferation of gut-specific pathogens capable of inducing diseases in both livestock 
and humans. Due to the concerns associated with growth performance, bird welfare and 
poultry product contamination, enteric pathogens are considered an important issue in 
the poultry industry. Consequently, the inclusion of antibiotic growth promoters (AGP) 
in poultry rations has been the main strategy for controlling enteric pathogens for many 
years. Nevertheless, there is an ongoing debate that the continued use of in-feed AGP 
may result in selection pressure for intestinal microbes that are resistant to certain 
antimicrobials (JETACAR 1999). In most cases, the drug resistance is encoded on 
plasmids which may be transferred to other bacteria even in the absence of selection 
pressure by antibiotics. Hence, the widespread use of antimicrobials, both as therapeutic 
agents and as AGP, is believed to have contributed to the increased incidence of 
bacterial resistance to antimicrobials in various human and animal pathogens (WHO 
1997; JETACAR 1999). Consequently, use of antibiotics in the livestock industry is 
closely monitored by all concerned parties; hence, a reduction or total ban on the use of 
in-feed antibiotics is expected to improve human and animal health, lowering the stress 
of antibiotic resistance (Ratcliff 2000).  
 Dietary incorporation of antibiotics in broiler ration formulation has been the 
commonly employed approach to control the proliferation of Clostidium (C.) 
perfringens, the causative organism responsible for the disease necrotic enteritis (NE) 
that leads to reduced productivity and severe economic losses to producers. However, a 
ban on growth-promoting antibiotic usage in the animal feed industry of some countries 
has resulted in a re-emergence of NE incidences in broiler chickens (Drouin 1999; 
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Kaldhusdal and Lovland 2000). Accordingly, with this ban on AGP in these countries 
and the potential for deterrence in other poultry producing countries, there is an earnest 
interest in finding alternative strategies to antibiotics to combat this hygienically and 
economically important pathogen. In this context, there has been increasing investments 
of both time and money to explore alternatives to keep the growth performance intact, 
while maintaining the health, safety and acceptability of the resultant product for human 
consumption (Ewing and Cole 1994). 
 With a total ban of AGP in animal feed industry, a change in the microbial 
ecosystem in the GIT of broilers would be inevitable (Knarreborg et al. 2002; 
Dumonceaux et al. 2006). Nevertheless, our understanding of the microbial ecosystem 
and its management is enriched by the recent research in this area. Accordingly, this 
advanced understanding of the microbial ecology of the GIT and associated management 
practices can potentially be utilized for a sustainable broiler industry, keeping 
threatening enteric bacterial infections like NE in broiler chickens in check. These 
approaches must address not only the cost and efficiency of production, but also the 
impact of health and diseases to both livestock and consumer. Thus, the experiments 
described herein were undertaken to study the interaction between dietary amino acids 
(AA) and gut C. perfringens populations and concomitant effects on the productivity of 
broiler chickens. 
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2. LITERATURE REVIEW 
2.1. Necrotic enteritis in broiler chickens 
2.1.1. The disease 
The disease NE was first reported in Australia (Bennetts 1930), but fully depicted in the 
United Kingdom in the early nineteen sixties (Parish 1961a, b, c). However, NE did not 
attract much attention until the recent past (van der Sluis 1997) and now it is a global 
threat to the entire poultry industry (van der Sluis 2000a, b; Van Immerseel et al. 2004). 
Broiler chickens of 17 or 18 days of age are most susceptible to this disease and 
overgrowth of the causative organism, C. perfringens, in the small intestine of affected 
birds leads to mucosal necrosis and acute diarrhea (Fukata et al. 1991; Ross 1999). 
Furthermore, entering into the portal circulation and biliary system, this pathogen 
instigates hepatitis and cholangio-hepatitis in broiler chickens (Lovland and Kaldhusdal 
1999, 2001; Sasaki et al. 2000). If immediate measures are not taken to treat and control 
the situation, mortality rates can reach 1% per day within a flock and up to 40% 
mortality in an affected flock can be expected (Boulianne 1999; Ross 1999). 
Nevertheless, the sub-clinical type of NE has a greater economic impact due to impaired 
productivity of a far greater number of birds and increased carcass condemnation at 
slaughter, due to the concealed nature of the disease (Prescott 1979; Stutz and Lawton 
1984; Kaldhusdal and Hofshagen 1992; Lovland and Kaldhusdal 1999, 2001). In 
addition, the existence of C. perfringens in poultry products is a public health concern, 
as well, due to the potential for food born infections (Van Immerseel et al. 2004). 
Necrotic enteritis has thus become one of the most important poultry diseases from both 
a productivity and health standpoint. 
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2.1.2. The pathogen 
William H. Welch first recovered Bacillus welchii in 1890 from a person who had died 8 
hours before as a result of a variety of complications (Lucey and Hutchins 2004). Based 
on microscopic characteristics, the organism was described as akin to anthrax bacilli, but 
having rods with boxed edges and often detected singularly or in pairs rather than 
chains. Later, the name was changed to Clostridium welchii and then again to the current 
C. perfringens (Gatsos 2007). This Gram-positive, rod-shaped, spore-forming and non-
motile microorganism is anaerobic in nature and widespread in the environment as well 
as the GIT of clinically infected and healthy birds (Hatheway 1990; Ficken and Wages 
1997). In addition, this microorganism is a common member of the intestinal microflora 
of most bird species (Asaoka et al. 2004). Previous studies (Hofacre et al. 2003) have 
categorized C. perfringens as an opportunistic pathogen owing to its ability to elicit the 
onset of NE under some circumstances.   
Several bacterial species have been identified as toxin producing, but none 
produce as many varieties as C. perfringens (Hatheway 1990). This pathogen can secrete 
a variety of toxins and enzymes which may act in a synergistic or additive manner to 
produce the associated lesions and symptoms in hosts (Awad et al. 1995; Stevens and 
Bryant 1997; Shimizu et al. 2002). Over a dozen toxins of C. perfringens have been 
documented so far and have been categorized into major and minor groups (Hatheway 
1990; Shimizu et al. 2002).  
Strains of C. perfringens are biologically grouped as A, B, C, D and E, according 
to the synthesis of four key toxins: α, β, ε and ι (Songer 1996; Petit et al. 1999). Mainly 
toxinotype A, but to a lesser degree type C are responsible for the clinical and 
subclinical versions of NE in poultry (Songer and Meer 1996; Engström et al. 2003). 
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Toxinotypes A and C both are able to synthesize α toxin, but type C produces β toxin 
besides α toxin (Petit et al. 1999), but the role of β toxin in the avian NE development 
process has not been fully elucidated yet. Toxinotypes B, D and E are not usually 
associated with poultry diseases (Van Immerseel et al. 2004). 
Even though the synthesis of these four major toxins has been the basis for the 
categorization of C. perfringens into the five toxinotypes, various strains still secrete a 
number of minor toxins and enzymes such as enterotoxin (CPE), β2 toxin, perfringolysin 
O (θ-toxin) and collagenase (κ-toxin).  
Some C. perfringens toxinotypes, predominantly type A, synthesize CPE at the 
sporulation stage, causing gastroenteritis in humans (Narayan 1982; Ridell et al. 1998; 
Sarker et al. 1999). This enterotoxin is the only toxin not secreted from vegetative C. 
perfringens cells (Rood 1998). However, only about 10% of C. perfringens type A 
derived from poultry carry the enterotoxin encoding gene, cpe (Tschirdewahn et al. 
1992), and the position of enterotoxin in the development of NE has not been elucidated.  
Clostridium perfringens produce β2 toxin that may play a role in pathogenecity 
of NE (Petit et al. 1999). However, Tschirdewahn et al. (1992) did not observe a 
correlation between β2 toxin production and incidence of NE. Similar observations were 
reported by a number of subsequent studies (Chalmers et al. 2007, 2008a, 2008b; Crespo 
et al. 2007; Thompson et al. 2006), providing clear evidence that β2 toxin is not a critical 
factor for inducing NE in broiler chickens. A recently identified pore-forming toxin with 
partial homology to beta-toxin, NetB, has demonstrated to play a significant role in the 
pathogenesis of NE in broiler chickens (Keyburn et al. 2008). This study demonstrated 
that a netB mutant was incapable of producing NE in an experimental disease model and 
that virulence was re-established with the complementation of the mutation by a 
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functional netB gene. Nevertheless, 22% of the NE-causing strains of C. perfringens 
tested in this study were negative for netB, indicating the existence of NetB might not be 
vital for all C. perfringens isolates to elicit NE in broiler chickens. Moreover, Chalmers 
et al. (2008b) did not detect netB in all isolates from chickens affected with NE. These 
findings suggest that NetB toxin appeared to be a critical, but not an essential, virulent 
agent in the induction of avian NE caused by C. perfringens. In an earlier study with 
chickens, Keyburn et al. (2006) did not observe a positive correlation between in vitro θ-
toxin production of C. perfringens and the severity of NE. Thus, the majority of toxins 
secreted by this pathogen do not appear to be associated with the development of clinical 
NE. The characteristics of identified toxins synthesized and secreted by C. perfringens 
are shown in Table 2.1. 
 
2.1.3. Pathogenesis 
Clostridium perfringens is typically resident in the GIT of avian species, including 
chickens (Gazdzinski and Julian 1992; Branton et al. 1997) and can be recovered in high 
numbers from almost every section of the GIT of presumably healthy birds (Ficken and 
Wages 1997; Engberg et al. 2002; Pedersen et al. 2003). Despite the fact that 75 – 95% 
of birds are colonized by C. perfringens, the mere existence of the organism in the GIT 
does not inevitably causes NE in broiler chickens (Shane et al. 1984; Kaldhusdal et al. 
1999; Craven et al. 2001; LaRagione and Woodward 2003). This can be attributed either 
to the total absence of NE-producing strains of C. perfringens in the GIT of birds or 
maintenance of dominance by non-NE strains over the NE-producing strains in the 
normal intestinal flora. However, the domination of non-NE strains suppressing the 
growth of NE-producing isolates of C. perfringens in the normal intestinal flora is 
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Table 2.1. Characteristics of identified toxins of C. perfringens. 
Toxin type Produced by Biological activity 
Major toxins   
α-toxin All types Phospholipase C, lecithinase and sphingomyelinase activity, hemolytic, 
cytolytic (platelets, leukocytes), dermonecrotic 
   
β-toxin Types B and C Cytolytic to human leukaemia 60 cell line, increases capillary permeability, 
increases blood pressure, decreases heart rate, neurotoxic 
   
ε-toxin Types B and D Protoxin – requires trypsin activation, induces neurotransmitter release resulting 
in hippocampal damage, able to pass blood/brain barrier, cytotoxic for Madin-
Darby canine kidney cell line, increases vascular permeability thus enhancing 
its own uptake in intestinal wall, causes swollen hyperaemic kidneys, edemic 
lungs, excess pericardial fluid 
   
ι-toxin Type E Binary toxin: Ia and Ib, protoxin requiring trypsin for activation, Ia; ADP-
ribosylating enzyme, Ib; binding and translocation, increases vascular 
permeability, dermonecrotic on intradermal and lethal on i.v injection 
   
NetB toxin Type A Pore forming 
   
Minor toxins   
θ – toxin All types Perfringolysin-O, haemolysin, cytolysin, O2-labile 
   κ – toxin All types Collagenase/gelatinase activity 
   μ – toxin Types A, B, C and D Hyaluronidase activity 
   λ – toxin Types B, D and E Protease activity 
   ν – toxin All types DNase activity 
   δ – toxin Types B and C Haemolysin activity 
   α – clostripain like protease Type A (not yet tested 
for other types) 
Cysteine protease activity 
   Neuraminidase/Sialidase All types N-Acetylneuraminic acid glycohydrolase activity 
Sources: Hatheway (1990), Shimizu et al. (2002), Gatsos (2007) and Keyburn et al. (2008)  
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dubious, because Barbara et al. (2008) reported that normal flora strains do not inhibit 
each other or any NE-producing strains of C. perfringens residing in chicken GIT. On 
the other hand, if NE-producing strains are present, even in undetectable small numbers, 
in the GIT of healthy birds, it is against the Koch’s postulate that a pathogenic strain 
should not be present in healthy individuals. 
In general, NE-associated lesions cannot be observed in birds inoculated 
experimentally with C. perfringens strains from the normal flora. However, taking 
selective advantage under appropriate conditions, NE-producing pathogenic strains of C. 
perfringens expel non-pathogenic strains from the intestinal tract of affected birds 
(Barbara et al. 2008). The pathogenic strains of C. perfringens suppress the proliferation 
of other NE-causing strains, in addition to growth inhibition and displacement of non-
NE strains, a feature not detected in the normal flora strains (Barbara et al. 2008). Later, 
using 26 non-NE strains and 24 NE-producing strains in an in vitro experiment, 
Timbermont et al. (2009) reported that 58% of the non-NE strains and 17% of NE-
producing strains were not successful in suppressing the proliferation of other C. 
perfringens isolates.  As per the results from pulsed-field gel electrophoresis, normal 
birds harbor a variety of C. perfringens clones, but birds with NE carry only one or two 
clones (Engström et al. 2003; Nauerby et al. 2003). Using C. perfringens isolates from 
broiler chickens without clinical problems and from birds suffering from NE, 
Gholamiandekhordi et al. (2006) reported similar observations. These findings suggest 
that NE in poultry is caused only by certain strains of C. perfringens bearing specific 
characteristics and NE-producing strains can selectively exclude the non-pathogenic 
strains. The reason for the selective proliferation of a clone in case of NE in poultry is 
still obscure. However, this phenomenon can, entirely or in part, be attributed to factors 
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such as better adhesion capabilities, faster proliferation, and synthesis of certain toxins 
and/or substances that selectively suppress the growth of the non-NE strains and other 
NE-producing strains of C. perfringens (Barbara et al. 2008; Timbermont et al. 2009). 
 
2.1.4. Clostridium perfringens virulence factors 
Upon inoculation of C. perfringens-derived α - toxin, NE-associated lesions and 
mortality were observed in regular (Al-Sheikhly and Truscott 1977a,b) as well as 
gnotobiotic (Fukata et al. 1988) chickens. Besides, Fukata et al. (1988) observed the 
neutralization of the particular effect of α - toxin by anti-α - toxin serum. These and 
subsequent studies led the researchers to conclude that, being the main toxin produced 
by C. perfringens, α - toxin must be the key virulent determinant of NE in broilers. 
Accordingly, α - toxin attracted much attention in the pathogenesis of avian NE and 
studies conducted over three decades have been the principal testimonies to validate the 
suggested role of α - toxin as the most potent virulence agent in the pathological process 
of NE in broiler chickens. 
Being a phospholipase C sphingomyelinase, α - toxin breaks down membrane 
phospholipids and thus, disrupts cellular structure (Naylor et al. 1998; Titball et al. 
2000). Diacylglycerol is formed as a result of membranous lecithin hydrolysis, leading 
to the activation of protein kinase C, which in turn stimulates the arachidonic acid 
pathway. This prompts the production of a variety of inflammatory mediators (Titball 
1993; Bunting et al. 1997). Some physical conditions initiated due to the effects of these 
mediators can cause the death of the host.   
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The expression of the α - toxin gene has been considered as one of the 
fundamental steps in the initiation of NE. Differential gene expression can be attributed 
to the variances in the level of α - toxin, although definitive proof that NE is associated 
with an upregulation of C. perfringens α - toxin has not been demonstrated. A two 
component regulatory system, VirR/VirS, controls the genes of extracellular toxin 
synthesis of this pathogen (Ba-Thein et al. 1996). Acting as a sensor histidine kinase, 
VirS phosphyorylates VirR in response to a local signal. Upon phosphorylation, VirR 
regulates transcription of specific genes, including cpa, as seen in other two component 
regulatory systems (Rood and Cole 1991). In their review, McDevitt et al. (2006) 
speculate that expression of cpa by C. perfringens is down-regulated in the normal 
healthy gut, and in response to an environmental signal, is upregulated to initiate enteric 
disease. Nevertheless, based on the observations reported by Barbara et al. (2008), C. 
perfringens strains of the normal intestinal flora are incapable of executing the clinical 
disease.  
The nature of the environmental signal is less clear, although evidence suggests 
that quorum sensing (QS) may regulate toxin production by C. perfringens (Novak and 
Fratamico 2004). Many bacteria coordinate gene expression within as well as between 
species by synthesizing, secreting, detecting and responding to signaling molecules. 
These molecules are named as auto inducers (AI), the extracellular concentration of 
which is correlated to the bacterial cell density (Neaslon 1977; Neaslon and Hastings 
1979). This phenomenon of QS is employed by certain bacteria including C. 
perfringens. Each bacterial species synthesizes and reacts to a specific AI (Lu et al. 
2005). For instance, Gram-negative QS bacteria commonly utilize homoserine lactones, 
while various oligopeptides act as AI for Gram-positive organisms. A novel AI, termed 
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AI-2, has been discovered and shown to comprise a furanosyl borate diester (Chen et al. 
2002). The gene luxS regulates the synthesis of AI-2 from S-adenosyl methionine (SAM: 
Xavier and Bassler 2003); hence all bacterial species with luxS synthesis AI-2 using the 
same biosynthetic pathway. Accordingly, this system has been suggested to be a 
universal signal for inter-species cell-cell communication (Mok et al. 2003). Some 
studies found the regulation of a range of ‘niche-specific’ genes by AI-2 in a wide 
variety of bacterial species (Surette et al. 1999; Miller and Bassler 2001). In C. 
perfringens, regulatory functions like the control of toxin production are associated with 
the luxS gene (Ohtani et al. 2002). Secreted AI-2 binds to luxP, a periplasmic binding 
protein, which, through a phosphorelay system of kinase activations, ultimately leads to 
changes in expression of the α-toxin gene, cpa.  
Based on these observations, C. perfringens appears to be regulated in a QS 
manner, using either oligopeptides or AI-2, or both to regulate expression of the cpa 
gene, and thereby the production and secretion of α-toxin. Oligopeptide AI are species 
specific whereas AI-2 can act as an inter-species inducer owing to its universal 
characteristics. This brings up an interesting possibility regarding the initiation of NE in 
poultry. Synthesis of the oligopeptide AI is a response to focal population density of C. 
perfringens, however the response to AI-2 could be due to a critical population of a 
different bacterial species. Accordingly, interspecies communication and interaction in 
the GIT may be attributed to the initiation of NE in broiler chickens. In this scenario, 
cell-cell interaction would be a novel concept for the induction of enteric diseases.  
Despite numerous research efforts to justify α - toxin as the key virulent 
determinant in the pathogenesis of NE, the validity of this concept has been challenged 
by a number of studies. Using C. perfringens isolates derived from clinically healthy 
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birds and from birds diagnosed as undergoing NE, Gholamiandekhordi et al. (2006) 
demonstrated that in vitro α - toxin production of C. perfringens was not positively 
correlated with the clinical outcome. Similarly, Keyburn et al. (2006) did not observe a 
correlation between severity of NE and in vitro α - toxin production. One can argue that, 
under in vitro circumstances it is very difficult to provide the exact conditions which 
mimic the conditions of the predilection sites of the respective organism. Therefore, 
interactions between the members of intestinal microflora and between the causative 
organism and the host, and the surrounding environment are limited, which in turn can 
lead to the lack of the QS regulation of the pathogen. However, another study found that 
in vivo α - toxin level as well, was not correlated with the intestinal lesion score of 
affected birds (Wilkie et al. 2006). In contrast, some studies reported a direct correlation 
between in vitro α - toxin production and, C. perfringens count and the clinical disease 
status of broilers (Hofshagen and Stenwig 1992; Dahiya 2007). With these conflicting 
results, it seems clear that production and level of α - toxin cannot be used as indicators 
to differentiate the strains from NE and strains from clinically healthy chickens. 
Keyburn et al. (2006) was able to induce NE in broiler chickens using defined 
chromosomal cpa mutants of a pathogenic C. perfringens strain isolated from poultry. 
Microscopic and macroscopic lesion comparison did not show noticeable differences 
between regular and mutant challenged groups. This study provides definitive evidence 
that α - toxin is not a key pathogenic determinant in the development of NE in broilers. 
Consequently, further work in the same lab reported the isolation and 
characterization of a novel pore-forming toxin, NetB, from avian C. perfringens strains 
(Keyburn et al. 2008). This study demonstrated that netB mutant was non-pathogenic in 
a chicken disease model and the virulence was re-established with the complementation 
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of the mutation by the regular netB gene. However, all NE-producing strains tested in 
this study were not essentially netB positive. In addition, findings of later studies 
(Chalmers et al. 2008b; Martin and Smyth 2009) revealed that NetB was not an essential 
virulent factor in the pathogenesis of NE in poultry.      
As previously described, α - toxin, being a phospholipase, promotes 
disorientation of the cellular membrane thus instigates tissue necrosis in the intestinal 
mucosal epithelium (Taguchi and Ikezawa 1976; Hofshagen and Stenwig 1992). 
Nevertheless, a new etiological point for the development of NE in broiler chickens was 
revealed by Olkowski et al. (2008), based on ultra-structural and molecular changes in 
the intestinal tissue. The authors first discovered the secretion of several potent 
collagenolytic enzymes by C. perfringens strains isolated from field outbreaks of NE 
and then observed high levels of a number of collagenolytic enzymes in the intestinal 
tissues of the broilers challenged with field isolates of pathogenic C. perfringens strains. 
Using immuno-histochemistry, the study confirmed the expression of a collagenolytic 
enzyme at high levels in mucosal tissue affected with NE. This reveals a pathogen-host 
interaction in the pathological process of NE in broiler chickens, wherein C. perfringens 
appears to persuade the host’s collagenases to elicit intestinal tissue damage. This study 
demonstrated that the baso-lateral membranes of mucosal epithelial cells were disrupted 
by collagenolytic enzymes whereas the apical membranes appeared unharmed even in 
progressive phases of the disease. These findings suggest that the damage caused by α - 
toxin to the intestinal epithelial cell membrane, is not an integral part in the pathogenic 
process of NE. 
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Αlpha toxin derived from C. perfringens strains from chickens displaying clinical 
signs of NE demonstrates high homology to the α - toxin from mammalian strains which 
mediate gas gangrene (Sheedy et al. 2004). Despite this similarity (> 98% identity), 
contradictions in terms of immune response are associated with the role of α - toxin in 
the induction of mammalian gas gangrene and NE in broiler chickens. Substantial 
leukostasis with little inflammatory infiltration can be observed in the affected tissues in 
gas gangrene (Flores-Diaz and Alape-Giron 2003). In contrast, extensive immune cell 
infiltration can be detected in affected tissues in NE, revealing the differences in 
etiologic processes of the two diseases, or possibly differences in host immune function 
and/or response. 
 
2.2. Experimental induction of necrotic enteritis 
Several approaches to reproduce NE in broiler chickens have been documented in the 
literature. Nevertheless, no widely recognized disease model exists to induce NE 
experimentally in broiler chickens (Kaldhusdal et al. 1999). Several methods have been 
described in the literature but little information about their repeatability is available 
(Williams et al. 2003). Such methods are listed in Table 2.2. However, numerous efforts 
made to reproduce NE experimentally in different facilities have resulted in inconsistent 
findings, ranging from no clinical signs or lesions to typical clinical symptoms and 
lesions in most of the challenged birds. In fact, recent attempts to induce NE 
experimentally in broiler chickens were less successful than earlier experimental work. 
This can be attributed to the significant changes that took place over the subsequent time 
period in the major determinants of pathogenesis of the disease, the virulence of the 
pathogen, the host resistance and the respective environment. Accordingly, it appears  
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Table 2.2. Different methods employed for the experimental induction of necrotic 
enteritis in broiler chickens. 
Method Reference  
Rearing of birds on C. perfringens infected 
poultry-house litter 
Maxey and Page 1977; Wicker et al. 1977; 
Hamdy et al. 1983; Cowen et al. 1987; 
Kaldhusdal et al. 2001 
Oral administration of C. perfringens  
 
 
       in feed Long and Truscott 1976; Prescott 1979 
       in drinking water Jansson et al. 1990; Takeda et al. 1995 
       by gavage Bernier et al 1977; Baba et al. 1997; Répérant 
and Humbert 2002; Wilkie et al. 2005; Dahiya 
et al. 2005, 2007a,b 
Intravenous administration of C. perfringens Bernier and Filion 1971; Bernier et al. 1977 
Inoculation of C. perfringens  
       into the canuulated duodenum Truscott and Al-Sheikhly 1977 
       into the cloaca Williams et al. 2003 
Infusion of crude toxins of C. perfringens into 
the duodenum 
Truscott and Al-Sheikhly 1977 
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that current broiler strains are less susceptible to NE compared to past broiler genotypes 
(Olkowski et al. 2006). Here, the possible efforts made by primary breeding companies 
in eliminating undesirable traits may have contributed to the improved resistance of the 
current broiler genotypes. In addition, changes in the pathogen that may have occurred 
over the last three decades could have prompted a reduction in the degree of 
pathogenecity. 
 
2.3. Clostidium perfringens and broiler growth performance 
The clinical version of NE leads to increased mortality owing to the acute effect of 
toxins produced by C. perfringens (Kaldhusdal and Lovland 2000). However, in the sub-
clinical form, damage caused by the toxins to the intestinal tissue and associated organs 
(liver) leads to inferior growth performance of birds in an affected broiler flock 
(Elwinger et al. 1992; Hofshagen and Kaldhusdal 1992; Lovland and Kaldhusdal 1999; 
Kaldhusdal et al. 2001; Hofacre et al. 2003). Knarreborg et al. 2002, reported the 
expression of bile salt hydrolase activity in C. perfringens recovered from the chicken 
gut, which, may impair fat digestion by reducing the emulsification of dietary lipids. 
Accordingly, this pathogen may negatively affect broiler growth performance by de-
conjugating bile acids and hindering the absorption of dietary lipids and fat-soluble 
vitamins. Efficient fat digestion and absorption is vital for optimum broiler growth 
performance, because the lipid fraction of the diet contributes towards a considerable 
share of dietary energy and other important nutrients. Moreover, bile salts are 
antibacterial in nature (Inagaki et al. 2006), thus the hydrolysis of bile salts by C. 
perfringens may lead to impaired broiler growth performance, due to increased intestinal 
microbial activity.   
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The real economic cost caused by C. perfringens to the poultry industry is hard 
to assess. The cost of control methods for all infectious diseases in poultry in the USA 
has previously been estimated as almost $3 billion per annum (Shane and Van der Sluis 
2002).  About a decade ago the cost of the sub-clinical form of NE alone believed to be 
$0.05 per bird in the US with an annual global loss of almost $2.6 billion (Van der Sluis 
2000a). Nevertheless, the economic impact of sub-clinical NE may be much higher in 
current production situations. There is little data available on the economic cost of NE to 
countries within the EU, however, highly infected broiler flocks have brought the profits 
down by 33% when compared to flocks with low levels of the disease (Lovland and 
Kaldhusdal 2001). Accordingly, economic cost of NE is difficult to estimate but both 
clinical and sub-clinical forms of the disease have a significant impact on the economics 
of current broiler production.  
 
2.4. Control using antibiotics 
Antibiotics are used in animal production for a variety of purposes, including therapy, 
disease prevention and improvement of productivity. In addition, AGP enhance the food 
safety by reducing food-borne pathogens in the GIT of poultry (Stanley et al. 1994; 
Verstegen and Williams 2002). Prophylactic use of certain antibiotics in feed as growth 
promoters for an extended period of time is a general practice in the poultry industry. 
The exact mechanism by which AGP exert their performance enhancing effect is still 
obscure. The observed effects are assumed to be the result of 1) prevention of sub-
clinical bacterial infections, 2) reduction of bacterial metabolites and toxins in the GIT, 
3) reduced competition for nutrients by gastrointestinal microorganisms, 4) optimization 
of nutrient absorption and utilization by promoting the gut health or 5) reduction of 
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microbial metabolism of essential nutrients (François 1962; Visek 1978b; Yokoyama et 
al. 1982; Gaskins et al. 2002). Use of AGP in broiler rations accounts for 3–5% 
improvement in growth as well as feed conversion ratio (FCR; Thomke and Elwinger 
1998). Based on the assessment of the Animal Health Institute of America, without the 
use of AGP in poultry rations, the USA would require an additional 452 million 
chickens to reach the levels of production achieved with AGP (AHI 1998).  
The use of most AGP results in a significant decrease in the occurrence of NE in 
poultry, compared to non-medicated counterparts (Dahiya et al. 2006). Traditionally, 
main NE prevention strategies have taken the form of in-feed AGP such as 
virginiamycin, bacitracin, tylosin, lincomycin, avoparcin and penicillin (Maxey and 
Page 1977; George et al. 1982; Stutz and Lawton 1984; Hofshagen and Kaldhusdal 
1992; Ficken and Wages 1997; Watkins et al. 1997). Nevertheless, use of AGP applies 
selection pressure on bacteria to acquire resistance via genetic mutations (Walsh 2000). 
This acquired resistance may be transferred horizontally and vertically across bacterial 
strains (Davies 1994; Shoemaker et al. 2001), particularly a cross-resistance between the 
AGP virginiamycin and the human antibacterial agent quinopristin/dalfopristin 
(Wegener et al. 1999) and the cross-resistance of the AGP avoparcin with human 
antibiotic vancomycin in Enterococcus faecium (Aarestrup et al. 2000). In this scenario, 
broiler producers have come under increasing pressure to reduce or eliminate in-feed 
antibiotics and to curtail prophylactic application of these antimicrobials despite their 
evident benefits. Consequently, national policies have lead to a ban of AGP in the 
poultry industry, first in Scandinavian countries followed by the European Union. While 
these products are still allowed in feeds in North America, recently President Obama has 
announced that his administration will pursue the banning of the routine use of 
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antibiotics in animal production (New York Times, July 13, 2009). A total ban on usage 
of antimicrobials in livestock industry has been estimated to cost about US$ 1.2–2.5 
billion annually to US consumers (Gill and Best 1998). Thus, a considerable interest 
exists in the development of alternative non-antibiotic means for the control of gut-
specific pathogens, particularly, C. perfringens in broilers.  
 
2.5. Alternative strategies 
Pathogen reduction, nutritional approaches and biologicals such as vaccines and 
probiotics are considered to be the three main basic areas in controlling NE in broilers 
raised without in-feed antibiotics (Revington 2002). Pathogen reduction can be 
accomplished through the introduction of comprehensive biosecurity and hygienic 
practices. Surprisingly, there are no recent reports of the effectiveness of this approach 
in managing NE. Effective vaccines against C. perfringens have proved difficult to 
produce and there are currently no commercial vaccines for the prevention of NE in 
broilers. Research in this area appears promising, however. Both recombinant live oral 
(Thompson et al. 2006; Zekarias et al. 2008; Kulkarni et al. 2010), and recombinant 
subunit (Jiang et al. 2009) vaccines have been investigated as methods for preventing 
clinical NE. Probiotics have also been investigated with some success (Hofacre et al. 
1998; Craven et al. 2000; McReynolds et al. 2009). These approaches appear promising 
and commercial products may become available in the next decade. Several alternative 
strategies for the control of NE in broilers have been discussed in a recent review by 
Dahiya et al. (2006), including (1) direct-fed microbials (undefined microbial cultures 
and probiotics), (2) prebiotics, (3) organic acids, (4) plant products and essential oils, (5) 
feed enzymes, (6) hen egg antibodies, (7) vaccination, (8) anticoccidial vaccination, (9) 
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bacteriophages and (10) diet formulation and ingredient selection. To date none of these 
strategies have yielded control equivalent to in-feed antibiotics for the control of NE in 
broilers.  
 Currently, there is a widespread interest in using antimicrobials from natural 
sources as replacements or alternatives to conventional antibiotics. These include 
lysozyme from hen egg white, lactoferrin and lactoferricin B from milk and protamine 
from fish, molecules with well characterized antimicrobial activity and which are 
available commercially. These antimicrobials have a wide spectrum of activity and are 
effective against Gram-positive bacteria including C. perfringens (Bellamy et al. 1992; 
Teraguchi et al. 1995; Truelstrup et al. 2001; Masschalck and Michiels 2003). 
Nevertheless, attempts to control NE with these antimicrobials have not been successful 
so far due to the fact that a loss in activity during transit through the digestive tract, 
leading to insufficient delivery to affected sites and to the target organism. Therefore, 
experiments are underway to develop potential delivery system for these antimicrobials. 
 
2.6. Predisposing factors 
Many factors have been documented as predisposing poultry to the development of 
clinical signs and lesions of NE. These identified predisposing factors fall into two broad 
categories; management- and diet-associated. Still, the documented list of risk factors is 
most likely far from complete. Moreover, the contribution of the predisposing factors 
towards the overgrowth of the pathogenic strains and hence the subsequent progression 
of disease is poorly elucidated and experimental results have been conflicting. For 
instance, Olkowski et al. (2006) did not observe an increase risk of NE in broiler 
chickens with either dietary- or management-associated predisposing factors when the 
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perceived factors were introduced individually. Therefore, the likelihood of developing 
NE in a poultry flock possibly depends on interactions between these various factors, 
which further bolster the concept of multifactorial pathogenesis of NE.  
Management-related predisposing factors include concurrent or prior infections 
with enteropathogenic agents, coccidia in particular (Cowen et al. 1987; Baba  et  al. 
1992a,b; Williams et al. 2003), stress factors such as transportation, high stocking 
density, litter conditions, sudden changes in the diet, sudden environmental changes and 
immunecompromising agents like cyclophosphamide (Truscott and Al-Sheikhly 1977; 
Cowen et al. 1987; Stuve et al. 1992; Kaldhusdal et al. 1999; Lovland et al. 2003), and 
absence of in-feed AGP. In addition, introduction of a new strain of C. perfringens via a 
vector such as house-hold flies is another important management-associated 
predisposing factor since the consumption of flies or fly excretory deposits can cause NE 
in broiler chickens (Dhillon et al. 2004). Nevertheless, diet related risk factors of NE 
have seized much attention, especially with the withdrawal of antibiotics from broiler 
diet, due to their substantial role in the pathogenesis of NE, thus will be discussed 
widely herein.  
 
2.6.1. Cereal type 
Cereal grains normally represent the largest proportion of poultry diets giving them a 
large potential to influence gut function and intestinal microbiota. Many studies have 
reported a lower prevalence and intensity of NE in broilers fed corn-based diets than in 
birds fed diets based on other cereal grains, such as wheat, barley, rye or oats (Branton et 
al. 1987; Kaldhusdal and Hofshagen 1992; Riddell and Kong 1992; Kaldhusdal and 
Skjerve 1996; Branton et al. 1997; Annett et al. 2002; Kocher 2003). Feeding C. 
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perfringens-inoculated feed for periods of 1 to 5d, starting at 14 to 18d of age, Riddell 
and Kong (1992) compared NE-associated mortality in broiler chickens fed corn, wheat, 
rye or barley based diets. They reported a mortality rate ranging from 26 to 35% in birds 
fed wheat, rye or barley-based diets compared to a mortality rate reached only 12.5% in 
birds fed the corn-based diet.  
 Kaldhusdal and Skjerve (1996) evaluated feed formulation data for a period of 
20 years and reported two considerable episodes of NE in Norway during years with 
high inclusion of wheat and barley in broiler formulations. They reported a significant 
direct relationship between the development of NE and the ratio of wheat plus barley to 
corn fed in the country. Using broiler chickens infected with C. perfringens, Craven 
(2000) reported an increase in the pathogen numbers in the distal gut and droppings of 
birds fed a diet containing 50% rye, from log10 3.4 to log10 7.1 – 7.9 with the progression 
of age from 2 to 21d. Conversely, C. perfringens numbers in all segments of the GIT of 
birds fed a corn-based diet remained constant during this time period. In a more recent 
study, Jia et al. (2009a) inoculated broilers fed corn- or wheat-based diets with C. 
perfringens at d 13 of age for 16h and observed significantly higher pathogen counts and 
intestinal lesion scores in broilers fed wheat-based diet than in birds fed corn-based diet. 
However, NE-associated mortality was not different between the two treatment groups. 
In another study in the same lab (Jia et al. 2009b), broilers fed wheat/soybean meal and 
wheat/flaxseed meal were inoculated with C. perfringens at d 14 of age for 16h and the 
final body weight (BW), intestinal C. perfringens numbers, NE lesion scores and 
mortality were compared. Pathogen numbers, intestinal lesion score and NE-associated 
mortality were higher in birds fed wheat/flaxseed meal than in birds fed wheat/soybean 
meal. Flaxseed contains approximately 280 g kg
-1
 carbohydrates, with around one third 
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of the fibre being water-soluble mucilage (Oomah et al. 1995). Mucilage has been 
reported to cause the proliferation of intestinal microflora (Alzueto et al. 2003; Langhout 
et al. 1999) and may contribute to increased NE-associated mortality in broilers.  
 While the observation that diets based on corn decrease the development of NE 
has been widely reported, the mechanism(s) underlying this reduced incidence have not 
extensively been evaluated. Several hypotheses have been suggested. One hypothesis 
suggests that the cell wall- associated non-starch polysaccharides (NSP) such as 
arabinoxylans (wheat, rye and triticale) and β-glucans (barley and oats) may increase the 
enteric bacterial proliferation and toxin production by reducing the mixing of intestinal 
contents and creating a barrier between nutrients and the intestinal epithelium (Choct et 
al. 1996; Langhout et al. 1999; Hubener et al. 2002). This may result in decreased 
efficiency of nutrient digestion and absorption by the host and increased intestinal transit 
time, which in turn increases nutrient availability to enteric pathogens. Moreover, 
digesta viscosity may induce intestinal mucus secretion by the host (Larsen et al. 1993; 
Langhout et al. 1999; Piel et al. 2005) possibly leading to increased proliferation of 
mucolytic bacteria in the GIT (Langhout et al. 1999). Deplancke et al. (2002) reported a 
significant acidomucolytic ability of C. perfringens and observed a faster proliferation of 
the pathogen on a medium that contain mucin. Consequently, Collier et al. (2003) 
suggested that the growth of this pathogen in the GIT might be supported by high mucus 
secretion linked with diet and intestinal infections. Corn contains negligible levels of 
NSPs (Choct et al. 1996) and this may explain why it has lesser effect on broiler growth 
performance and intestinal C. perfringens numbers compared to other main cereal grains 
(Chesson 2001).  
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Other hypotheses have also been put forth to explain the mechanism associated 
with reduced effects of corn-based diets on NE in broilers. Riddell and Kong (1992) 
compared the NE-associated mortality of broilers fed a corn-based diet with or without 
an added carbohydrate source (glucose) and observed an increase in mortality rate upon 
inclusion of glucose to the diet. They hypothesized that compared to carbohydrates in 
other main cereal grains, lower availability of those in corn for microbes may limit the 
intestinal microbial activity. Annett et al. (2002) hypothesized that certain unknown 
constituents present in wheat and barley may impair the activity of host digestive 
enzymes, hindering the degradation of α-toxin thus triggering the intestinal C. 
perfringens proliferation and/or α-toxin synthesis. They conducted an in vitro 
experiment in which supernatants originating from either digested or non-digested 
broiler rations based on corn, wheat or barley were mixed with thioglycollate broth. No 
significant differences were observed in C. perfringens growth among non-digested 
diets. However, C. perfringens growth in the digested corn diet was significantly lower 
than in the respective barley and wheat diets. These findings suggest that digestive 
enzymes play role in NE pathogenesis by releasing or activating one or more elements 
from corn to suppress or from wheat and barley to stimulate the C. perfringens 
proliferation in the avian GIT.  In contrast, Branton et al. (1996) observed a suppression 
of C. perfringens proliferation in thioglycollate broth upon addition of wheat extracts 
with compared to deionized water. However, prior digestion of the wheat was not used 
in this experiment and the release of nutrients and other inhibitory factors may have 
been absent due to the lack of enzymatic breakdown. Williams (1992) correlated the 
nutritional characteristics of cereal types to one of the predisposing factors of NE to 
explain the different proliferation rates of C. perfringens in birds fed corn- and wheat-
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base diets. The author hypothesized that the higher vitamin A and E concentrations in 
corn than in wheat might reduce the pathogenicity of E. tenella and higher niacin and 
riboflavin concentrations in wheat compared to corn may increase its’ pathogenicity. 
Growing C. perfringens in supernatants derived from wheat and corn, 
Christianson (2011) demonstrated higher pathogen proliferation in wheat supernatant 
than in corn supernatant. However, the alpha toxin production per cfu was significantly 
lower when the pathogen was grown in wheat supernatant compared to corn supernatant. 
Nevertheless, since no indication on the toxin concentration in each supernatant used in 
this study, it would be hard to correlate these observations to C. perfringens 
pathogenicity. 
 
2.6.2. Exogenous enzymes 
As previously stated, increased digesta viscosity created by some NSP components of 
cereal grains negatively affect the digestive process of the host animal and has a 
significant influence on the intestinal microbial activity. In this context, utilization of 
exogenous carbohydrases may be beneficial in decreasing intestinal viscosity and 
limiting the amount of nutrients available to intestinal microbes including C. perfringens 
(Choct et al. 1999; Bedford 2001; Bedford and Apajalahti 2001). Unfortunately, due to 
the differences in challenge models, types of feed and the characteristics of 
supplementary enzymes, the documented findings seem to be inconsistent and thus hard 
to interpret. Evidence suggests that when supplemented with xylanase-based enzyme 
preparations, wheat-based diets are able to reduce intestinal bacterial counts by 60% in 
broiler chickens (Bedford and Apajalahti 2001). These findings were in agreement with 
Hubener et al. (2002). However, feeding a wheat-based diet supplemented with 
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pentosanase, Riddell and Kong (1992) did not observe an effect on NE-associated 
mortality but this study lacked information on parameters like C. perfringens counts and 
intestinal lesion scores. Jia et al. (2009a) used a similar disease model to challenge 
broiler chickens fed diets based on either wheat or corn supplemented with a 
carbohydrase enzyme cocktail mainly containing cellulase, pectinase, xylanase, 
glucanase, mannanase and galactanase. The authors did not observe any effect of 
supplementary enzyme on the proliferation of C. perfringens, intestinal lesion scores or 
NE-related mortality.  However, Choct et al. (2006) demonstrated a reduction in cecal C. 
perfringens counts in apparently healthy broilers fed xylanase-supplemented wheat-
based diets. Challenging broilers with both C. perfringens and Eimeria, Jackson et al. 
(2003) reported increased growth performance and reduced intestinal lesion scores in 
birds fed β-mannanase supplemented corn-based diets. The negative effects of β-
mannans may be due to their potent stimulatory effect on inflammation and resultant 
cytokine production (Zhang and Tizard 1996; Duncan et al. 2002).   
In a study conducted at the University of Manitoba, broiler chickens were offered 
wheat/soybean meal-based and flaxseed meal containing feeds with or without a 
supplementary carbohydrase enzyme cocktail. Intestinal sections excised from broilers 
were ligated and inoculated with C. perfringens spores. The findings of this in vitro 
study revealed a significant reduction in the proliferation of C. perfringens in digesta 
contents of both treatment groups by 50 and 67%, respectively, in the presence of 
supplementary enzymes, the flaxseed fed group showing a more distinct outcome (Jia et 
al. 2009b). They reported a significant reduction in digesta viscosity and C. perfringens 
counts in broiler chickens fed a multicarbohydrase enzyme supplemented diet based on 
wheat/flaxseed meal.  
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 Although a number of hypotheses have been presented to describe the mode of 
action of exogenous enzymes, the exact mechanism behind the role of these enzymes on 
the proliferation of C. perfringens and induction of NE remains unclear. Bedford (2000) 
categorized the effects of exogenous microbial enzymes on intestinal microflora into two 
phases: ileal and cecal. In the ileal phase, enzymes increase the efficiency of nutrient 
utilization of host and limit the amount of nutrients available to microbes. In the ceca, 
enzymes de-polymerize complex carbohydrates into soluble, poorly absorbed sugars, 
mainly oligosaccharides (de Silva et al. 1983). These oligomers may act as prebiotics 
with the selective support of the proliferation and/or activity of favorable bacteria 
(Gibson and Roberfroid 1995; Monsan and Paul 1995), and suppressing the proliferation 
of certain enteric pathogens including C. perfringens (Fukata et al. 1991; Gibson and 
Roberfroid 1995; La Ragione and Woodward 2003). Some previous studies reported a 
stimulatory effect of supplementary enzymes on intestinal proliferation of lactic acid-
producing bacteria in broiler GIT (Vahjen et al. 1998; Engberg et al. 2004). Further, 
feeding diets containing a supplementary carbohydrase enzyme cocktail, Kiarie et al. 
(2007) reported higher lactobacilli counts and lactic acid levels in the piglet ileum. In 
fact, using lactic acid-producing bacterial strains such as Lactobacillus acidophilus and 
Streptococcus faecalis, Fukata et al. (1991) has demonstrated promising results in 
containing C. perfringens growth in broiler GIT. The ability of a lactic acid bacterial 
culture in the reduction of C. perfringens-related broiler mortality was not affected by 
either presence or absence of mannonoligosaccharides (MOS: Hofacre et al. 2003). 
However, spraying a commercially available microbial enzyme preparation with 
xylanase and β- glucanase enzyme activities on isocaloric and isonitrogenous diets based 
on major cereal grains used in poultry feeds (barley, corn, wheat and sorghum), 
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Shakouri et al. (2009) did not observe an effect of enzyme supplementation either on 
lactobacilli or C. perfringens numbers either in ileum or cecum. In conclusion, the 
discrepancies in responses in birds to supplementary exogenous enzymes can primarily 
be attributed to the diverse characteristics of cereal grains used in feed formulation, the 
content of water soluble NSP and the origin and nature of microbial enzymes used.   
 
2.6.3. Non-nutritional ingredients 
A number of what can be termed non-nutritional ingredients has been investigated as 
means to control C. perfringens and NE in broilers. Prebiotics are non-nutritional 
carbohydrates that selectively promote the growth, activity or both of potentially 
beneficial commensal bacterial species in the GIT (Gibson and Roberfroid 1995). 
Prebiotics are primarily oligosaccharides which resist degradation by host intestinal 
enzymes. Most of these oligomers are fermentable in nature thus serve as substrates for 
beneficial microbes of the intestinal tract (Blaut 2002). Non-fermentable prebiotic 
oligosaccharides such as fructoologosaccharides (FOS) and MOS provide an alternative 
attachment site for the pathogen rather than the intestinal mucosa hence eliminating 
them from the GIT of the host (CFNP 2002). Available information on the role of 
prebiotics on the growth and activity of C. perfringens, present a complex and often 
contradictory picture. Studies with mammals have demonstrated a significant decrease in 
C. perfringens numbers in the GIT of rats, cats and dogs fed diets containing FOS, than 
in those fed diets without FOS (Gallaher et al. 1996; Sparkes et al. 1998; Swanson et al. 
2002). On the other hand, Hofacre et al. (2003) did not observe a significant effect on 
NE-associated mortality in broilers fed either FOS or MOS. Similarly, in a study with 
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quail, oligofructose did not demonstrate any effect on C. perfringens in the GIT (Butel et 
al. 2002).     
The antibacterial effects of a variety of herb and spice products (Besra et al. 
2002; Fabio et al. 2003; Wilkinson et al. 2003) and essential oil components (Briozzo et 
al. 1989; Cosentino et al. 1999; Dorman and Deans 2000; Losa and Kohler 2001; Fabio 
et al. 2003; Mitsch et al. 2002, 2004) have been assessed for their ability to control 
intestinal pathogens. However, few of these studies have investigated the use of these 
products for the control of C. perfringens. An exception to this is the use of muscadine 
pomace, a by-product from grape- (Vitis rotundifolia) based juice and wine industries, to 
control NE in chickens. This by-product has a high antioxidant capacity (Pastrana-
Bonilla et al. 2003; Talcott and Lee 2002), is rich in polyphenolic compounds (Lee et al. 
2005; Yilmaz and Toledo 2004) and possesses marked topical and systemic anti-
inflammatory properties (Greenspan et al. 2005). McDougald et al. (2008) reported that 
supplementation of a corn/soybean meal-based commercial type diet with muscadine 
pomace at 0.5 and 2% inclusion levels increased growth performance along with lower 
intestinal lesion scores and mortality in broilers co-infected with Eimeria (acervulina 
and maxima) and C. perfringens. Moreover, another experiment in the same study 
demonstrated an increase in resistance to coccidiosis in birds fed same muscadine 
pomace-supplemented diets. Accordingly, the reduced pathogenesis of C. perfringens 
can primarily be attributed to the negative effects of this by-product on both enteric 
pathogens. The available information suggests some beneficial properties of natural 
products in controlling NE in broiler chickens. Nevertheless, more studies are needed in 
this area to apply the utilization of these products in commercial feeding practices.           
  
30 
 
2.6.5. Feed processing and feeding 
While ingredients and nutrients have significant effects on gut C. perfringens 
populations and clinical NE, the manufacturing of feed can also modulate these effects. 
Feeding broilers with mash and pellet form diets, Engberg et al. (2002) observed higher 
C. perfringens and lactobacilli counts in the GIT of birds fed mash diet compared to 
those fed pellets. In addition, microbial fermentation in the cecum as reflected by VFA 
production was significantly higher in birds fed the pelleted diet. Branton et al. (1987) 
observed a reduction in NE-related mortality when broilers were fed coarsely ground 
wheat (28.9%) compared to finely ground wheat fed counterparts (18.1%). Coarse 
grinding of cereals is beneficial in terms of controlling gut pathogens compared to fine 
grinding (Engberg et al. 2002). When birds are fed finely ground rations the normal 
gastric reflux does not take place and consequently, more proteins reach the lower 
intestinal tract where these proteins are subjected to microbial fermentation. Highly 
processed feeds may cause gizzard atrophy and malfunction, hindering the grinding 
capabilities of the organ (Engberg et al. 2002). Whole wheat incorporation into the diet 
optimizes the gizzard activity with a resulting increase in nutrient digestibility and 
utilization (Hetland et al. 2003). Broilers fed whole wheat demonstrated lower gizzard 
pH and lesser C. perfringens numbers in the intestinal contents compared to finely 
ground wheat fed counterparts (Engberg et al. 2004; Bjerrum et al. 2005). Whitehead 
(2002) observed an increase in both healthiness and feed efficiency in broiler chickens 
reared under meal feeding and feed restriction during the early phase of the cycle. 
Finally, meal feeding results in higher nutrient utilization by broilers compared to ad 
libitum feeding which in turn restricts nutrient availability to the gut bacteria. While no 
experiments have been reported the effect of meal feeding on intestinal C. perfringens 
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populations, this approach appears promising and future studies in this area would be a 
welcome addition to the literature. 
 
2.7. Dietary protein, amino acids and necrotic enteritis 
 Among other well-identified dietary factors, the source and level of dietary protein have 
a distinct effect on the growth of C. perfringens in the GIT. The protein fraction in a 
broiler diet is variable as local and world prices determine the source and quality of 
protein(s) to be included (Palliyeguru et al. 2010). Amino acid balance and crude protein 
(CP) content have a significant effect on the C. perfringens numbers in the GIT of 
broiler chickens (Kaldhusdal 2000; Drew et al. 2004) as well as mammals such as pigs 
(Mansson and Smith 1962; Mansson and Olhagen 1967) and dogs (Zentek 1998). 
Studies with broiler chickens have revealed that birds fed high protein diets, particularly 
diets high in animal-derived proteins are predisposed to clinical NE (Kaldhusdal 2000; 
Kocher 2003; Drew et al. 2004; Wilkie et al. 2005). Kaldhusdal and Skjerve (1996) 
reported evidence of a link between animal-derived proteins and NE. In a longitudinal 
study, they examined the relationship between NE and feeding systems for a more than 
20 year period in Norway, and reported an increase in the occurrence of NE in broiler 
chickens during years when animal-derived proteins were used at higher levels. This 
correlation while suggestive did not prove a cause and effect relationship between NE 
and animal-derived proteins. However, existing evidence correlates the proliferation 
and/or α toxin production of C. perfringens to some specific AA (Titball et al. 1999). 
Methionine was reported to be required for sporulation and to be highly stimulatory for 
growth, although not an essential nutrient for C. perfringens (Muhammed et al. 1975). 
However, in vitro experiments conducted in our laboratory reported a significant 
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reduction in the proliferation of this microorganism upon incubation of mixed bacterial 
culture for 24 hours in minimal salt media with supplementary DL-methionine (DLM) 
added at a concentration of 10 mg/mL, compared to the unsupplemented media (Wilkie 
et al. 2005; Wilkie 2006). Moreover, Dahiya et al. (2007b) observed significantly lower 
C. perfringens growth in the GIT of broiler chickens fed either of the two commercially 
available methionine forms: DLM and 2-hydroxy-4-methylthiobutanoic acid (HMB). 
Several studies have reported the stimulatory properties of dietary glycine on the 
proliferation of C. perfringens in broiler GIT, thus suggesting an increased possibility in 
the development of NE (Ispolatovskaya 1971; Nakamura et al. 1978; Dahiya et al. 2005; 
Wilkie et al. 2005). In support of this observation, the presence of peptides with glycine 
in them is a requirement for C. perfringens to produce α toxin in chemically defined 
media (Nakamura et al. 1978; Stevens and Rood 2000). As a percentage of CP, proteins 
originating from animal sources, such as meat and bone meal (MBM), contain two to 
four fold higher levels of glycine compared to plant-derived proteins (AminoDat 2001). 
Therefore, glycine in excessive amounts in diets containing animal-derived proteins can 
promote the growth of C. perfringens in the GIT of broilers. In support of this notion, 
Wilkie et al. (2005) tested diets containing 40% CP formulated using seven different 
ingredients as the primary sources of protein namely, fish meal, MBM, feather meal, 
potato protein concentrate (PPC), pea protein concentrate, soy protein concentrate or 
corn gluten meal. The ileal and cecal C. perfringens numbers in broilers fed diets 
containing animal-derived protein sources were significantly higher than those in birds 
fed the control diet or diets with plant-derived proteins, except for the diet containing 
PPC. In addition, a significant positive correlation was observed between the dietary 
glycine level and both ileal and cecal C. perfringens numbers. Potato protein concentrate 
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contains a relatively higher level of glycine as a percent of CP (18.6 g/kg), so differs 
from most plant protein sources (Wilkie et al. 2005). However the CP level and test 
ingredient inclusion rates were much higher in the diets formulated for this study than 
would be used in commercial type diets. Furthermore, a correlation does not establish a 
causal relationship between the glycine level in the diet and C. perfringens numbers in 
the intestine. Palliyeguru et al. (2010) formulated three nutritionally complete corn-
based iso-caloric and iso-nitrogenous diets containing PPC (15.8%), fish meal (19.3%) 
and a blend of soy protein (soybean meal and full-fat soy: 17.8 and 12.0%, respectively), 
to evaluate the effects of type of protein on the development of sub-clinical NE in broiler 
chickens. These diets were fed to broilers raised on litter composed of new wood savings 
and litter material from a previous poultry flock in 4:1 ratio. The authors found that birds 
fed PPC had higher values for proximal small intestinal necrotic lesions, distal ileal 
lesion score, liver lesions, and α - toxin antibody level and also had reduced growth 
performance in comparison to birds fed the other protein sources. Nevertheless, no 
treatment effect was observed on C. perfringens numbers in proximal jejunal mucosal 
scraping. The glycine content in PPC (0.94%) and soy protein (0.90%) containing diets 
used in this experiment were not significantly different. Similarly, the methionine 
content (0.49%) was same for both dietary treatments. Accordingly, these findings, on 
one hand, are rather in agreement with the previously testified effects of dietary gylcine 
and methionine on C. perfringens growth and colonization. However, on the other hand, 
C. perfringens numbers in distal segments of the GIT were not determined, thus hard to 
correlate and interpret the findings because, if determined, the numbers could have been 
higher in birds fed PPC, owing to the NE- associated pathological, immunological and 
growth changes with that particular dietary treatment. The increased severity of the 
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disease and substandard growth performance of birds fed PPC can be attributed either to 
possible virulence enhancement of the pathogen by some component present in PPC or 
to increased proliferation and activity of C. perfringens in the distal GIT, which was not 
determined or to other factors associated with PPC itself or the diet containing PPC. The 
estimated glycoalkaloid level of PPC seems to be much higher (257 mg/kg: Lokra et al. 
2008) than the general safety limit (200 mg/kg) for humans (Smith et al. 1996). 
Solanine, the major heat-stable glycoalkaloid present in PPC, along with deleterious 
compounds derived from aromatic AA, which are present in higher amounts in PPC 
containing diet, might have initiated intestinal epithelial damage, encouraging C. 
perfringens growth and activity in the GIT (Smith et al. 1996; Smith and Macfarlane 
1997). In addition, the authors identified other factors, such as higher trypsin inhibitor 
activity as well as lower lipid content in PPC containing diet, as stimulatory to the 
proliferation of C. perfringens. Trypsin inhibitors suppress the protein digestibility, 
increasing the amount of protein that reaches the distal GIT. Low lipid consumption 
reduces bile acid synthesis and secretion, diminishing the bile salt-associated 
antibacterial activity. Both these factors may contribute towards an increase growth and 
colonization of C. perfringens in birds fed the diet containing PPC. Drew et al. (2004) 
evaluated the impact of protein source (fish meal vs. soy protein concentrate, SPC) and 
level (23, 31.5 or 40 % CP) on C. perfringens growth in the broiler intestinal tract and 
revealed a significantly higher C. perfringens numbers in broilers fed the diet containing 
fish meal at 40% CP. Both ileal and cecal C. perfringens numbers were increased as the 
amount of CP went up from 23 to 40% in broilers fed diets containing fish meal, 
however not in broilers fed diets with SPC. The numbers were low in broilers fed diets 
containing SPC at all CP levels. According to the results of feed analysis, dietary 
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concentrations of both glycine and methionine were higher in fish meal-based diets 
compared to SPC-based diets. To further verify the influence of glycine on the growth of 
C. perfringens, Dahiya et al. (2007a) incorporated crystalline and protected forms of 
glycine into the experimental diets and observed stimulatory effect of this AA on C. 
perfringens growth only in broilers fed diets with the protected glycine. This observation 
can be attributed to the fact that crystalline form is considered to be 100% true digestible 
(Izquierdo et al. 1988; Chung and Baker 1992) and rapidly absorbed in the upper part of 
the GIT (Lingens and Molnar 1996; Maenz and Engele-Schaan 1996a; Drew et al. 
2003), making it unavailable to the microbes residing in the distal part, while glycine 
incorporated in the encapsulated preparation is released slowly so reaches the lower 
GIT, increasing the availability to microbes.  Nevertheless, more research is warranted 
in this area to further elicit the role glycine plays in the proliferation of C. perfringens in 
the broiler intestinal tract.  
 
2.7.1. Low protein diets 
In view of the above discussion, diets containing low levels of CP can be speculated as a 
potential nutritional strategy to control C. perfringens growth in the GIT of broilers, in 
post-in-feed antibiotic era. Commercially available synthetic forms of AA have created a 
great opportunity for nutritionists to formulate diets that are lower in CP. These 
synthetic AA are included in poultry rations in order to substitute a portion of such AA 
supplied by protein rich, comparatively expensive raw materials. Accordingly, the 
advantages of synthetic AA incorporated-low CP (lCP) diets include reduced N 
excretion by precisely formulating diets to meet the bird’s AA requirement and giving 
the nutritionists more flexibility in ingredient selection (Bercovici and Fuller 1995). As a 
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result, more environmentally friendly diets can be formulated at a lower cost. In fact, 
Rostagno et al. (1995) demonstrated superior growth and production performance and 
considerable economic benefits, when relatively inexpensive feed ingredients were 
incorporated in the formulation of lCP - AA supplemented broiler diets. However, 
despite great efforts to understand lCP diets in broilers, the greatest point of concern is 
that growth and carcass performance seem to be impaired when broilers are fed lCP 
diets even if formulated to meet all known nutrient requirements. This area has been 
reviewed in depth by Payne (2006) evaluating a total of 59 datasets, which spans over 15 
years worth of research. A majority of datasets reviewed by Payne (2006) suggests that 
growth performance is reduced when broilers are fed lCP diets. In their review, Aftab et 
al. (2006) proposed a number of potential factors to describe the negative effects of lCP 
diets on growth performance of broilers, including: (1) alterations in potassium or the 
electrolyte balance in the diet; (2) deficiency of the non-protein nitrogen for the 
synthesis of non-essential AA; (3) possible reduction in broiler feed intake; (4) change in 
essential : non-essential AA ratio; (5) limited production of  non-essential AA to fulfill 
the demand of fast-growing broilers; (6) efficiency of AA utilization from a synthetic 
product compared to intact dietary protein, for the synthesis of body protein; (7) 
deficiency of certain essential AA; (8) correlation between the dietary metabolizable 
energy (ME) and the net energy of lCP vs. high CP (hCP) diets. The effects of lCP diets 
on broiler growth and production performance in different age groups, as reported by 
previous studies, are outlined in Table 2.3. When attempting to bring the CP level down 
to formulate lCP (AA supplemented) diets, two approaches have been documented in the 
literature; maintaining either a constant ME:CP ratio or a constant energy level. The lCP 
diets formulated to be isocaloric (increasing the ME:CP ratio) increase feed intake with a 
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Table 2.3. Effect of low crude protein diets on performance of broilers (After Aftab et al. 2006). 
CPi
 a
 Control CPAA ME/CP Age Gain FE Breast Abdominal  Reference 
(CPAA)
b
% CP % (Control)  (days)   Yield Fat  
     CPAA/Control CP group  
16.2 (16.6) 22.2 0.75 193 0-18 0.99 1.05* - - Dean et al. (2006) 
18.3 22.9 0.80 171 8-21 1.03 0.96 0.97
e
 0.95
f
 Fatufe and Rodehutscord (2005) 
22.0 24.0 0.92 145 0-21 0.95 0.95 - - Jiang et al. (2005) 
20.0 23.0 0.87 160 7-17 1.01 1.01 - 1.06 Sterling et al. (2005)
c
 
20.3 (21.5) 22.5 0.96 149 0-21 0.93 0.97 - 1.07 Si et al. (2004) 
17.3 19.3 0.90 155 0-21 1.06 1.01 - - Aftab et al. (2004a)
d
 
15.3 17.2 0.89 180 21-42 1.04 0.99 - - Aftab et al. (2004b)
d
 
17.6 (18.3) 23.4 0.78 175 7-21 0.97 0.94* 0.95*
e
 1.46*
f
 Bregendahl et al. (2002) 
20.5 21.9 0.94 151 0-21 1.00 1.00 - - Cauwenberghe  and Burnham (2001) 
18.6 20.7 0.90 169 22-35 0.96 1.00 - - Cauwenberghe  and Burnham (2001) 
16.0 17.6 0.91 202 35-49 1.00 1.00 0.99 - Cauwenberghe  and Burnham (2001) 
18.0
g
 /18.7
h
 20.4/21.5 0.88/0.87 174 29-42 0.94 0.92 - - Jeroch and Pack (1995) 
20.0 (20.8) 24.2 0.86 154 0-21 1.01 0.98 - - Moran et al. (1992) 
17.0 (17.8) 20.5 0.87 180 21-42 0.97 0.97 - 1.17 Moran et al. (1992) 
19.0 (21.4) 23.0 0.93 150 0-21 1.00 0.98 - 1.16
f
 Han et al. (1992) 
16.0 (18.5) 20.0 0.93 173 21-42 1.00 0.96 - - Han et al. (1992) 
3
7
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a
 CPi - CP from intact proteins. 
b
 CPAA - CP including crystalline amino acid nitrogen. 
c
 0.9% lysine in lCP and control diets. 
d
 low-ME (2700–2750 kcal ME per kg) diets. 
e
 CP,% whole body composition. 
f
 Fat,% whole body composition. 
g
 experiment 1. 
h
 experiment 2.  
* significantly (P <0.05) differed from the control.
3
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simultaneous increase in the deposition of abdominal fat (Fancher and Jensen 1989a, b; 
Rosebrough and Steele 1990; Rosebrough and McMurtry 1993; Aletor et al. 2000; 
Dozier et al. 2006). However, according to Hidalgo et al. (2004) and Kamran et al. 
(2008), no differences in the yield of abdominal fat were seen in chickens fed lCP diets 
if a constant ME:CP ratio was maintained. On the contrary, lowering the protein content 
in isocaloric diets (increasing the ME:CP ratio) optimizes the utilization of dietary 
protein in broilers, as indicated by protein efficiency ratio (PER: determined as grams of 
weight gain per gram of protein intake: Cheng et al. 1997; Aletor et al. 2000). Yet, the 
PER is reduced linearly in broilers during the grower, finisher and overall growth 
periods with the reduction of the protein content in diets which maintain a constant 
ME:CP ratio (Kamran et al. 2008). The authors link this observation to the significantly 
reduced growth rate in birds fed lCP and low ME diets, despite the consumption of the 
same amount of protein with increased feed intake. Similarly, the breast meat yield is 
reduced when broilers are fed isocaloric diets, reducing the CP content (Dozier et al. 
2006). Demonstrating enhanced performance in broilers fed glycine supplemented lCP 
diets, Parr and Summers (1991), Jiang et al. (2005) and Dean et al. (2006) indicated that 
the NRC recommended glycine level (1994) was not sufficient for broilers fed lCP diets. 
Despite the prompt synthesis of glycine by the broilers, the rate of synthesis might not 
be quick enough to fulfill the demand for muscle growth and nitrogen excretion in 
rapidly growing birds (Parr and Summers 1991; Jiang et al. 2001, 2005; Corzo et al. 
2004; Dean et al. 2006), thus should be supplied in the diet. Nevertheless, due to the 
stimulatory nature of this specific AA on C. perfringens growth in the GIT of broilers as 
previously described, the possibility of exceeding NRC (1994) suggested requirement is 
limited in the absence of AGP in the diet. However, based on the findings of Dahiya et 
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al. (2007a), lCP broiler diets can be supplemented with crystalline glycine, averting the 
risk of accelerated C. perfringens proliferation. 
 
2.7.2. High protein diets 
The level of protein in the diet can directly or indirectly influence the growth 
performance of broiler chickens. In addition, AA themselves can have adverse effects on 
growth and production performance, in the form of dietary imbalances or antagonisms. 
According to the definition, an imbalance is an alteration to the proper ratio of dietary 
AA with subsequent reduction in feed intake and growth, whereas an antagonism is a 
negative interaction between structurally similar AA (D’Mello 2003). Both imbalance 
and antagonism reduce the efficacy of AA utilization: nevertheless, formulating broiler 
rations based on the ideal protein concept, both these undesirable factors can easily be 
avoided, with the assurance of proper ratio of essential AA in the diet (Baker 1994; NRC 
1994; Emmert and Baker 1997; Mack et al. 1999; Lemme 2003a,b). When diets are 
formulated based on ideal protein concept, the CP and AA requirements for broiler 
chickens to maximize growth performance and feed efficiency may be higher than 
current NRC requirement (Baker and Han 1994; Mack et al. 1999). Hoehler et al. (2001) 
reported that hCP diets balanced according to ideal protein ratios may be commercially 
feasible. However, there is a potential for negative interaction between the diets with 
excess protein and NE. As discussed above, previous studies have demonstrated the 
intestinal overgrowth of C. perfringens in broilers fed diets containing high 
concentrations of protein, increasing the potential for NE in broiler chickens (Drew et al. 
2004; Wilkie et al. 2005). 
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Although digestion by endogenous enzymes and absorption from the small 
intestine are very effective, a constant supply of nutrients to the lower GIT occurs in the 
form of undigested dietary components, host enzymes, mucoproteins, serum albumin, 
amides and desquamated intestinal epithelial cells. The amount and composition of 
substances reaching the lower GIT can be readily modified by the diet. For instance, 
diets containing protein in relatively high amounts, and diets with imbalanced patterns of 
AA, result in low AA digestibility and utilization in the proximal GIT thus higher 
amounts of AA accumulate in the lower GIT as undigested proteins (Lan et al. 2004; 
McDevitt et al. 2006). This accumulation, together with low fermentable carbohydrate 
sources lead to more proteolytic fermentation (Piva et al. 1995). Accordingly, some of 
the intestinal VFA are derived from proteins which are apparently the major source of 
mainly branched-chain VFA such as isobutyrate, isovalerate and isocaproate, formed by 
the metabolism of branched-chain AA (valine, leucine, isoleucine; Macfarlane et al. 
1992). In addition, certain bacteria are capable of metabolizing AA, producing 
potentially toxic metabolites which can negatively affect the intestinal cell turnover and 
broiler growth performance (Ewing and Cole 1994; Macfarlane and Macfarlane 1995; 
Gaskins 2001; van der Klis and Jansman 2002). Ammonia, volatile phenols and indoles, 
and a number of amines represent such toxic metabolites and these metabolites can 
negatively impact the overall health thus growth performance of livestock animals 
(Yokayama et al. 1982; Russell et al. 1983; Macfarlane et al. 1992 Gaskins 2001; van 
der Klis and Jansman 2002; Juskiewicz et al. 2004). Available information suggests that 
high concentrations of ammonia, generated by bacterial urease and deamination of AA 
from both dietary and endogenous protein (Visek 1978a; Wrong and Vince 1984; Pond 
and Yen 1987), readily passes across the gut wall thus gaining access to other tissues of 
  
42 
 
the body (Rowland 1992). This ammonia tends to depress growth of animals as a result 
of cell toxicity and subsequent increase in intestinal epithelial cell turnover and mucin 
degradation followed by an increase in synthesis and secretion of mucin (Lin and Visek 
1991). In addition, ammonia has been reported to be negatively correlated to reduced 
villus height as well (Nousiainen 1991). Furthermore, elimination of the produced and 
absorbed ammonia requires about 7% of the total energy expenditure in monogastrics 
and ruminants (Eisemann and Nienaber 1990). Sub acute concentrations of ammonia can 
affect the metabolism of the host, resulting in reduced performance (Piva et al. 1995). 
Microbially generated amines, such as histamine and cadaverine can alter the amount of 
acid and bicarbonate added from the gut mucosa and rate of transit through the gut 
(Calloway 1968). Accordingly, Porter and Kenworthy (1969) have attributed these 
amines to the occurrence of diarrhea in weanling pigs as a result of increased peristalsis 
of the alimentary tract. Growth performance can also be negatively affected by phenols 
and indoles derived from the microbial metabolism of aromatic AA (Yokoyama et al. 
1982). In addition, the presence of nitrogenous degradation products tends to elevate the 
distal gut pH due to their relatively high pKa values thereby counteracting the bacterial 
generated acetic and lactic acid associated pH changes and potentially increasing 
intestinal C.  perfringens proliferation (Juskiewicz et al. 2004; Lan et al. 2005).  
 
2.7.3. Amino acid digestibility and availability 
The supply of AA as protein supplements and in synthetic form represents a significant 
cost of production in poultry feed industry. Accordingly, optimum utilization of these 
expensive nutrients is one of the vital aspects in poultry feed formulation. In fact, the 
existing knowledge on AA availability is a key approach to improve utilization. The 
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concept of AA digestibility is recognized as a sensitive indicator of AA availability in 
dietary ingredients for poultry (Parsons 1986; Johns et al. 1986; Albino et al. 1992), 
because AA availability has been defined as the portion of dietary AA which is in a state 
suitable for digestion, absorption and utilization (Batterham 1992). Accordingly, AA of 
poorly digestible protein sources are less available to birds and are concentrated in the 
lower GIT making them available for gut-specific pathogens (Williams et al. 2001; Lan 
et al. 2004; McDevitt et al. 2006). This provides a good source of nutrients for the 
proliferation of pathogenic microbes in the gut and affects gut health of broilers 
especially when antibiotic free diets are fed. As a result, feeding these types of protein 
can negatively affect the growth performance of broilers, as well. 
 
2.8. Digestible amino acid values in broiler ration formulation 
Reliance upon total AA content of the diet is considered inappropriate in poultry feed 
formulation. Poultry ration formulation on digestible AA basis is becoming important, 
because according to available information broiler chickens fed diets formulated on 
digestible AA basis have demonstrated superior growth and production performance. 
One of the current debates is concerned with the relative merits of ileal and fecal/excreta 
digestibility as a basis for feed formulation. Digestibility coefficients of AA assessed at 
the terminal ileal level of monogastrics give sensible estimations for AA availability. 
One study evaluated differences in digestibility coefficients using terminal ileal digesta 
and excreta of broiler chickens and demonstrated that digestibility coefficients measured 
in the ileal digesta are more precise than those measured in the excreta for AA 
availability values (Ravindran et al. 1999). Formulating broiler rations based on ilial 
digestible AA values, Rostagno et al. (1995) reported a better prediction of dietary 
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protein quality and broiler performance than rations formulated on total AA. 
Nevertheless, ileal digestible AA values are used only by a few feed industry 
nutritionists at present to formulate commercial poultry rations (Bryden and Li 2004). 
The main concerns for this reluctance include: (a) inconsistency in available data from 
different sources on digestible AA values, owing to variation in ingredients, strain of 
birds and method of evaluation; (b) lack of knowledge of the batch related variations in 
AA digestibility coefficients; and (c) scarcity of available information on broiler growth 
performance to diets formulated based on digestible AA values (Bryden and Li 2004). In 
fact, in a study with grower finisher pigs to evaluate the effect of the basis for feed 
formulation (total, apparent ileal or apparent fecal digestibility values of AA) on the 
weight gain, Wiseman et al. (1991) reported no advantage of using ileal rather than 
faecal, apparent digestible AA values in terms of accuracy of diet formulation. Yet, 
much more pronounced reduction in weight gain was observed when total AA were used 
in feed formulation.    
 
2.9. Summary 
With the intensification of the poultry production systems, the risk of both clinical and 
sub-clinical types of diseases has increased to a considerable level. In an attempt to 
minimize the problems associated with enteric pathogens, use of antibiotics in-feed has 
commonly been practiced at both a therapeutic level to combat diseases and at a sub-
therapeutic level as growth promoters, since their discovery more than five decades ago. 
Nevertheless, various public health concerns associated with animal product 
consumption has resulted an increasing consumer pressure to limit the use of in-feed 
antibiotics. On the account of these concerns, some countries have already banned the 
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use of AGP in animal feed industry, which in turn has paved the way for an increased 
prevalence of NE in broiler chickens. This development has created a new insight in the 
research area which evaluates alternatives to AGP to improve both animal performance 
and enteric disease control. In this scenario, nutritional strategies have attracted much 
attention owing to their potential role in mitigating conditions that are favorable for the 
proliferation of C. perfringens, because a number of dietary factors that predispose birds 
to NE have already been identified. In fact, risk factors associated with all major 
components of the diet, namely carbohydrate, protein and fat, have extensively been 
discussed in the literature. Consequently, considerable amounts of time and research 
funds are being invested to explore ways to alleviate these risk factors and to manipulate 
the intestinal ecosystem to maintain the health, safety and consumer acceptability of the 
resultant product, without sacrificing the growth performance of broiler chickens, in a 
post in-feed antibiotic era. Nevertheless, to date, despite all these efforts, the non-
antibiotic measures introduced to control both clinical as well as sub-clinical forms of 
NE in broilers are not 100% satisfactory in every situation, and a deficiency stands 
against the existing knowledge of the issues which play an important role in the 
progression of this economically important infection.     
 Based on the above observations, the following objectives were developed for 
the experiments described in this thesis: 
 To evaluate the effects of dietary protein level and protein digestibility on growth 
performance and carcass characteristics of broiler chickens fed diets formulated 
based on ileal digestible protein and AA values. 
 To develop a feasible experimental model for NE in broiler chickens raised on 
litter in the absence of coccidial co-infection  
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 Using the developed experimental model, to investigate the effects of dietary 
protein level and protein digestibility on the proliferation of C. perfringens in the 
GIT of broiler chickens fed diets formulated based on ileal digestible protein and 
AA values. 
 To determine the dose response of C. perfringens-challenged and -unchallenged 
broiler chickens fed different methionine precursors in diets formulated based on 
ileal digestible protein and AA values. 
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3. EFFECTS OF PROTEIN LEVEL AND DIGESTIBILITY ON THE GROWTH 
AND CARCASS CHARACTERISTICS OF BROILER CHICKENS        
 
 
This chapter was published in the Poultry Science journal. The full citation is: 
Widyaratne, G. P. and Drew, M. D. 2011. Effects of protein level and digestibility on the 
grrowth and carcass characteristics of broiler chickens. Poult. Sci. 90: 595 - 603. This 
study was conducted to evaluate the effects of low protein diets formulated based on 
digestible AA values on broiler production, before testing the particular diets under C. 
perfringens challenged situations.  
 
3.1. Abstract 
A study was conducted to evaluate the effects of dietary protein level and protein 
digestibility on the growth performance and carcass characteristics of broilers from 1 to 
35d of age. Broiler chickens (N=320) were fed four different ideal protein-balanced 
(based on digestible AA), isocaloric diets in a 2 x 2 factorial design with two levels of 
ileal digestible protein (HiPro: 20 and 18% and LoPro 18 and 16% on days 1-14 and 15-
35 respectively) and two levels of protein digestibility (HiDig and LoDig; approximately 
85% and 80% CP digestibility respectively). The HiDig diets were formulated using 
soybean meal and fishmeal while the LoDig diets used wheat distillers grains and 
solubles (W-DDGS) and MBM as the primary protein sources. The standardized ileal 
digestibility (SID) and contents of AA in the W-DDGS and MBM were measured prior 
to the experiment to improve the accuracy of the diet formulations. The interaction 
between protein level and digestibility was significant for most of the AA for SID and, 
for digestible contents of all AA; birds fed HiPro:HiDig had significantly higher SID 
values and birds fed LoPro:HiDig had the lowest values for digestible AA content. 
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During the starter phase, the protein level x digestibility interaction was significant for 
average daily gain (ADG); with LoPro:HiDig and LoPro:LoDig fed birds showing the 
highest and lowest ADG, respectively. During the grower phase and the overall 
experimental period, the interaction between protein digestibility and level was 
significant for average daily feed intake (ADFI); that of birds fed the LoPro:LoDig diet 
was significantly lower than those fed diets with HiDig proteins, during the grower 
phase and lower than those fed the other three diets, during the overall experimental 
period. Total breast meat yield was significantly higher in birds fed the HiPro than those 
fed LoPro diets while birds fed HiDig diets had significantly more abdominal fat than 
those fed LoDig diets. The results suggest that low protein diets can support growth 
performance equal to high protein diets when highly digestible ingredients are used. 
However, breast meat yield goes down with the reduction of dietary protein level, 
regardless of ingredient digestibility. 
 
3.2. Introduction 
A considerable amount of research has been done to evaluate the effects of lCP–AA 
supplemented diets on the growth performance and carcass characteristics of broiler 
chickens. However, conflicting results from some research does not allow a clear 
conclusion on the effects of these diets in practical broiler production. Evaluating the 
impact of lCP-AA supplemented diets, some studies have reported inferior performance 
on broiler productivity (Edmonds et al. 1985; Fancher and Jensen 1989a,b,c; Holsheimer 
and Janssen 1991; Bregendahl et al. 2002; Kamran et al. 2008; Namroud et al. 2008), 
while others have reported no effect on performance when lCP diets are fed (Parr and 
Summers 1991; Deschepper and De Groote 1995; Moran and Stilborn 1996; Yamazaki 
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et al. 1996, 1998; Aletor et al. 2000; Kamran et al. 2010). The increased accumulation of 
abdominal fat in birds fed low protein (LoPro) diets was the only consistent observation 
reported in these studies. Nevertheless, the preponderance of information suggests that 
the rate and efficiency of growth is reduced, and carcass composition is inferior when 
dietary CP level is reduced by more than 3%, even when all known nutrient 
requirements are met (Fancher and Jensen 1989a,b,c; Aletor et al. 2000; Bregendahl et 
al. 2002; Sterling et al. 2005; Waldroup et al. 2005).  
Diet formulation based on digestible nutrients is clearly superior to formulation 
based on total nutrients (Dari et al. 2005). However, this approach does not take into 
account the fact that the indigestible portion of the feed remains in the intestinal tract 
and can affect the growth performance of broilers by acting as a substrate for intestinal 
bacteria (Hill et al. 2005; Dahiya et al. 2006; Pieper et al. 2008) and slowing down the 
rate of passage of digesta. Thus, the amount and chemical content of unabsorbed 
nutrients might play a significant role in nutrient utilization in otherwise nutritionally 
similar diets. Based on these observations, it was hypothesized that diets formulated 
using poorly digestible ingredients will decrease the growth performance and reduce the 
carcass quality of broiler chickens, and that this effect will be exacerbated in LoPro 
diets. The current study was performed to test this hypothesis.  
 
3.3. Materials and methods 
Two experiments were conducted at the Animal Care Unit in the Western College of 
Veterinary Medicine, University of Saskatchewan. Experimental protocols for both 
experiments were approved by the Animal Care Committee of the University of 
Saskatchewan and were performed in accordance with recommendations of the 
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Canadian Council on Animal Care as specified in the guide to the Care and Use of 
Experimental Animals (Canadian Council on Animal Care, 1993). 
 One-day-old male broiler chicks (Ross 308; Lilydale Hatchery, Wynyard, SK, 
Canada) were used in both experiments and standard management procedures were 
followed. Ambient temperatures gave optimal comfort for the birds with controlled 
temperature and humidity. The lighting schedule used was intended not to restrict early 
growth and consisted of 23 h light and 1 h dark from day 1 to 14 and, 20 h light and 4 h 
dark from day 15 onwards. Birds had free access to feed and water, throughout both 
experiments. 
 
3.3.1. Experiment 1 
Exp. 1 was performed to determine the apparent ileal digestibility (AID) and SID 
of the distillers dried grains and solubles derived from wheat (W-DDGS) and MBM 
derived from bovine materials. Compared to soybean meal and fish meal, the nutrient 
content and digestibility are not consistent in W-DDGS and MBM due to many factors. 
For example, factors including variety of wheat used for fermentation, method of 
fermentation, duration of the fermentation and drying processes, drying temperature, and 
the amount of solubles added to distiller’s dried grains may have substantial effect on 
the consistency of the product (Carpenter 1970; Olentine 1986; Spiehs et al. 2002; 
Belyea et al. 2004; Bandegan et al. 2009). Similarly, species origin and ratio, processing 
conditions (temperature and pressure), processing time and ash content may affect the 
nutritional characteristics of MBM (Johnson and Parsons 1997; Wang and Parsons 1998; 
Karakas et al. 2001). Therefore, to improve the accuracy of diet formulation AA 
digestibility co-efficients of these two ingredients were measured.  
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 A total of 72 broiler chickens were housed randomly in six electrically heated 
battery cages for a three week pre-experimental period during which they were fed a 
medicated, ideal protein-balanced (13.38 MJ/kg of ME; 1.2% Lys) corn-based starter 
crumble diet (Federated Coop Feeds, Saskatoon, SK, Canada; Table 3.1). At the end of 
the 3-week pre-experimental period, the birds (970.83 ± 18.57 g) were weighed and re-
randomized into 12 battery cages. Four cages of six birds each were assigned to each of 
the three experimental diets (a reference diet and two test diets; Table 3.2) in mash form. 
The test diets were produced by mixing 60% of the reference diet and 40% of the 
ingredients (W-DDGS; Mohawk Canada, Lloydminster, AB, Canada and MBM; 
Saskatoon Processors, SK, Canada) together. The reference diet contained 0.40% 
chromic oxide as an indigestible marker. The birds were killed by cervical dislocation on 
d 28 of the experiment. Intestinal tracts were removed immediately and the contents of 
the distal half of the ileum (from Meckel’s diverticulum to 2 cm proximal to the 
ileocecal junction) were collected. The collected digesta of the six birds within a cage 
were pooled at the sampling time and mixed with 4% formic acid. The pooled digesta 
samples were stored in a freezer maintained at –20°C until analyzed. 
 
3.3.2. Experiment 2 
A total of 320 birds (43.81± 1.07 g) were randomly distributed in 32 floor pens 
upon arrival at the research facility. Each pen (1 m
2
) was equipped with a pan feeder, a 
manual drinker and fresh wood shavings. The birds were subjected to a 2-phase feeding 
regimen consisting of starter (1 to 14d: 12.75 MJ/kg) and grower (15 to 35d: 13.17 
MJ/kg) phases. Eight pens of birds were randomly assigned to one of four dietary 
treatment groups in a 2 x 2 factorial arrangement of treatments with two AID protein   
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Table 3.1. Ingredient composition of the starter diet used from 0 to 21d of age in Exp. 1. 
Ingredient  Inclusion (%) 
Soybean meal 40.90 
Corn 39.50 
Wheat 10.00 
Tallow 4.52 
Dicalcium phosphate 1.53 
Calcium carbonate 1.29 
Canola oil 1.00 
DL-Methionine 0.26 
Sodium chloride 0.30 
Choline chloride 0.10 
Vitamin-mineral premix
1
 0.50 
BMD
®
 110G
2
 0.05 
Bio-Cox
®
 120G
3
 0.05 
1
Supplied per kilogram of diet: vitamin A, 11,000 IU; cholecalciferol, 2,200 IU; vitamin 
E, 30 IU; vitamin K, 0.5 mg; vitamin B12, 0.02 mg; thiamine, 1.5 mg; riboflavin, 6 mg; 
folic acid, 0.6 mg; biotin, 0.15 mg; niacin, 60 mg; pyridoxine, 5 mg; pantothenic acid, 
0.02 mg; chloride, 788 mg; sodium, 511 mg; iron, 80 mg; manganese, 21.8 mg; 
selenium, 0.1 mg; iodine, 0.35 mg; zinc, 100 mg. 
2
Bacitracin (as methylene disalicylate) 110g/kg
 
(Αlpharma Inc. Fort Lee, NJ). 
3
Salinomycin sodium 120g/kg
 
(Αlpharma Inc. Fort Lee, NJ). 
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Table 3.2. Ingredient and nutrient composition of the reference diet used in Exp.1. 
Ingredient  (%) 
Corn 54.00 
Soybean meal 40.00 
Test ingredient 0.00 
Canola oil 0.97 
Choline chloride 0.10 
Vitamin – mineral premix1 0.50 
Dicalcium phosphate 2.12 
Limestone 1.53 
Sodium chloride 0.38 
Chromic oxide 0.40 
  
Calculated ME (MJ/kg) and nutrients (%)  
ME  12.00 
Crude protein 18.09 
Calcium  1.09 
Available phosphorus  0.52 
Lysine
2
  1.04 
Methionine+Cystine
2
  0.69 
Linoleic acid  1.51 
Sodium  0.18 
1
Supplied per kilogram of diet: vitamin A, 11,000 IU; cholecalciferol, 2,200 IU; vitamin 
E, 30 IU; vitamin K, 0.5 mg; vitamin B12, 0.02 mg; thiamine, 1.5 mg; riboflavin, 6 mg; 
folic acid, 0.6 mg; biotin, 0.15 mg; niacin, 60 mg; pyridoxine, 5 mg; pantothenic acid, 
0.02 mg; chloride, 788 mg; sodium, 511 mg; iron, 80 mg; manganese, 21.8 mg; 
selenium, 0.1 mg; iodine, 0.35 mg; zinc, 100 mg. 
2
Standardized ileal digestible: based on values obtained from AminoDat 3.0 Platinum 
version (Evonik-Degussa GmbH, Hanau, Germany). 
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levels; high (HiPro: 20 and 18% in starter and grower phases, respectively) and low 
(LoPro: 18 and 16% in starter and grower phases, respectively) and two ileal protein 
digestibilities; high (HiDig: approximately 85%) and low (LoDig: approximately 80%). 
Celite (10 g/kg; Celite 545, Celite Corporation, World Minerals Co., Lompoc, CA, 
USA) was added as a filler to balance the diets for all nutrient specifications. The ideal 
protein-balanced diets were formulated to have the same standardized ileal digestible 
(SID) AA concentrations for the reference AA, lysine. The SID AA contents were 
calculated in accordance with dietary ME level in each growth phase, using QuickChick 
1.0 program (Evonik-Degussa GmbH, Hanau, Germany), as per values determined in 
Exp. 1 for W-DDGS and MBM and values obtained for all other ingredients from 
AminoDat 3.0 Platinum version (Evonik- Degussa GmbH, Hanau, Germany). The 
HiDig diets were formulated with soybean meal and Nova Scotia herring meal (Shur-
Gain Aquaculture, Truro, Nova Scotia, Canada) as the major protein sources while the 
LoDig diets were formulated using W-DDGS and MBM as the main protein sources 
(Tables 3.3 and 3.4). 
Birds and feeders were weighed by pen at the initiation of the experiment (d 0), 
and weekly thereafter, (d 7, 14, 21, 28, and 35). Birds were monitored twice a day (8:30 
and 15:30) and in the case of mortality, the weight of the dead bird/s and remaining feed 
in the respective feeder/s were recorded immediately.  
At 35 d of age, all birds were killed by cervical dislocation and carcasses were 
weighed individually. Intestinal digesta samples of four randomly selected birds from 
each pen were collected, pooled and stored as previously described. Upon manual 
evisceration, weights of the abdominal fat pads and boneless, skinless breast fillet and 
tenders (Pectoralis major and P. minor muscles) were recorded. As defined by Fancher  
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Table 3.3. Ingredient and nutrient composition of starter diets
1
 used in Exp. 2. 
Ingredient (%) LoPro:LoDig LoPro:HiDig HiPro:LoDig HiPro:HiDig 
  Wheat 20.00 20.00 30.00 30.00 
  Corn 22.55 28.47 2.64 7.40 
  Barley 5.51 1.40 11.50 4.77 
  Peas 7.73 5.83 15.00 15.00 
  Soybean meal 7.50 17.00 6.43 13.75 
  Canola meal 12.00 1.56 8.10 2.27 
  W-DDGS
2
 4.00 - 6.00 - 
  Wheat middlings - 7.13 - 8.00 
  Meat and bone meal 3.06 - 4.15 - 
  Fish meal 3.31 4.00 - 0.50 
  Blood meal - - 3.35 3.88 
  Canola oil 5.71 5.00 6.00 6.00 
  Dicalcium phosphate 0.85 1.25 0.95 1.62 
  Calcium carbonate 0.50 1.03 0.61 1.22 
  Sodium chloride 0.38 0.46 0.31 0.40 
  Vitamin/mineral premix
3
 0.50 0.50 0.50 0.50 
  Choline chloride 0.10 0.10 0.10 0.10 
  L-Lysine.HCL 0.40 0.32 0.32 0.24 
  DL-Methionine 0.25 0.27 0.29 0.31 
  L-Threonine 0.12 0.09 0.09 0.07 
  Arginine 0.13 0.10 0.07 0.07 
  Isoleucine 0.12 0.08 0.16 0.15 
  Valine 0.13 0.14 0.05 0.07 
  Glycine 0.10 0.22 0.05 0.19 
  AVIZYME
® 
1302
4
 0.05 0.05 0.05 0.05 
  Celite 5.00 5.00 3.27 3.45 
 
Calculated ME (MJ/kg) and nutrients (%) 
   ME  12.75 12.75 12.75 12.75 
   Total protein 22.5 21.0 24.5 23.0 
   AID protein 18.0 18.0 20.0 20.0 
   Neutral detergent fiber  9.6 9.5 9.5 9.5 
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   Calcium 0.94 0.94 0.94 0.94 
   Available Phosphorus 0.42 0.42 0.42 0.42 
   Linoleic acid 3.46 3.22 3.26 3.35 
   Sodium 0.20 0.20 0.20 0.19 
 
AA (%) - analyzed and (calculated digestible
5
) 
   Arginine 1.47 (1.28) 1.44 (1.28) 1.52 (1.28) 1.47 (1.29) 
   Isoleucine 0.99 (0.84) 0.94 (0.84) 0.98 (0.84) 0.95 (0.85) 
   Leucine 1.71 (1.33) 1.71 (1.33) 1.88 (1.35) 1.89 (1.35) 
   Lysine 1.44 (1.24) 1.40 (1.24) 1.47 (1.24) 1.51 (1.24) 
   Methionine 0.64 (0.57) 0.64 (0.57) 0.62 (0.57) 0.65 (0.57) 
   Methionine+Cystine 1.04 (0.90) 0.98 (0.90) 1.00 (0.90) 0.98 (0.90) 
   Threonine 0.93 (0.78) 0.87 (0.78) 0.90 (0.78) 0.85 (0.79) 
   Valine 1.19 (0.98) 1.15 (0.98) 1.27 (0.98) 1.29 (0.99) 
   Tryptophan (0.19) (0.20) (0.21) (0.21) 
Protein digestibility 
(calculated%) 80.0 85.7 81.6 87.0 
1
 LoPro: low protein level, HiPro: high protein level, LoDig: low protein digestibility, 
HiDig: high protein digestibility. 
2Wheat distiller’s dried grains with solubles. 
3
Supplied per kilogram of diet: vitamin A, 11,000 IU; cholecalciferol, 2,200 IU; vitamin 
E, 30 IU; vitamin K, 0.5 mg; vitamin B12, 0.02 mg; thiamine, 1.5 mg; riboflavin, 6 mg; 
folic acid, 0.6 mg; biotin, 0.15 mg; niacin, 60 mg; pyridoxine, 5 mg; pantothenic acid, 
0.02 mg; chloride, 788 mg; sodium, 511 mg; iron, 80 mg; manganese, 21.8 mg; 
selenium, 0.1 mg; iodine, 0.35 mg; zinc, 100 mg. 
4
Xylanase 5000 U/g; Protease 1600 U/g (Halchemix Canada Inc.). 
5
Standardized ileal digestible: based on values determined in Exp. 1 for W-DDGS and 
MBM and values obtained for all other ingredients from AminoDat 3.0 Platinum version 
(Evonik-Degussa GmbH, Hanau, Germany). 
 
 
 
 
 
  
57 
 
Table 3.4. Ingredient and nutrient composition of grower diets
1
 used in Exp. 2. 
Ingredient (%) LoPro:LoDig LoPro:HiDig HiPro:LoDig HiPro:HiDig 
  Wheat 33.58 33.75 74.50 70.00 
  Corn 14.39 18.67 - - 
  Barley 12.29 8.31 - - 
  Peas 4.96 0.72 0.64 4.65 
  Soybean meal - 8.45 - - 
  Canola meal 14.72 4.48 3.28 6.50 
  W-DDGS
2
 4.50 - 6.50 - 
  Wheat middlings - 9.50 - 3.87 
  Meat and bone meal 4.25 - 8.50 - 
  Fish meal - 2.75 - 2.18 
  Blood meal - - 0.23 2.47 
  Canola oil 6.00 6.00 2.70 3.93 
  Dicalcium phosphate 0.88 1.31 0.33 1.52 
  Calcium carbonate 0.58 1.11 0.001 1.07 
  Sodium chloride 0.31 0.42 0.22 0.39 
  Vitamin/mineral premix
3
 0.50 0.50 0.50 0.50 
  Choline chloride 0.10 0.10 0.10 0.10 
  L-Lysine.HCL 0.50 0.40 0.59 0.47 
  DL-Methionine 0.20 0.20 0.21 0.21 
  L-Threonine 0.15 0.12 0.18 0.16 
  Glycine 0.29 0.42 0.18 0.41 
  Arginine 0.16 0.16 0.20 0.25 
  Isoleucine 0.15 0.10 0.18 0.20 
  Valine 0.10 0.11 0.12 0.09 
  AVIZYME
® 
1302
4
 0.05 0.05 0.05 0.05 
  Celite 1.33 2.36 0.80 1.00 
 
Calculated ME (MJ/kg) and nutrients (%) 
  ME  13.17 13.17 13.17 13.17 
  Total protein 20.50 19.00 22.50 21.00 
  AID protein 16.00 16.00 18.00 18.00 
  Neutral detergent fiber 10.6 10.5 11.4 11.1 
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  Calcium 0.92 0.92 0.92 0.92 
  Available Phosphorus 0.40 0.40 0.40 0.40 
  Linoleic acid 3.50 3.58 1.74 2.34 
  Sodium 0.18 0.18 0.17 0.17 
     
AA (%) - analyzed and (calculated digestible
5
) 
   Arginine 1.30 (1.08) 1.21 (1.08) 1.35 (1.10) 1.26 (1.10) 
   Isoleucine 0.91 (0.72) 0.81 (0.72) 0.93 (0.74) 0.85 (0.74) 
   Leucine 1.45 (1.12) 1.39 (1.12) 1.44 (1.12) 1.49 (1.12) 
   Lysine 1.33 (1.04) 1.14 (1.04) 1.39 (1.05) 1.29 (1.04) 
   Methionine 0.57 (0.47) 0.51 (0.47) 0.59 (0.47) 0.55 (0.47) 
   Methionine+Cystine 0.97 (0.77) 0.85 (0.77) 0.98 (0.78) 0.91 (0.77) 
   Threonine 0.85 (0.67) 0.76 (0.66) 0.86 (0.68) 0.80 (0.68) 
   Valine 1.05 (0.82) 0.95 (0.82) 1.09 (0.84) 1.10 (0.84) 
   Tryptophan (0.17) (0.17) (0.18) (0.18) 
Protein digestibility 
(calculated%) 78.0   84.2 80.0 85.7 
1
 LoPro: low digestible protein, HiPro: high digestible protein, LoDig: low protein 
digestibility, HiDig: high protein digestibility 
2Wheat distiller’s dried grains with solubles 
3
Supplied per kilogram of diet: vitamin A, 11,000 IU; cholecalciferol, 2,200 IU; vitamin 
E, 30 IU; vitamin K, 0.5 mg; vitamin B12, 0.02 mg; thiamine, 1.5 mg; riboflavin, 6 mg; 
folic acid, 0.6 mg; biotin, 0.15 mg; niacin, 60 mg; pyridoxine, 5 mg; pantothenic acid, 
0.02 mg; chloride, 788 mg; sodium, 511 mg; iron, 80 mg; manganese, 21.8 mg; 
selenium, 0.1 mg; iodine, 0.35 mg; zinc, 100 mg. 
4
Xylanase 5000 U/g; Protease 1600 U/g (Halchemix Canada Inc.) 
5
Standardized ileal digestible: based on values determined in Exp. 1 for W-DDGS and 
MBM and values obtained for all other ingredients from AminoDat 3.0 Platinum version 
(Evonik-Degussa GmbH, Hanau, Germany) 
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and Jensen (1989a), the tissue surrounding the gizzard and intestines, extending within 
the ischium, and neighboring the cloaca, bursa of Fabricius and adjoining the abdominal 
muscle was considered as the abdominal fat pad, in the present study.  
 
3.3.3. Chemical analysis 
The feed ingredients, feed and freeze-dried digesta samples were ground through a 1 
mm screen using a Retsch Mill (Model ZM 100, Haan, Germany) prior to chemical 
analyses. Chemical analyses were conducted in duplicate. The ingredient, feed and 
digesta samples were analyzed for dry matter (DM) content by drying at 135°C in an 
airflow type oven for 2 h (method 930.15; AOAC 1990). For the digestibility study, feed 
and digesta samples were analyzed for chromic oxide after ashing at 450°C (Fenton and 
Fenton 1979) and for the performance study, grower diets and digesta samples were 
analyzed for acid insoluble ash after ashing at 500°C (MaCarthy et al. 1974). Samples 
were analyzed for CP and AA content (method 982.30E; AOAC 1990) by the Evonik 
Corporation (Evonik-Degussa GmbH, Hanau, Germany). 
 
3.3.4. Calculations and statistical Analysis 
The AID coefficients of AA for the W-DDGS and MBM evaluated in the Exp. 1 were 
calculated using the method of Ten Doeschate et al. (1993) from the formulae: 
DCdiet = 1 – [(Mdiet/Mi) × (Ci/Cdiet)] 
DCti = (DCdiet × Cdiet – DCref × Cref × 0.60)/(Cdiet – Cref × 0.60) 
Where DCdiet and DCti= digestibility coefficient of an AA in the diet and test ingredient 
Mdiet and Mi = chromic oxide content of the feed and the ileal digesta 
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 Ci, Cdiet and Cref = AA content of ileal digesta, of feed, and reference diet 
 DCref is the digestibility coefficient for the reference diet and was calculated using the 
same equation as for DCdiet. 
The AID coefficients of DM, CP and AA were determined for the four dietary 
treatments used in Exp. 2 with the same formula previously described for DCdiet, but 
using acid insoluble ash as the marker. For both experiments, SID of AA was calculated 
from AID coefficients using the method of Yin et al. (2002), based on the mean 
endogenous AA composition of basal endogenous protein (Kadim et al. 2002). The 
digestible AA content was calculated using total nutrient content multiplied by the 
digestibility coefficients. The PER was calculated as grams of weight gain per gram of 
protein intake, for each growth phase and the overall experimental period. Abdominal 
fat, breast fillets, breast tenders and total white muscle (breast fillet + breast tenders) 
yields were calculated relative to the final BW. 
Pen was considered as the experimental unit for the digestibility and growth 
performance variables while individual birds were considered as the experimental unit 
for the carcass variables in the Exp 2. Data from Exp 2 were analyzed as a 2 × 2 factorial 
arrangement with two levels of dietary protein and two levels of protein digestibility. 
Digestibility and carcass variables were analyzed using the GLM procedure of SAS 
(SAS Institute, Inc. Version 9.2) at the 5% level of significance. Performance variables 
were analyzed by analysis of variance using the MIXED procedure of SAS.  For the 
performance and carcass variables, the initial BW was used as a covariate.  
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3.4. Results  
The AA composition and the AA digestibility values of W-DDGS and MBM samples 
used in Exp. 1 are shown in Table 3.5. Of particular note, the SID for lysine in the W-
DDGS was only 56.5% indicating that the product may have been overheated during 
drying causing the formation of Maillard reaction products (Widyaratne and Zijlstra 
2007).  
 The DM digestibility of grower diets of Exp.2 was affected by the digestible 
protein level (P < 0.05), but not by the protein digestibility (Table 3.6). The DM 
digestibility was higher for HiPro diets than for LoPro diets. The CP digestibility was 
significantly affected by both main effects (P < 0.05) and was higher for HiPro diets and 
HiDig diets. The interaction between protein level and digestibility had a P-value of 0.06 
and was due to the birds fed the HiPro:HiDig diet having significantly higher ileal 
protein digestibility than birds fed the other three diets. This suggests that the effects of 
HiPro and HiDig are additive for CP digestibility. The interaction between protein level 
and digestibility was significant for the SID of most of the AA (P < 0.05). As with AID 
for CP, the SID coefficients of most of the AA were significantly higher for the 
HiPro:HiDig diet compared to the other three diets. Similarly, the main effects 
interacted for the SID AA content of all tested AA, except for glutamate (P < 0.05; 
Table 3.7), and digestible AA contents were lower for the LoPro:HiDig diet than for the 
other grower diets.  
During the starter phase of Exp. 2, neither of the main effects significantly 
affected growth performance (P > 0.05), but the protein level and digestibility interacted 
for ADG (P < 0.05; Table 3.8).  Compared to LoDig proteins, the HiDig proteins in the 
LoPro diet increased the ADG of starter birds by 5.2% (P < 0.05) while protein 
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Table 3.5. Moisture (%), crude protein, ammonia and amino acid composition (% DM) and, apparent (AID) and standardized (SID) 
ileal digestibility (%) of amino acids in the test ingredients measured in 28-d old broiler chickens in Exp. 1. 
 Item 
 Wheat DDGS
1
    Meat and bone meal
 
  
Composition AID
2
 SID
2
  Composition AID SID   
Moisture 9.77    4.73    
Crude protein 39.58    60.69    
Ammonia 1.37    0.77    
Amino acid         
  Alanine 1.53 64.0 ± 3.89
3
 67.4 ± 3.89  4.20 72.4 ± 1.33 73.6 ± 1.33  
  Arginine 1.78 76.4 ± 2.68 79.1 ± 2.68  3.83 72.0 ± 1.27 73.2 ± 1.27  
  Aspartate 2.04 47.0 ± 5.38 49.9 ± 5.38  4.65 47.5 ± 1.70 48.7 ± 1.70  
  Glutamate 10.52 85.9 ± 1.71 86.6 ± 1.71  7.40 62.5 ± 1.57 63.5 ± 1.57  
  Glycine 1.62 63.2 ± 3.30 65.9 ± 3.30  6.95 64.4 ± 0.97 65.0 ± 0.97  
  Histidine 0.95 67.2 ± 2.55 69.1 ± 2.54  1.42 69.3 ± 1.14 70.6 ± 1.14  
  Isoleucine 1.36 68.2 ± 3.86 71.4 ± 3.85  1.87 64.7 ± 1.59 67.1 ± 1.60  
  Leucine 2.58 75.7 ± 3.24 77.8 ± 3.24  3.89 69.9 ± 1.34 71.2 ± 1.34  
  Lysine 1.05 52.5 ± 4.46 56.5 ± 4.46  3.34 70.7 ± 1.21 72.0 ± 1.21  
  Methionine 0.63 74.6 ± 2.88 77.6 ± 2.88  0.96 74.9 ± 1.09 76.9 ± 1.09  
  Phenylalanine 1.72 80.2 ± 2.90 82.6 ± 2.90  2.08 68.0 ± 1.32 70.0 ± 1.32  
  Proline 3.68 84.1 ± 1.56 85.4 ± 1.56  4.58 59.7 ± 1.53 60.8 ± 1.53  
  Serine 1.78 72.4 ± 2.88 76.4 ± 2.88  2.44 57.3 ± 1.50 60.3 ± 1.50  
  Threonine 1.26 62.9 ± 3.40 68.7 ± 3.40  2.14 63.1 ± 1.55 66.5 ± 1.55  
  Valine 1.66 68.9 ± 3.68 72.1 ± 3.68   2.65 67.8 ± 1.36 69.8 ± 1.36   
  Total 36.29    54.00    
6
2
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1
Wheat distillers dried grains with solubles 
2
Values were calculated from results of Exp. 1 
3
Values are means ± standard deviation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6
3
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Table 3.6. Effect of the interaction between digestible protein level and protein digestibility on apparent (AID: DM and CP) and 
standardized (SID: AA) ileal digestibility (%) measured in 35-d old broiler chickens. 
Item 
LoPro
1
  HiPro
1
 
SEM 
P Value 
LoDig
2
 HiDig
2
  LoDig HiDig Protein Digestibility Interaction 
Dry matter 68.79 68.20  70.52 70.73 0.78 0.011 0.809 0.613 
Crude protein 77.06b 77.24b  77.25b 80.89a 0.87 0.040 0.037 0.057 
Amino acid          
  Lysine 86.96ab 86.09b  86.53b 89.26a 0.90 0.138 0.307 0.054 
  Methionine 92.41ab 91.31b  91.44b 93.72a 0.71 0.321 0.416 0.025 
  Threonine 82.48 83.15  83.11 87.40 1.08 0.031 0.029 0.104 
  Isoleucine 87.11b 86.64b  87.47b 90.08a 0.87 0.038 0.230 0.087 
  Arginine 88.23ab 88.09ab  86.06b 88.98a 0.75 0.402 0.073 0.051 
  Phenylalanine 85.35 85.16  86.45 89.11 1.00 0.017 0.225 0.163 
  Histidine 83.10b 82.60b  81.95b 88.22a 0.90 0.019 0.003 0.001 
  Leucine 84.50b 84.21b  84.30b 88.60a 0.94 0.035 0.042 0.022 
  Valine 84.23b 84.30b  84.39b 88.34a 0.87 0.023 0.029 0.035 
  Alanine 82.50b 82.41b  80.62b 86.53a 1.09 0.311 0.012 0.010 
  Aspartate 74.13b 75.62b  68.72c 79.66a 1.19 0.569 <0.0001 0.001 
  Glutamate 89.09b 88.66b  90.07b 92.24a 0.63 0.001 0.175 0.049 
  Glycine 82.95c 85.19b  79.50d 87.52a 0.74 0.457 <0.0001 0.001 
  Proline 84.18 86.30  86.73 90.78 0.70 <0.0001 0.0001 0.182 
  Serine 82.37 84.53  82.86 87.71 0.99 0.075 0.002 0.186 
1
 LoPro: low digestible protein, HiPro: high digestible protein 
2
 LoDig: low protein digestibility, HiDig: high protein digestibility 
a-d
Means within rows with different superscripts are significantly different (P < 0.05)  
6
4
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Table 3.7. Effect of the interaction between digestible protein level and protein digestibility on standardized ileal digestible amino acid 
contents (%) measured in 35-d old broiler chickens. 
Amino acid 
LoPro
1
  HiPro
1
 
SEM 
P Value 
LoDig
2
 HiDig
2
  LoDig HiDig Protein Digestibility Interaction 
Lysine 1.16b 0.99c  1.20a 1.16b 0.01 <0.0001 <0.0001 <0.0001 
Methionine 0.53b 0.46c  0.54a 0.52b 0.00 <0.0001 <0.0001 <0.0001 
Threonine 0.70a 0.63b  0.72a 0.70a 0.01 <0.0001 <0.0001 0.010 
Isoleucine 0.80a 0.71c  0.81a 0.77b 0.01 <0.0001 <0.0001 0.005 
Arginine 1.14ab 1.07c  1.16a 1.12b 0.01 0.0004 <0.0001 0.050 
Phenylalanine 0.74b 0.72b  0.80a 0.82a 0.01 <0.0001 0.832 0.018 
Histidine 0.40b 0.37c  0.40b 0.52a 0.00 <0.0001 <0.0001 <0.0001 
Leucine 1.23b 1.17c  1.22b 1.33a 0.01 <0.0001 0.060 <0.0001 
Valine 0.89c 0.80d  0.92b 0.97a 0.01 <0.0001 0.037 <0.0001 
Alanine 0.75a 0.69b  0.77a 0.77a 0.01 <0.0001 0.002 0.002 
Aspartate 0.98b 1.06a  0.88c 1.07a 0.02 0.009 <0.0001 0.002 
Glutamate 3.79c 3.47d  4.46a 4.03b 0.03 <0.0001 <0.0001 0.062 
Glycine 1.14a 1.05b  1.15a 1.15a 0.01 <0.0001 <0.0001 <0.0001 
Proline 1.30b 1.14c  1.55a 1.33b 0.01 <0.0001 <0.0001 0.009 
Serine 0.71c 0.72c  0.78a 0.75b 0.01 <0.0001 0.209 0.022 
1
 LoPro: low digestible protein, HiPro: high digestible protein 
2
 LoDig: low protein digestibility, HiDig: high protein digestibility 
a-d
Means within rows with different superscripts are significantly different (P < 0.05) 
 
 
6
5
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Table 3.8. Effect of the interaction between digestible protein level and protein digestibility on growth performance during starter, 
grower and overall periods of broiler chickens. 
 LoPro
1
  HiPro
1
 
SEM 
P Value 
Variable LoDig
2
 HiDig
2
  LoDig HiDig Protein Digestibility Interaction 
Starter          
ADG
3
 33.94
b
 35.72
a
  34.92
ab
 34.14
ab
 0.57 0.603 0.389 0.034 
ADFI
4
 
 
44.00 45.88  45.49 45.34 0.69 0.504 0.223 0.153 
FCR
5
 1.30 1.29  1.31 1.33 0.02 0.240 0.803 0.425 
 
         
Grower          
ADG 83.07 85.65  85.31 86.10 1.31 0.312 0.207 0.499 
ADFI 
 
134.35
b
 144.45
a
  139.83
ab
 141.22
a
 1.92 0.562 0.006 0.031 
FCR 1.55b 1.60a  1.57ab 1.58ab 1.01 0.795 0.026 0.077 
          
Overall          
ADG 58.51 60.69  60.11 60.12 0.85 0.545 0.209 0.212 
ADFI 
 
89.18
b
 95.17
a
  92.66
a
 93.28
a
 1.12 0.483 0.007 0.024 
FCR 1.42 1.44  1.44 1.45 0.01 0.353 0.189 0.883 
          
Final BW 2483
b
 2649
a
  2627
a
 2592
ab
 0.04 0.322 0.137 0.023 
1
 LoPro: low digestible protein, HiPro: high digestible protein 
2
 LoDig: low protein digestibility, HiDig: high protein digestibility 
3
average daily gain (g/d); 
4
average daily feed intake (g/d); 
5
feed conversion ratio (g/g); 
6
Final body weight at 35d of age (g) 
a,b
Means within rows with different superscripts are significantly different (P < 0.05)
6
6
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digestibility did not affect the growth of starter birds fed HiPro diets (P > 0.05). Neither 
dietary protein level nor protein digestibility affected the ADG of birds during the 
grower phase (P > 0.05), but an interaction between the two factors affected ADFI (P 
<0.05). The LoDig proteins reduced ADFI of growers fed LoPro diets by 7.5% (P < 
0.05), but not of birds fed HiPro diets (P > 0.05). The FCR was 1.9% higher for growers 
fed HiDig proteins (P <0.05). The dietary protein level did not affect the FCR (P > 
0.05), only tended to interact with digestibility (P = 0.08).  The protein level, protein 
digestibility or their interaction did not affect the overall growth and the FCR of the 
birds (P > 0.05), but an interaction between the two main effects affected the overall 
ADFI of birds (P < 0.05). Similar to grower phase, LoDig proteins reduced the overall 
ADFI of birds fed LoPro diets by 6.3% (P < 0.05), but not of birds fed HiPro diets (P > 
0.05). The interaction between protein level and digestibility was significant for the final 
BW of the birds (P < 0.05; Table 3.8).  The overall growth of birds fed the LoPro:HiDig 
diet was significantly higher than those fed the LoPro:LoDig diet (P < 0.05) and similar 
to birds fed HiPro diets (P > 0.05). 
Both main effects were significant for PER during the starter and grower periods 
as well as over the whole experiment (P < 0.05; Figure 3.1). Birds fed LoPro diets and 
HiDig proteins significantly increased the PER throughout the experiment than those fed 
HiPro diets and LoDig proteins, respectively. In addition, the PER was significantly 
higher for starter birds than for growers (P < 0.05; Figure 3.1). 
Protein level but not digestibility affected the Pectoralis major, P. minor and 
total breast muscle yield (P < 0.05; Table 3.9); the birds fed HiPro diets yielded 6.7, 3.6 
and 6.2% more P. major, P. minor and total breast meat, respectively than birds fed 
LoPro diets. In contrast, protein digestibility but not level significantly increased the  
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(A) 
 
(B) 
 
Figure3.1. Effect of dietary protein level and protein digestibility (A) and, growth phase 
(B) on the PER of broiler chickens used in Exp.2. 
a,b
Means for each factor within starter, grower and overall growth periods with different 
superscripts are significantly different (A) and means with different superscripts are 
significantly different (B) (P < 0.05). 
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Table 3.9. Effect of dietary protein level and protein digestibility on breast muscle yield 
and accumulation of abdominal fat in broiler chickens in Exp. 2. 
 Level  Digestibility  P Value 
Variable Low High  Low High SEM  Level Digestibility Interaction 
Yield (% of live weight)         
   Pectoralis major 15.3
b
 16.3
a
  15.9 15.7 0.11 <0.01 0.39 0.79 
   Pectoralis minor 3.29
b
 3.41
a
  3.38 3.32 0.04 0.01 0.19 0.79 
   Total breast meat 18.6
b
 19.7
a
  19.2 19.1 0.12 <0.01 0.26 0.87 
   Abdominal fat 1.33 1.27  1.20
b
 1.40
a
 0.03 0.17 <0.01 0.39 
a,b
Means within a main effect with different superscripts are significantly different (P < 
0.05)
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amount of abdominal fat (P < 0.05). Birds fed HiDig proteins yielded 16.7% more 
abdominal fat than birds fed LoDig diets.  
 
3.5. Discussion  
One of the main limitations associated with this type of study is the inability to meet the 
required nutrient specifications with the same set of ingredients. This results in the 
problem of distinguishing nutrient effects from ingredient effects. Balancing diets based 
on SID may reduce this problem (Lemme et al. 2004). The premise of formulating feeds 
based on SID is that diets with equal SID AA should give equal growth performance 
(Angkanaporn et al. 1996). This result is independent of feed intake and the ingredients 
used in the diets (Angkanaporn et al. 1996; Ravindran and Bryden 1999; Stein et al. 
2001; Lemme et al. 2004). In the current study, the low digestible (LoDig) diets were 
prepared using W-DDGS and MBM as the primary sources of protein. Given that the 
digestible nutrient contents of these products are extremely variable, a digestibility trial 
was performed so that feed formulation would be accurate. In contrast, soybean meal is 
consistent in its digestible nutrient content to a great extent and the fishmeal used was of 
high quality and had previously been analyzed for total nutrient content and nutrient 
digestibility calculated from a reliable database. 
The AID of DM was higher in birds fed HiPro diets than in birds fed LoPro diets 
at d 35. This can be attributed to the ingredient composition of the grower diets used in 
this study. Wheat was the main cereal grain in the HiPro diets while barley was 
included, albeit at low levels, in LoPro diets in addition to wheat. All diets contained 
xylanase which degrade arabinoxylan, the key anti-nutritional factor presents in wheat 
(Zijlstra et al. 1999). Nevertheless, no enzyme was included in diets to break down β-
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glucan, the main anti-nutritional factor in barley (Bach Knudsen 1997). Accordingly, the 
intact β-glucan present in LoPro diets might have constrained the DM digestibility of 
respective diets. As expected, the AID of CP was higher in diets containing high 
digestible (HiDig) protein sources. In addition, HiPro diets demonstrated higher CP 
digestibility, entirely due to markedly higher CP digestibility in HiPro:HiDig diet.  
Birds fed LoPro:HiDig diet demonstrated the lowest values for SID content for 
most of the AA, despite lower and similar SID, compared to birds fed HiPro:HiDig and 
LoDig diets, respectively. Since the diets were formulated on the SID AA basis, the 
standardized ileal digestible AA contents should hypothetically be similar for each AA 
among the four grower diets. Nevertheless, the standardized ileal digestible AA content 
in those birds fed LoPro:HiDig diet closely resembled the numbers used in feed 
formulation. Digestible nutrient content is a factor of digestibility of particular nutrient. 
Ileal AA digestibility is calculated considering the disappearance of AA at the terminal 
ileum as a percentage of dietary intake, assuming the portion that disappeared on its way 
to the terminal ileum is digested and absorbed by the host animal. However, an amount 
of this disappeared portion is subjected to intestinal microbial metabolism and 
utilization. Accordingly, that assumption makes ileal AA digestibility, hence the ileal 
digestible AA content overestimated. The amount utilized by microbes correlates to the 
degree of intestinal microbial activity. In the present study, however, the ADG of birds 
fed LoPro:HiDig diet was similar to that of birds fed the other three diets, during the 
grower and the overall experimental periods. The PER data demonstrated maximum 
protein utilization in birds fed LoPro diets and HiDig proteins. The birds fed 
LoPro:HiDig diet demonstrated the highest final BW. These observations suggest that 
the maximum utilization of disappeared portion of AA for protein accretion occurred in 
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birds fed LoPro:HiDig diet. In birds fed the other three diets, a considerable amount of 
AA may have been utilized for increased microbial activities. Accordingly, it can be 
predicted that feeding poorly digestible proteins or high dietary protein may increase the 
intestinal microbial activity (Apajalahti et al. 2004). However, intestinal bacterial 
numbers or microbial activity was not evaluated in this study, therefore this hypothesis 
needs to be tested. 
Neither protein level nor digestibility affected the feed intake of the birds in the 
starter phase. This was probably as a result of physical restrictions on feed intake of 
birds due to limited gut capacity (Griffiths et al. 1977).  However, birds fed 
LoPro:HiDig diet grew faster than the birds fed LoPro:LoDig diet. It is well understood 
that, to be of any value to the animal, dietary protein must be digested and the ensuing 
AA absorbed prior to reaching the hind gut. The nutrients available to intestinal bacteria 
are primarily derived from the indigestible portion of feeds. Changes in the composition 
of intestinal contents can lead to changes in intestinal microbial numbers, species and 
species diversity (Drew et al. 2002; Hill et al. 2005; Dahiya et al. 2006; Pieper et al. 
2008). Intestinal microbes of the birds fed diets containing LoDig proteins would likely 
receive relatively higher amounts of AA as undigested proteins. Some metabolites 
derived as a result of bacterial fermentation of certain AA can affect the enterocyte 
turnover thus overall growth performance of the host (Ewing and Cole 1994; Macfarlane 
and Macfarlane 1995; Gaskins 2001; van der Klis and Jansman 2002). However, broiler 
starters fed LoPro:HiDig diet had a better growth compared to the starters fed 
LoPro:LoDig diet, likely due to higher availability of AA for hind gut bacterial activity, 
as described above.  
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The capacity of the GIT of bird increases with age, therefore the physical state of 
restriction on the quantity of feed intake should be decreased (Hidalgo et al. 2004; 
Kamran et al. 2008), However, the feed intake of growers fed LoPro diets was not 
increased in the present study. Instead, the feed intake of birds fed the LoPro diet 
containing LoDig proteins reduced by 7.5% compared to LoPro:HiDig diet fed 
counterparts. This trend was observed in birds fed HiPro:LoDig diet, as well. Despite 
the equal amounts of digestible protein within each of the LoPro and HiPro diets used in 
the present study, the diets with HiDig proteins contained a lesser amount of total 
protein (CP) than in diets with LoDig proteins. Aletor et al. (2000) reported an increase 
in feed intake in broiler growers fed lCP – AA supplemented diets. On the other hand, 
higher amounts of nitrogen received by the gut microbes of the birds fed diets containing 
LoDig proteins as undigested proteins may result in an increased in hind gut 
fermentation (Piva et al. 1995). The physical distention of the hind gut and the resultant 
low digesta passage rate caused by high microbial fermentation might reduce feed 
consumption (Cherbut et al. 1988). Despite reduced feed intake, birds fed LoDig 
proteins (hCP) utilized feeds more efficiently compared to the birds fed HiDig proteins 
(lCP), as reflected by the FCR. This observation was in agreement with Aletor et al. 
(2000), who reported a corresponding increase in FCR, associated with increased feed 
consumption in broiler growers fed lCP – AA supplemented diets.  
Despite the similar SID AA levels in all experimental diets, utilization of dietary 
protein was more effective in birds fed LoPro (either total or digestible) diets and HiDig 
protein than in birds fed HiPro diets and LoDig proteins, respectively, as indicated by 
the PER. This observation was in agreement with the findings of Cheng et al. (1997) and 
Aletor et al. (2000), who reported a significant increase in PER with the reduction in 
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dietary CP content. In addition, non essential AA supplementation of lCP diets reduced 
the PER values compared to the un-supplemented counterparts (Aletor et al. 2000). 
Broilers used in this study utilized dietary protein more efficiently during the starter 
phase compared to the grower phase. Similarly, Johnson and Parsons (1997) and 
Kamran et al. (2008) measured the PER in broiler chickens at different growth stages 
and reported a reduction in PER with increasing age. These findings can probably be 
attributed to the increasing nutrient requirements for maintenance with the progression 
of the age. Overall, the PER results suggest that for the most efficient utilization of 
dietary protein, high quality proteins should be assimilated in broiler rations and 
essential AA should be included in amounts not greater than compelled for optimum 
performance. This was well supported by the final BW of the birds which was optimized 
in birds fed LoPro diets containing HiDig proteins.  
Birds fed HiPro diets yielded more breast muscle (breast fillets, breast tenders 
and total white muscle) compared to birds fed LoPro diets. Since the experimental diets 
of the current study were formulated to be iso-energetic, the ME: CP ratio of HiPro diets 
was lower than that of LoPro diets. Some previous studies reported similar observations 
in broilers fed diets with low ME:CP ratio with an increase in breast meat yield with the 
age of the birds (Moran 1977; Peng et al. 1985; Swatland 1989; Bartov and Plavnik 
1998; Corzo et al. 2005; Dozier et al. 2006). The reported findings suggest that breast 
muscle yield is responsive to dietary protein level above that required for growth. 
Accordingly, the propensity to reduce dietary protein level in diets fed during the latter 
phases of broiler production should be reassessed if maximal breast meat yield is of 
importance and the birds are schedule for marketing at a relatively advanced age.  
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The content of abdominal fat was higher in the birds fed HiDig proteins than in 
birds fed LoDig proteins. Many previous studies have reported that birds fed lCP had 
increased feed intake with a concurrent increase in the deposition of abdominal fat 
(Fancher and Jensen 1989b,c; Rosebrough and McMurtry 1993). Although the iso-
energetic diets used in the present study contained equal amounts of digestible protein at 
each low and high level, the ME:CP ratio was higher in diets containing HiDig proteins, 
compared to respective diets with LoDig proteins. It is generally accepted that feeds 
containing a high energy: protein ratio promote the retention of excess energy as fat 
(Kamran et al. 2008) and as a result, the birds fed those diets containing HiDig proteins 
with a higher ME:CP ratio deposited the excess energy as body fat in the present study. 
 In conclusion, the overall findings of this study suggest that the use of highly 
digestible feed ingredients when formulating low-protein diets may significantly reduce 
the negative effects of low-protein diets on the growth performance of broilers. This 
interaction between protein level and protein digestibility may partially explain the lack 
of consensus in the literature on the effects of low-protein diets on the growth 
performance of broiler chickens. However, the relationship between lowered gut AA 
content and improved growth performance requires further investigation to elucidate the 
mode of action. 
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4. EVALUATION OF MICROBIOLOGICAL, PATHOLOGICAL AND 
HEMATOLOGICAL PARAMETERS IN AN EXPERIMENTAL DISEASE 
MODEL FOR NECROTIC ENTERITIS IN BROILER CHICKENS RAISED ON 
LITTER 
 
4.1. Abstract 
Two experiments were conducted to establish a potential experimental model for NE in 
broiler chickens raised on litter. In Exp. 1, 96 birds were placed in two rooms in eight 
floor pens/room. Birds in one room were challenged, either by gavaging or offering feed 
mixed with cooked meat medium containing C. perfringens type A. In Exp. 1, C. 
perfringens challenge reduced the ADG of birds during d 14 to 21, d 29 to 35 and d 14 
to 35 (entire) periods, by 9.14, 16.06 and 8.65%, respectively (P < 0.05). The ADG was 
not affected by challenging mode during particular periods (P > 0.05). The two main 
effects interacted for the ADFI and FCR of birds for the period of d 14 to 21 (P < 0.05); 
C. perfringens challenge reduced the feed consumption and in-feed challenge reduced 
the ADFI by 19.8% compared to gavaging. The FCR in unchallenged birds was not 
affected by the mode of challenging, but the pathogen administration with feed reduced 
the FCR by 17.34% compared to gavaging. In the d 29 to 35 period, ADFI was reduced 
and the FCR was increased 9.88 and 8.33%, respectively, by the C. perfringens 
challenge (P < 0.05). C. perfringens challenge reduced the ADFI during the overall 
experimental period by 9.39% compared to the unchallenged birds (P < 0.05). Neither C. 
perfringens challenge nor challenge mode affected the growth performance during the d 
22 to 28 period (P > 0.05) and the challenge mode did not affect the parameters either in 
d 29 to 35 or the overall experimental period (P > 0.05). Neither of the main effects 
affected the FCR during the overall experimental period (P > 0.05). Two challenge 
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modes did not affect the C. perfringens counts either in the ileum or cecum (P > 0.05). 
In Exp. 2, 48 broiler chickens raised on litter were orally inoculated with C. perfringens 
in cooked meat medium, using two modes (water or feed) at two dose rates (2 or 4 mL 
per bird). Neither the mode nor the dose of C. perfringens administration did not 
affected the growth performance, during d 14 to 21, d 21 to 28 and d 14 to 28 (entire) 
periods (P > 0.05). The two main effects did not affect the C. perfringens counts in the 
ileum and the cecum and histopathological and hematological variables (P > 0.05). The 
results suggest that each modes of C. perfringens administration described herein can be 
exploited with either dose rates to induce NE in broiler chickens raised on litter. 
 
4.2. Introduction 
Necrotic enteritis is a bacterial infection with a considerable economic impact on the 
poultry industry (McDevitt et al. 2006). This infection is caused by some C. perfringens 
type A strains carrying the genes for α or NetB toxins (Keyburn et al. 2008, Van 
Immerseel et al. 2008). The disease may emerge in clinical or subclinical forms (Van 
Immerseel et al. 2004). Broiler producers experience high flock mortality with the acute 
clinical version of the disease (Wages and Opengart 2003), while the subclinical form of 
the disease negatively affects the growth performance of broiler chickens (Elwinger et 
al. 1992; Porter 1998; Lovland and Kaldhusdal 2001). Traditionally, NE prevention 
strategies have taken the form of antibacterial feed additives, often referred to as growth 
promoters (Maxey and Page 1977; George et al. 1982; Stutz and Lawton 1984; 
Hofshagen and Kaldhusdal 1992; Ficken and Wages 1997; Watkins et al. 1997). The 
current debate regarding the non-therapeutic use of antibiotics in animal feed has 
suggested the requirement of a substantial understanding of the factors associated with 
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the pathogenesis of NE. Nevertheless, the major problem in the evaluation of the factors 
associated with the development of NE and potential controlling methods is the lack of a 
reproducible disease model. Several approaches to reproduce NE in broiler chickens 
have been documented in the literature, describing different disease models. The 
majority of approaches have used the factors which predispose birds to NE, such as 
coccidial co-infection, to induce the disease (Kageyama et al. 1987; Williams et al. 
2003). However, none of the methods developed so far is recognized as a robust disease 
model for NE.   
Several parameters are used in estimating the severity of NE; intestinal gross 
lesions and bacterial counts in digesta contents are the main determinants for the 
subclinical form of the disease while mortality is the key response for the acute form of 
NE (Kaldhusdal and Lovland 2000). Methods such as whole-blood chemiluminescence 
(WBCL) assay (Papp and Smits 2007; Papp et al. 2009) and microscopic lesion scoring 
systems (Gholamiandehkordi et al. 2007) are emerging as novel approaches to quantify 
the severity of the disease. 
 The current challenge model used in our laboratory involves the gavage of 
chickens on d15-19 post-hatch with 1 ml of an overnight culture of C. perfringens 
(Wilkie et al. 2005; Dahiya et al. 2005; 2007a,b). This method requires the handling of 
every bird daily for 5 consecutive days, and this limits the size of the experiment to a 
relatively small number of birds. However, studies examining the effect of C. 
perfringens infection on growth performance of broilers require a larger number of birds 
making the current method of infection impractical. The current study was thus 
conducted to evaluate the mode and the dose of C. perfringens challenge on the growth 
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performance, innate immune status, intestinal lesions and growth of C. perfringens in 
ileal and cecal contents in broiler chickens. 
 
4.3. Materials and methods 
Two experiments were conducted at the Animal Care Unit in the Western College of 
Veterinary Medicine, University of Saskatchewan. Experimental protocols for both 
experiments were approved by the Animal Care Committee of the University of 
Saskatchewan and were performed in accordance with recommendations of the 
Canadian Council on Animal Care as specified in the guide to the Care and Use of 
Experimental Animals (Canadian Council on Animal Care 2005). 
 
4.3.1. Birds and management 
One-day-old male broiler chicks (Ross 308; Gallus gallus), obtained from a local broiler 
hatchery (Lilydale Hatchery, Wynyard, Saskatchewan, Canada) were used in both 
experiments and standard management procedures were followed. Floor pens used in 
both experiments were equipped with a pan feeder, a manual drinker and new soft-wood 
shavings. Ambient temperatures gave optimal comfort for the birds with controlled 
temperature and humidity. The lighting schedule used was intended not to restrict early 
growth and consisted of 23 h light and 1 h dark from day 1 to 14 and, 20 h light and 4 h 
dark from d 15 onwards. Feed and water were available for ad libitum consumption, 
throughout both experiments. Upon arrival, a total of 96 birds were randomly placed in 
two rooms (48 birds in eight pens/room) in Exp. 1 and 48 birds were randomly 
distributed into eight pens in one room in Exp. 2.  
 
  
80 
 
4.3.2. Feed and feeding 
The birds were fed the same corn/soybean meal-based starter crumble diet (3,200 
kcal/kg of ME; 1.2% Lys) described in chapter 3 (Table 3.1: Federated Coop Feeds, 
Saskatoon, Saskatchewan, Canada) for the first 14 d of both experiments. On d 14, the 
birds were weighed and introduced to ideal protein-balanced, unmedicated grower 
rations. In Exp. 1, the crumbled grower diet contained 18% AID CP and 13.17 MJ/kg of 
ME (Table 4.1). In Exp. 2, the grower diet was in mash form and formulated to contain 
23% AID CP and 12.75 MJ/kg of ME (Table 4.2). Both grower diets met or exceeded 
the NRC requirements for broiler chickens for all other nutrients [National Research 
Council (NRC) 1994] and were fed until the end of the experiments. 
 
4.3.3. Preparation of innoculum 
For this study a C. perfringens field strain isolated from a clinical case of NE in broiler 
chickens was used (Dr. M. Chirino, Western College of Veterinary Medicine, University 
of Saskatchewan, Saskatoon, SK). The particular strain was characterized using 
Polymerase chain reaction (PCR) technique as a type A toxin producer (Dumonceaux et 
al. 2006). The organism was cultured anaerobically on BBL Blood Agar Base (Becton 
Dickinson Co., Sparks, MD) containing 5% sheep blood and 100 mg/L of Neomycin 
Sulphate (The Upjohn Co., Orangeville, ON, Canada) for 18 h at 37ºC, then aseptically 
inoculated into a sterilized preparation of Robertson’s cooked meat broth (Difco 
Laboratories, Detroit, MI), and incubated anaerobically and statically for 8 h at 37ºC.  
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Table  4.1. Ingredient and nutrient composition of grower diet used for all birds from d 
14 to 35 of age in Exp. 1 (as fed basis). 
Component Inclusion (%) 
Ingredient content  
  Wheat 74.50 
  Peas 0.64 
  Canola meal 3.28 
  Wheat distiller’s dried grains with solubles 6.50 
  Meat and bone meal 8.50 
  Blood meal 0.23 
  Canola oil 2.70 
  Dicalcium phosphate 0.33 
  Calcium carbonate 0.001 
  Sodium chloride 0.22 
  Vitamin-mineral premix
1
 0.50 
  Choline chloride 0.10 
  L-Lysine.HCL 0.59 
  DL-Methionine 0.21 
  L-Threonine 0.18 
  Glycine 0.18 
  Arginine 0.20 
  Isoleucine 0.18 
  Valine 0.12 
  AVIZYME
® 
1302
2
 0.05 
  Celite 0.80 
  
Calculated energy and nutrient content (%)  
  ME (MJ/kg) 13.17 
  AID CP 18.00 
  AID Glycine 1.00 
  Calcium 0.92 
  Available phosphorus 0.40 
  Linoleic acid 1.74 
  Sodium 0.17 
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SID Lysine 1.05 
SID Methionine 0.47 
SID Met+Cys 0.78 
SID Threonine 0.68 
SID Tryptophan 0.18 
SID Arginine 1.10 
SID Valine 0.84 
SID Isoleucine 0.74 
SID Leucine 1.12 
1
Supplied per kilogram of diet: vitamin A, 11,000 IU; cholecalciferol, 2,200 IU; vitamin 
E, 30 IU; vitamin K, 0.5 mg; vitamin B12, 0.02 mg; thiamine, 1.5 mg; riboflavin, 6 mg; 
folic acid, 0.6 mg; biotin, 0.15 mg; niacin, 60 mg; pyridoxine, 5 mg; pantothenic acid, 
0.02 mg; chloride, 788 mg; sodium, 511 mg; iron, 80 mg; manganese, 21.8 mg; 
selenium, 0.1 mg; iodine, 0.35 mg; zinc, 100 mg. 
2
Xylanase 5000 U/g; Protease 1600 U/g (Halchemix Canada Inc.) 
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Table  4.2. Ingredient and nutrient composition of the grower diet used for all birds from 
d 14 to 28 of age in Exp. 2 (as fed basis). 
Component Inclusion (%) 
Ingredient content  
  Corn 34.00 
  Wheat 30.00 
  Peas 0.08 
  Soybean meal 11.93 
  Canola meal 0.66 
  Corn gluten meal 5.72 
  Blood meal 1.83 
  Meat and bone meal 4.69 
  Fish meal 1.16 
  Gelatin 4.00 
  Canola oil 1.00 
  L-Lysine HCl 0.22 
  DL-Methionine 0.13 
  Dicalcium phosphate 1.81 
  Calcium carbonate 0.97 
  Sodium chloride 0.20 
  Choline chloride 0.10 
  Vitamin-mineral premix
1
 0.50 
  Celite 1.00 
  
Calculated energy and nutrient content (%)   
  ME (MJ/kg) 12.75 
  AID CP  23.00 
  Calcium (%) 1.20 
  Available phosphorus  0.60 
    AID Met + Cys 0.83 
    AID Lysine 1.11 
    AID Threonine 0.72 
    AID Trptophan 0.20 
    AID Arginine 1.36 
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    AID Isoleucine 0.73 
    AID Leucine 2.08 
    AID Valine 1.03 
    AID Glycine 1.75 
1
Supplied per kilogram of diet: vitamin A, 11,000 IU; cholecalciferol, 2,200 IU; vitamin 
E, 30 IU; vitamin K, 0.5 mg; vitamin B12, 0.02 mg; thiamine, 1.5 mg; riboflavin, 6 mg; 
folic acid, 0.6 mg; biotin, 0.15 mg; niacin, 60 mg; pyridoxine, 5 mg; pantothenic acid, 
0.02 mg; chloride, 788 mg; sodium, 511 mg; iron, 80 mg; manganese, 21.8 mg; 
selenium, 0.1 mg; iodine, 0.35 mg; zinc, 100 mg. 
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4.3.4. Experimental design and challenge procedure 
Both experiments were conducted based on 2 x 2 factorial arrangements. The main 
effects for the Exp. 1 were C. perfringens infection (challenged or unchallenged) and 
challenge mode (oral gavage or in-feed) whereas for the Exp. 2, mode (feed or water) 
and dose (2 or 4 ml of broth culture/bird) of challenging the birds. Respective birds were 
challenged once daily with the actively growing broth culture of C. perfringens on d 15 
to 19 (inclusive). Fresh cultures were prepared daily and culture-feed/water mixing was 
done immediately before offering to the birds. Bacterial counts were performed on the 
culture daily before inoculation and the counts ranged from 5.89 x 10
6
 to 7.24 x 10
6 
colony forming units per ml (cfu/ml). 
In Exp.1, all birds in one room were challenged, either by gavaging or offering 
feed mixed with cooked meat medium broth containing C. perfringens type A. Each bird 
in four pens received 1/3 of ADFI (24 g of feed each at the particular age) mixed with 4 
ml of the broth culture whereas the birds in the remaining four pens in the same room 
were orally gavaged with 1.0 ml of same broth culture. Birds in the other room were 
either orally gavaged with 1.0 ml sterile cooked meat medium broth or fed 1/3 of ADFI 
mixed with 4 ml of sterile cooked meat medium broth (Table 4.3).  
In Exp. 2, birds in four pens received 1/3 of ADFI mixed with either 2 or 4 ml of 
broth culture (2 pens each) whereas the birds in the remaining four pens received 0.1% 
sterile peptone buffer with 5 g/L Cys hydrochloride (Sigma Chemical Co., St. Louis, 
MO), an amount equivalent to 1/4 of average daily water consumption (35 ml each at the 
particular age) mixed with either 2 or 4 ml of the same broth culture (2 pens each: Table 
4.3). To ascertain a better survival of the organism in the environment, peptone water 
containing Cys hydrochloride (5g/L) was used, instead of tap water.  
  
86 
 
Table 4.3. Experimental designs to evaluate mode and dose of C.perfringens challenge 
in broiler chickens. 
Experiment 1 
Treatment Number of birds C.perfringens challenge Mode 
1 24 Challenged Oral gavage1 
2 24 Challenged Feed2 
3 24 Unchallenged Oral gavage3 
4 24 Unchallenged Feed4 
Experiment 2 
Treatment Number of birds Mode Dose5 (ml) 
1 12 Water6 2 
2 12 Water 4 
3 12 Feed 2 
4 12 Feed 4 
1 1.0 ml of an 8 h broth culture of C. perfringens in cooked meat medium 
21/3 of ADFI mixed with 4 ml of the broth culture 
31.0 ml of sterile cooked meat medium broth 
41/3 of ADFI mixed with 4 ml of the sterile broth 
5 An 8 h broth culture of C. perfringens in cooked meat medium  
6Sterilized peptone water with 5 g/L Cys hydrochloride 
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 Prior to daily challenge, feed and water were restricted in respective pens for 4 h, 
overlapping the dark period of the lighting schedule and feed/water restriction time 
together. Accordingly, the culture mixed feed and peptone water were offered right after 
the dark period to make certain rapid consumption of large numbers of live bacterial 
cells by all birds. The respective feeders were top-dressed with culture/sterile broth 
mixed feed and a separate set of drinkers were used to offer culture mixed peptone 
water. The drinkers with normal drinking water were placed in the particular pens when 
the birds had consumed all peptone water with broth culture. 
   
4.3.5. Sample and data collection 
Birds were weighed on pen basis at the initiation of feeding the grower diet (d 14), and 
weekly thereafter. Feed disappearance was measured on each weigh day. The data were 
used to calculate ADG, ADFI and FCR for the periods of d 14 to 21 and d 21 to 28 in 
both experiments and for d 28 to 35 in Exp. 1. Randomly selected 50% of the birds in 
each pen in Exp. 1 and all birds in Exp. 2 were killed by cervical dislocation on d 28 and 
the contents of the ileum (from Meckel’s diverticulum to 2 cm proximal to the ileocecal 
junction) and the contents of both ceca were aseptically collected from each bird. One 
aliquot  (0.1 – 0.2 g) of each digesta sample was aseptically transferred into preweighed 
15 ml sterilized conical plastic tubes containing 1 ml of 0.1% sterile peptone buffer with 
5 g/L Cys hydrochloride (Sigma Chemical Co., St. Louis, MO) for plating. Immediately 
after collection, each tube was shaken well to facilitate sample mixing in the peptone 
water and kept on ice until plated within 3 h of collection. In Exp 1, a second aliquot 
was frozen at -20ºC for subsequent DNA extraction. Digesta samples from both  
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locations were collected from the remaining 50% of birds on d 35 of Exp. 1, as 
previously described, for DNA extraction. 
Peripheral blood was collected from the brachial vein from all birds on d 28 of 
Exp. 2 for the WBCL assay as described by Papp and Smits (2007). Approximately 3 ml 
blood was collected into 4 ml commercial sodium heparin tubes (Vacutainer
®
, BD 
Oakville, Ontario, Canada). The blood samples were stored at 4ºC immediately after 
collection until tested within 10 h of collection. 
 
4.3.6. Whole-blood chemiluminescence assay 
Samples were run in duplicate using a Clear Polysorp 96-well microplate (Nunc, 
Roskilde, Denmark). Zymosan-stimulated, Lucigenin-enhanced WBCL assay was 
performed according to the method of Papp and Smits (2007) with slight modifications. 
Briefly, blood was diluted first to achieve 1:10 dilution. Then Zymosan A from 
Saccharomyces cerevisiae (Sigma Chemical Co., St. Louis, MO) was prepared as 
described by Marnila et al. (1995), and was used non-opsonized as a stimulator of cells 
at 1mg/ml. Lucigenin (N,N’-Dimethyl-9,9’-biacridium dinitrate; Sigma Chemical Co., 
St. Louis, MO) working solution was prepared to achieve 0.5 mM concentration. Hanks’ 
balanced salt solution (Sigma Chemical Co., St. Louis, MO) was used for the dilution of 
blood and for the preparation of working solutions of reagents. For the assay, diluted 
blood samples were added to the microplate first followed by the addition of zymosan 
and finally the working solution of lucigenin. Both the prepared reagents were added to 
the wells using a multi-channel pipettor directly prior to reading the plate in a 
Fluoroskan Ascent FL luminometer (Thermo Scientific Inc. Hudson NH). Diluted blood, 
zymosan and lucigenin were added 50 μl each into respective wells to achieve the final 
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reaction volume of 150 μl in each well. Light emission was recorded for 48 cycles, at 4 
minute intervals and 1.5 seconds/reading at 39 ºC. Plates were shaken for 5 seconds 
before each interval. Light emission results were presented as relative light units (RLU). 
Background light emission was subtracted. The peak RLU is the peak CL response. 
Accordingly, peak RLU values were used in all statistical analyses.  
 
4.3.7. Pathological examination 
All birds were kept under constant observation for any sign of NE, which include 
depression, diarrhea, dehydration, somnolence, ruffled feathers and reduced feed intake 
or mortality (Helmboldt and Bryant 1971; Al-Sheikhly and Truscott 1977a,b; Al-
Sheikhly and Al-Saieg 1980; Gazdzinski and Julian 1992). As described above, birds 
were euthanized by cervical dislocation on the respective sample collection days and 
their intestinal tracts were removed. Prior to digesta collection, intestinal lesions were 
scored blindly, according to the criteria described by Dahiya et al. (2005), using a scale 
from 0 to 4 (Table 4.4). 
 
4.3.8. Genomic DNA extraction and purification    
Digesta samples (350 mg per tube) were placed in a bead-beating tube (Mo-Bio 
Laboratories, Solano Beach, CA) and incubated first at 37°C for 30 min with RNase A 
(73 μg), lysozyme (750 μg), and proteinase K (400 μg) in 0.365 ml of buffer containing 
50 mM Tris-Cl, 50 mM EDTA, 0.5% Tween and 0.5% Triton X-100, followed by 
another 30 min incubation at 50°C, upon addition of 0.135 ml of a buffer containing 3 
mM guanidine-HCl and 20% Tween 20. The samples were subjected to one freeze–thaw  
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Table 4.4. Intestinal gross lesion scoring system for necrotic enteritis (after Dahiya et al. 
2005). 
Score Observation/s 
0 No gross lesions,  normal intestinal appearance  
0.5 Severely congested serosa and mesentery engorged with blood 
1 Thin-walled, friable intestines with small red petechiae (> 5) 
2 Focal necrotic intestinal lesions 
3 Sizable patches of necrosis (1 to 2 cm long) 
4 Diffused necrosis typical of field cases 
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cycle (-70°C/25°C), then placed in a bead beater (Bio101 ThermoSavant FP120) and 
shaken three times for 20 s (setting 5) with 1 vol. (700 μl) of 25:24:1 
phenol:chloroform:isoamyl alcohol (Sigma). The tubes were centrifuged at 13,000 x g 
for 15 min, the top aqueous phase was transferred to a new tube, mixed with an equal 
volume (~ 700 μl) of chloroform and centrifuged again at 13,000 x g for 10 min. The top 
aqueous phase was removed to a new tube and nucleic acids were precipitated with 1 vol 
isopropanol and 0.1 vol 3 M Na acetate, pelleted by centrifugation for 10 min. The pellet 
was washed once in 1 ml of 70% ethanol, aspirated, air dried, and re-suspended in 100 
μl of sterile filtered UV’d water. 
The extracted DNA samples were purified using FastDNA kit (Bio 101). Briefly, 
the DNA samples were mixed with 300 μl of binding matrix and incubated at room 
temperature for 10 min. Then the samples were centrifuged at 13,000 x g for 30 sec and 
the supernatants were discarded. The pellets were re-suspended in SEWS-M wash buffer 
and centrifuged at 13,000 x g for 1 min. The supernatants were discarded and the 
resulting pellets were air dried over night at room temperature. The next day, the pellets 
were re-suspended in 100 μl of sterile filtered UV’d water and incubated at 55°C for 20 
min. Upon a 5 min centrifugation at 13,000 x g, the supernatants were transferred to new 
tubes and DNA was precipitated by adding 100 μl isopropanol and 10 μl 3 M Na acetate. 
The pellet was washed once in 1 ml of 70% ethanol, aspirated, air dried, and re-
suspended in 50 μl of sterile filtered UV’d water. The purified DNA samples were 
stored at -20°C.         
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4.3.9. Bacterial enumeration 
The ileal and cecal digesta samples collected for plating in both experiments were 
weighed and further diluted to an initial 10
-1
 dilution using peptone water. Ten-fold 
dilutions were spread in duplicate with an automated spiral plater (Autoplate, Spiral 
Biotech Inc., Bethesda, MD) on BBL blood agar base (Becton, Dickinson and Co.) 
containing 5% sheep blood and 100 mg/L of Neomycin Sulphate (The Upjohn Co., 
Orangeville, ON, Canada). The plates were incubated anaerobically for 24 h at 37ºC. 
The α- and β-hemolytic colonies on the plates were counted as C. perfringens, with 
presumptive colonies being randomly picked, Gram stained, plated on mannitol yolk 
polymixin agar (Oxoid Inc., Nepean, Ontario, Canada), and examined under the 
microscope to confirm as C. perfringens. The C. perfringens strain obtained from the 
infected birds was characterized by PCR technique as a type A toxin producer. Counts 
were expressed as log10 cfu per gram of intestinal contents.  
The purified DNA was used for molecular enumeration of C. perfringens in 
digesta samples. PCR primers (50-CTGGGGTATCAACTAAAGTCTACGC-30 and 50-
CCTTTGCTGCATAATCCCAATC- 30) were designed to amplify a 693 base pair (bp) 
fragment (PLC-A) of the C. perfringens α - toxin gene (GenBank accession number 
X17300). These primers (500 nM each) were used in a PCR containing C. perfringens 
genomic DNA (40 ng), 1.5 mM MgCl2, 0.2 mM each dNTP, and 1 U Taq DNA 
polymerase (Invitrogen) under the following conditions: 94°C, 4 min followed 
immediately by 40 cycles of 94°C, 1 min; 55°C, 1 min; 72°C, 1 min. The PCR product 
was purified on an agarose gel and incubated with 1 U Taq polymerase (Invitrogen) and 
0.2 mM each dNTP at 72°C for 15 min, then purified using a QiaQuick PCR purification 
column (Qiagen). Purified PCR products were ligated into pGEM-T Easy (Promega) 
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overnight at 4°C and the ligation mixture was used to transform E. coli JM109 
(Promega). A single insert-containing clone was retrieved and used as a PCR standard as 
described below. 
A second set of α - toxin-specific PCR primers was designed for molecular 
enumeration of C. perfringens using real-time quantitative PCR (qPCR). These primers 
(50-GAAGCTATGCACTATTTTGGAGAT-30 and 50- 
ATACTGTTCTTTCCTTTCTT- -CTGC- 30) amplified a 120 bp fragment (PLC-B) of 
the C. perfringens α - toxin gene that was nested within the larger cloned PLC-A 
fragment. To enumerate C. perfringens in digesta samples, we first optimized the 
dilution of the DNA extracts to mitigate the effects of PCR inhibition (Dumonceaux et 
al. 2005). DNA extracts were diluted 1:16 in TE buffer (10 mM Tris–Cl pH 8.0, 1 mM 
EDTA) and used in a qPCR assay along with standards consisting of known amounts of 
PLC-A plasmid DNA. Plasmid standards were expressed as copy number per qPCR 
assay, which was calculated as the weight of plasmid DNA in each standard divided by 
the plasmid molecular weight (2.4 - 106 g/mol based on a plasmid size of 3697 bp). 
qPCR assays used Platinum1 SYBR Green Quantitative PCR SuperMix-UDG 
(Invitrogen) and included 3 mM MgCl2 and 500 nM each primer. Amplifications were 
proceeded by the following steps: 50°C, 2 min (UDG activation), then 95°C, 3 min (well 
factor collection); this was followed immediately by 40 cycles of 94°C, 30 s; 55°C, 30 s; 
72°C, 30 s. Data collection was set at the extension step. Amplifications were performed 
using an iCycler (BioRad). qPCR counts were converted to genomes detected/g digesta 
based on the weight of digesta extracted and the dilution factors. 
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3.3.10. Statistical analysis 
Pen was considered the experimental unit for the growth performance variables and 
individual birds for the other variables. Performance variables were analyzed by analysis 
of variance using the MIXED procedure of SAS (SAS Institute, Inc. Version 9.2) using a 
statistical model with the following factors: mode and challenge in Exp.1 and mode, 
dose and mode x dose in Exp. 2. Initial BW was used as a covariate. All other variables 
were analyzed using the GLM procedure of SAS. Means were reported as least-square 
means [± pooled standard error of the mean (SEM)] and were separated using the 
probability of difference. Differences were considered significant when P < 0.05.  
 
4.5. Results 
Subsequent to challenge with C. perfringens, most of the birds initially became dull and 
depressed and, had abnormally wet droppings. Those symptoms subsided after few days 
and the birds exhibited no obvious signs of morbidity 7 to 9 d post-challenge. No 
mortality was observed during the course of the study. 
 During d14 - 21 in Exp. 1, the C. perfringens challenge affected the ADG of 
birds (P < 0.05; Table 4.5), reducing the ADG by 9.14%. The challenge mode did not 
affect the ADG of birds during this period (P > 0.05), but interacted with C. perfringens 
challenge for ADFI and FCR (P < 0.05): feed consumption was reduced in challenged 
birds and introduction of the pathogen with feed reduced the ADFI by 19.8% compared 
to gavaging. The FCR in unchallenged birds was not affected by the mode of challenge, 
but the pathogen administration with feed reduced the FCR by 17.3% compared to 
gavaging. Neither C. perfringens challenge nor challenging mode affected the growth 
performance parameters in the d 22 to 28 growth period (P > 0.05). During d29 – 35, the 
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Table 4.5. Effect of Clostridium perfringens challenge and mode of inoculation (oral gavage vs feed) on growth performance of 
broiler chickens in Exp. 1.  
 C. perfringens infection  Mode 
SEM 
P Value 
Variable Unchallenged Challenged
1
  Gavage Feed Infection Mode Interaction 
d14 – d21          
Average daily gain (g) 64.43 58.54  60.78 62.20 1.37 0.01 0.48 0.16 
Average daily feed intake (g) 117.74 92.21  109.08 100.87 1.98 <.001 0.01 0.01 
Feed conversion ratio (g/g) 1.83 1.58  1.80 1.61 0.03 <.001 0.01 0.03 
          
d22 – d28          
Average daily gain (g) 84.51 85.02  84.11 85.42 2.67 0.89 0.73 0.64 
Average daily feed intake (g) 126.78 130.39  124.43 132.74 4.24 0.56 0.19 0.55 
Feed conversion ratio (g/g) 1.50 1.56  1.48 1.58 0.08 0.62 0.39 0.42 
          
d29 – d35          
Average daily gain (g) 101.40 85.12  95.21 91.31 3.00 0.01 0.38 0.72 
Average daily feed intake (g) 170.68 153.81  160.18 164.32 5.07 0.04 0.57 0.53 
Feed conversion ratio (g/g) 1.68 1.82  1.69 1.82 0.05 0.08 0.11 0.21 
          
d14 – d35          
Average daily gain (g) 83.45 76.23  80.03 79.64 1.89 0.02 0.89 0.45 
Average daily feed intake (g) 138.40 125.47  131.23 132.65 2.66 0.01 0.71 0.73 
Feed conversion ratio (g/g) 1.66 1.65  1.64 1.67 0.03 0.87 0.48 0.48 
1 An 8 h broth culture of C. perfringens in cooked meat medium
9
5
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ADG, ADFI and FCR were affected by the C. perfringens challenge (P < 0.05). The 
ADG and ADFI were reduced by 16.06 and 9.88%, respectively and the FCR was 
increased 8.33%, by the C. perfringens challenge. None of the growth performance 
parameters were affected either by challenge mode or challenge x mode interaction (P > 
0.05), in this period. For the entire experimental period (d14 – 35), the ADG and ADFI 
were affected by the C. perfringens challenge (P < 0.05), reducing by 8.65 and 9.39%, 
respectively. The challenging mode or challenge x mode interaction did not affect these 
parameters and the two main effects or the interaction did not affect the FCR during the 
overall experimental period (P > 0.05). 
Neither the mode nor the dose of C. perfringens administration affected the 
ADG, ADFI and FCR of birds, for the periods of d 14 to 21 and d 21 to 28 of age and 
for the entire experimental period (d 14 to 28) in Exp.2 (P > 0.05; Table 4.6). 
Furthermore, there was no significant interaction between the mode and dose of 
challenging for various performance parameters (P > 0.05).  
The mean intestinal gross lesion score of chickens under different treatments and 
killed on 28 d of age in both experiments and 35 d of age in experiment 1 is shown in 
Figure 4.1. The mode of challenging in Exp. 1 and the mode or the dose of oral 
administration of C. perfringens   in Exp. 2 had no significant effect on NE-related 
intestinal gross lesion score of birds (P > 0.05). No significant interaction was noted 
between the two factors of Exp. 2 for the intestinal gross lesion score (P > 0.05). Thin-
walled and friable small intestines with congested serosa and blood-engorged mesenteric 
vessels were detected in most of the birds in both experiments, irrespective of the 
treatment. Some birds had focal necrotic lesions while some displayed sizable (1 to 2 cm 
long) patches of necrosis in various segments of the small intestine, more frequently in  
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Table 4.6. Effect of mode (water and feed) and dose of administration of Clostridium perfringens on growth performance of broiler 
chickens in Exp. 2.  
 Mode  Dose1 (ml) 
SEM 
P Value 
Variable Water2 Feed  2  4  Mode Dose Interaction 
d14 – d21          
Average daily gain (g) 47.06 46.01  46.40 46.67 1.25 0.697 0.918 0.764 
Average daily feed intake (g) 79.53 76.97  75.24 81.25 1.38 0.405 0.094 0.951 
Feed conversion ratio (g/g) 1.69 1.68  1.63 1.74 0.03 0.779 0.114 0.662 
          
d22 – d28          
Average daily gain (g) 70.15 69.52  70.15 69.52 1.32 0.824 0.824 0.259 
Average daily feed intake (g) 126.91 134.35  122.26 138.99 7.16 0.631 0.307 0.818 
Feed conversion ratio (g/g) 1.82 1.93  1.75 2.00 0.10 0.591 0.261 0.516 
          
D14 – d28          
Average daily gain (g) 58.60 57.77  58.27 58.10 1.22 0.749 0.945 0.428 
Average daily feed intake (g) 103.21 105.65  98.75 110.12 4.07 0.779 0.235 0.832 
Feed conversion ratio (g/g) 1.77 1.83  1.70 1.90 0.07 0.654 0.216 0.540 
1 An 8 h broth culture of C. perfringens in cooked meat medium 
2 Sterilized peptone water with 5 g/L Cys hydrochloride
9
7
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Figure 4.1. Mean intestinal gross lesion scores of NE in broiler chickens challenged 
with C. perfringens in an 8 h cooked meat broth, (A) using two modes (oral gavage or 
feed) at d28 and d35 of age in Exp. 1, and (B) using two modes (water or feed) at two 
dose rates (2 and 4 mL) at d28 of age in Exp. 2. Lesions were scored on a 0 to 4 scale 
where 0 indicates no intestinal gross lesions (apparently normal), 0.5 = severely 
congested serosa and mesentery engorged with blood, 1 = thin walled and friable 
intestines with small red petechiae (>5), 2 = focal necrotic intestinal lesions, 3 = sizable 
patches of necrosis (1 to 2 cm long), and 4 = severe extensive necrosis typical of field 
cases. 
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the distal and proximal parts of the jejunum and ileum, respectively. Intestines with large 
amounts of gas and severe extensive necrosis with marked hemorrhage were not 
observed in any of the birds, as seen in typical field cases. 
The ileal and cecal C. perfringens counts enumerated using plate count and q-
PCR technique on d 28 and 35 of Exp. 1 are shown in the Table 4.7. The pathogen count 
by plate count on d 28 of Exp. 2 is shown in the Table 4.8. Both ileal and cecal pathogen 
numbers revealed no significant differences among challenged groups in both 
experiments (P > 0.05). There was no significant interaction between the mode and dose 
of challenge for C. perfringens counts either in ileal or cecal contents in Exp. 2 (P > 
0.05). 
The WBCL response was not significantly affected by the mode or dose of C. 
perfringens administration or the interaction (P > 0.05: Figure 4.2).  
 
4.6. Discussion 
NE is considered difficult to reproduce experimentally in broiler chickens, therefore, no 
widely recognized infection model exists for the experimental induction of the disease 
(Kaldhusdal et al. 1999). Several methods have been described in the literature but little 
information about their repeatability is available (Williams et al. 2003). Such methods 
include the rearing of birds on C. perfringens infected poultry-house litter (Maxey and 
Page 1977; Wicker et al. 1977; Hamdy et al. 1983; Cowen et al. 1987; Kaldhusdal et al. 
2001), oral administration of C. perfringens through feed (Long and Truscott 1976; 
Prescott 1979), drinking water (Jansson et al. 1990; Takeda et al. 1995) or by gavage 
(Bernier et al 1977; Baba et al. 1997; Répérant and Humbert 2002; Wilkie et al. 2005; 
Dahiya et al. 2005, 2007a,b), intravenous administration of C. perfringens (Bernier and 
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Table 4.7. Effect of Closrtidium perfringens challenge and mode of pathogen administration on organism proliferation in the ileum 
and the cecum of broiler chickens at 28 and 35 d of age in Exp. 1.  
Closrtidium perfringens counts 
Challenge  Mode 
SEM 
P Value 
Unchallenged Challenged  Gavaging1 In feed2 Challenge Mode Interaction 
Plate counts (d 28)          
Ileal digesta (log10 cfu/g) 0.00 3.13  1.61 1.58 0.180 <0.0001 0.708 0.708 
Caecal digesta (log10 cfu/g) 0.00 2.99  1.68 1.37 0.207 <0.0001 0.225 0.225 
          
q-PCR  counts (d 28)          
Ileal digesta (log10 cfu/g) 0.00 3.55  1.83 1.72 0.095 <0.0001 0.422
21 
0.422 
Caecal digesta (log10 cfu/g) 0.00 3.26  1.79 1.48 0.127 <0.0001 0.093 0.093 
          
q-PCR  counts (d 35)          
Ileal digesta (log10 cfu/g) 0.00 3.59  1.87 1.72 0.121 <0.0001 0.408 0.408 
Caecal digesta (log10 cfu/g) 0.00 3.07  1.65 1.42 0.151 <0.0001 0.289 0.289 
1
 1 ml/bird of an 8 h broth culture of C. perfringens in cooked meat medium 
2 4 ml in 24g of feed/bird of an 8 h broth culture of C. perfringens in cooked meat medium 
 
 
 
 
 
 
 
 
1
0
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Table 4.8. Effect of mode (water and feed) and dose of administration of Closrtidium perfringens on organism proliferation in the 
intestinal contents of broiler chickens at 28 d of age in Exp. 2.  
Closrtidium perfringens counts 
Mode  Dose1 (mL) 
SEM 
P Value 
Water2 Feed  2 4 Mode Dose Interaction 
Plate counts          
Ileal digesta (log10 cfu/g) 3.96 3.67  3.95 3.68 0.19 0.445 0.477 0.567 
Caecal digesta (log10 cfu/g) 4.86 3.98  4.53 4.30 0.35 0.214 0.743 0.994 
1 An 8 h broth culture of C. perfringens in cooked meat medium 
2 Sterilized peptone water with 5 g/L Cys hydrochloride
1
0
2
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Figure 4.2. Mean peak whole blood chemiluminesence detected in 28-d-old broiler 
chickens challenged with C. perfringens in an 8 h cooked meat broth, using two modes 
(water or feed) at two dose rates (2 and 4 ml) in Exp. 2. Lucigenin-enhanced, non-
opsonized zymosan-stimulated whole blood chemiluminesence response was measured 
9 d post-challenged. 
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Filion 1971; Bernier et al. 1977), inoculation of the organism into the cannulated 
duodenum (Truscott and Al-Sheikhly 1977) or into the cloaca (Williams et al. 2003) and 
infusion of crude toxins of C. perfringens directly into the duodenum (Truscott and Al-
Sheikhly 1997). The seeder-contact method practiced in the spreading diseases like 
salmonellosis in poultry flocks is another approach that could have been considered in 
developing a model for NE, but the anaerobic characteristics of C. perfringens might 
have limited the employment of such methods. 
Coccidiosis is considered as a factor associated with the occurrence of the 
disease NE in broiler chickens, under practical field (Long 1973) and controlled 
laboratory (Al-Sheikley and Al-Saige 1980) conditions. This is probably due to the 
frequent sharing of the site in the intestinal tract by the respective causative organisms 
plus the intestinal mucosal damage initiated by Eimeria species (Bradley and 
Radhakrishnan 1973; Long 1973; Kimura et al. 1976) and greater affinity of C. 
perfringens for adhesion to the previously damaged mucosa (Kageyama et al. 1987; 
Baba et al. 1992b). Many studies have taken this phenomenon into account and 
consequently, several coccidial species have been used in the process of developing a 
disease model for NE, such as E. acervulina (Al-Sheikley and Al-Saige 1980; Shane et 
al. 1985), E. brunetti (Baba et al. 1992b), E. maxima (Williams et al. 2003), E. necatrix 
(Al-Sheikley and Al-Saige 1980; Baba et al. 1997) or E. tenella (Kageyama et al. 1987). 
In general, these studies demonstrated that simultaneous infection with coccidia and C. 
perfringens produces more extensive pathogenic effects than each individual infection. 
Supporting these observations, Williams et al. (2003) further demonstrated a reduction 
in the severity of a virulent C. perfringens challenge in broiler chickens vaccinated 
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against coccidiosis, probably by preventing severe coccidial lesions that might 
predispose birds to NE.  
In the present investigation, one strain-pure culture of C. perfringens was used 
without a concurrent coccidial infection. Reproduction of NE without coccidial co-
infection permits the study of treatment effects on C. perfringens -induced enteritis 
without the possible confounding influence of the second pathogen. In addition, the 
separation of effects due to coccidiosis from those associated with NE can be 
complicated in immunological and molecular studies. 
Despite the lack of overt clinical signs of NE in both experiments, the relatively 
poor growth performance of birds was probably due to subclinical disease caused by C. 
perfringens challenge. In Exp. 1, the ADG of the challenged birds was reduced during 
the first week of challenge compared to unchallenged birds. The disease NE in poultry 
can arise either in acute clinical form or in subclinical version (Shane et al. 1985; 
Kaldhusdal and Hofshagen 1992). The clinical disease is associated with high mortality 
in broiler barns, as a result of severe necrotic damage to the small intestinal mucosa 
(Wages and Opengart 2003), whereas reduced growth performance in broilers is 
commonly accompanied by the subclinical form (Kaldhusdal and Hofshagen 1992; 
Porter 1998; Lovland and Kaldhusdal 2001; Hofacre et al. 2003). This inferior growth 
performance can be attributed to the necrosis of the intestinal epithelium caused by C. 
perfringens and subsequent impairment in nutrient digestion and absorption, substandard 
growth rate and increased FCR (Elswinger et al. 1992; Kaldhusdal and Hofshagen 1992; 
Kaldhusdal et al. 2001; Hofacre et al. 2003). In addition, evidence exists to link C. 
perfringens infections to hepatitis and cholangio-hepatitis in broiler chickens, which 
leads to substandard growth performance as well (Lovland and Kaldhusdal 1999, 2001). 
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Impaired overall performance has previously been reported in broiler chickens highly 
infected with C. perfringens (Stutz et al. 1983; Stutz and Lawton 1984; Kaldhusdal and 
Hofshagen 1992; Dahiya et al. 2005, 2007a, b). The C. perfringens challenge reduced 
the ADFI of birds and it was further affected by the pathogen administration with feed. 
This might be due to the undesirable effects of toxins and other metabolites produced by 
C. perfringens on the palatability of the feed. Accordingly, the FCR of that treatment 
group was reduced as well.    
However, during the second week of Exp. 1 (d22 – 28), neither C. perfringens 
challenge nor mode of challenge affected the growth performance of the birds, likely 
due to diminishing intensity of the infection. But the growth performance of C. 
perfringens challenged birds was reduced again during the third week, probably due to 
re-infection caused by the ingestion of the pathogen or their spores on the litter, shed by 
the infected birds. None of the growth performance parameters evaluated in Exp. 2 
showed a significant difference among treatment groups.  
Although gross intestinal lesions are not always observed in birds infected with 
C. perfringens (Olkowski et al. 2006), intestinal lesion scoring is widely and effectively 
being used to quantify the severity of NE in broiler chickens (Riddell and Kong 1992; 
Jackson et al. 2003; Williams et al. 2003; Dahiya et al. 2005, 2007a,b; 
Gholamiandehkordi et al. 2007; Kulkarni et al. 2007). Kaldhusdal and Hofshagen (1992) 
and Kaldhusdal et al. (1999) reported grossly visible intestinal lesions as an estimable 
indicator of an occurrence of NE. A perfect infection model to examine the pathogenesis 
of acute and subclinical form of NE is a setting with a high percentage of the challenged 
birds exhibiting grossly visible intestinal lesions without mortality (Gholamiandehkordi 
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et al. 2007). Accordingly, the demonstration of the development of NE-specific lesions 
is an important feature of the current study. 
 The C. perfringens numbers observed in the gut contents of challenged birds of 
the present study were much higher than that found in healthy birds (<10
4
 cfu/ g of 
digesta) and high populations of the organism in the intestinal (as high as 6.18 and 8.10 
log10/ g in ileal and cecal, respectively) contents were detected even in clinically healthy 
looking birds, confirming the subclinical version of NE, as reported by Dahiya et al. 
(2005). The plate count is based on the cfu formed only by live bacterial cells whereas in 
q-PCR, DNA from all live and dead bacterial cells contributes in enumeration, thereby 
overestimating the numbers (Dumonceaux et al. 2006). Therefore, the pathogen count 
determined using q-PCR technique on d28 of Exp. 1 was comparatively higher than that 
of plate counts.  
In challenged birds, the C. perfringens counts in both ileal and cecal digesta were 
considerably higher in Exp. 2 than those found in Exp. 1. This may have been caused by 
the higher contents of AID CP (23 vs 18%), animal protein (11.7 vs 8.7%) and AID 
glycine (1.75 vs 1.00%) in the grower diet fed in Exp.2. Previous studies with broiler 
chickens have reported the stimulatory effect of high dietary protein levels, higher 
amounts of animal protein supplements in the diet in particular, and high dietary glycine 
level on the proliferation of C. perfringens and predisposing of birds to NE 
(Ispolatovskaya 1971; Nakamura et al. 1978; Kaldhusdal 2000; Kocher 2003; Drew et 
al. 2004; Dahiya et al. 2005; Wilkie et al. 2005). In addition, the grower diet fed in Exp. 
2 contained no crystalline glycine, whereas a considerable amount of the AID glycine 
(18%) in the grower diet fed in Exp. 1 was provided by crystalline form, which is 
considered as 100% true digestible (Izquierdo et al. 1988; Chung and Baker 1992) and 
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rapidly absorbed in the upper part of the GIT (Lingens and Molnar 1996; Maenz and 
Engele-Schaan 1996a; Drew et al. 2003), making it unavailable to the microbes residing 
in the distal part. The grower diet fed in Exp. 1 contained supplementary xylanase while 
the diet used in Exp. 2 did not. Previous studies reported a significant decrease in 
intestinal C. perfringens numbers in broilers fed wheat-based diets supplemented with 
xylanase-based enzyme preparations (Jia et al. 2009b; Choct et al. 2006). This can be 
due to the reduction in NSP-associated digesta viscosity by the enzyme and thus 
increased nutrient digestion and absorption by the host, leaving less nutrients for the 
growth of gut microbes. Further, the birds in Exp. 1 received a pelleted grower diet 
whereas the grower diet fed in Exp. 2 was in mash form, which is considered as a 
triggering factor for C. perfringens proliferation in the GIT of broilers (Engberg et al. 
2002). Feeding fine particle (mash) feeds reduces the normal gastric reflux and gizzard 
activity which in turn reduces the nutrient digestion and absorption by the host. 
Consequently, more nutrients would be available to fuel microbial overgrowth.  
The intestinal lesion score and C. perfringens counts in the ileal and cecal digesta 
observed in both experiments of the present study bare the hallmarks of subclinical 
version of NE in most of the birds, as described by Lovland and Kaldhusdal (2001). 
While NE-induced mortality was not experienced during the course of the study, 
previous studies have suggested that C. perfringens counts and intestinal lesion score as 
more reliable and sensitive indicators of the disease than NE-related mortality 
(Kaldhusdal and Hofshagen 1992; Kaldhusdal et al. 1999). 
The WBCL assay is a simple but relatively quick and inexpensive analytical 
technique used in the assessment of reactive oxygen species (ROS) produced by 
circulating phagocytes (De Chatelet and Shirley 1981; Tono-Oka et al. 1983; Nagahata 
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et al. 1991). Thus, a positive correlation exists between the chemiluminescence response 
of a phagocyte and its ability to produce ROS (Ginsburg et al. 1993; Merrill et al. 2001), 
which are supposed to fight against invading pathogens, providing a first-line 
immunologic defense. The WBCL assay has widely and successfully been utilized in 
evaluating differences in innate immune responses measured using polymorphonuclear 
(PMN) status of peripheral blood among experimental groups or populations of some 
animal species such as fish (Nikoskelainen et al. 2004, 2006), frogs (Marnila et al. 1995; 
Gilbertson et al. 2003), badgers (McLaren et al. 2003), mallards (Laudert et al. 1993), 
bears, raptors, and domestic chickens (Papp and Smits 2007; Papp et al. 2009). The 
WBCL peak reflects the functional capacity of circulating PMNs and a positive 
correlation exists between the WBCL peak and the numbers of both PMNs and total 
white blood cells in peripheral blood (Tono-Oka et al. 1983; Nagahata et al. 1991). 
However, in chickens, the peak is correlated with the absolute heterophil numbers and 
heterophil: mononuclear cell ratio (Papp and Smits 2007). Papp et al. (2009) 
demonstrated a positive correlation between WBCL response and NE-related clinical 
findings such as elevated intestinal lesion score and increased proliferation of C. 
perfringens, in C. perfringens-challenged broiler chickens fed different experimental 
diets. In Exp. 2, no difference was observed among values of WBCL response of birds 
in different treatment groups. Here, the absence of an uninfected control group of birds 
hindered the chances of comparing the findings with that of uninfected birds. However, 
the WBCL values of the current study together with the other findings suggested the 
similarity among the treatments in terms of developing a disease model for NE. 
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 The overall findings of the present study suggest that any of the evaluated 
treatments (either dose of culture with either mode of challenge) can be exploited in the 
process of establishing a repeatable challenge model for NE in broiler chickens raised on 
litter, without a concurrent coccidial infection. This model stimulates a subclinical form 
of NE and is suitable for investigating the effect of diet on the pathogen proliferation and 
the disease progression. 
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5. EFFECTS OF DIETARY PROTEIN LEVEL AND PROTEIN DIGESTIBILITY 
ON THE GROWTH PERFORMANCE AND INTESTINAL ECOSYSTEM OF 
BROILER CHICKENS INFECTED WITH Clostridium perfringens 
 
5.1. Abstract 
To evaluate the effects of dietary protein level and digestibility on the growth 
performance and intestinal ecosystem of C. perfringens challenged and unchallenged 
broilers, 640 birds were fed four different ideal protein-balanced, isocaloric diets in a 2 x 
2 x 2 factorial design with two levels of AID protein (HiPro: 20 and 18% and LoPro 18 
and 16% on days 1-14 and 15-35 respectively) and two levels of Ileal protein 
digestibility (HiDig and LoDig; approximately 85% and 80% CP digestibility 
respectively) under challenged and unchallenged situations. During the starter period, 
neither protein level nor digestibility affected the ADG (P > 0.05), but interacted for 
ADFI (P < 0.05): in LoPro diets, HiDig proteins increased ADFI of birds compared to 
LoDig proteins, but protein digestibility did not affect the ADFI of birds fed HiPro diets. 
Not protein level (P > 0. 05), but protein digestibility significantly reduced the FCR of 
starters fed LoDig proteins (P < 0.05). None of the main effects affected the growth 
performance parameters during the grower period or the final BW (P > 0.05). The C. 
perfringens challenge significantly affected the ADG of grower birds (P < 0.05), but not 
the ADFI or FCR (P > 0. 05). Birds fed LoPro diets significantly improved PER 
throughout the experiment and HiDig proteins increased PER during the grower and 
overall periods (P < 0.05). The prospective challenge group demonstrated superior 
growth performance during the starter period however challenge reduced their PER (P < 
0.05). The overall PER of the birds was not affected by the challenge (P > 0. 05). PER 
was significantly higher during starter than grower period (P < 0.05). Ileal C. 
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perfringens counts and intestinal gross lesion score were higher in birds fed HiPro and 
LoDig proteins compared to LoPro and HiDig proteins fed counterparts, respectively (P 
< 0.05). Protein level, digestibility or C. perfringens challenge did not affect the cecal 
acetate level (P > 0.05), but challenged birds had more propionate than unchallenged 
counterparts (P > 0.05). The three main effects interacted for cecal butyrate and total 
VFA levels (P < 0.05). Unchallenged birds fed LoPro-HiDig diet had more cecal 
butyrate and total VFA than LoPro-LoDig diet fed birds. In birds fed LoPro-LoDig diet, 
C. perfringens challenge significantly increased cecal butyrate and total VFA levels than 
in unchallenged counterparts. None of the main effects affected cecal branched chain 
VFA levels (P > 0.05). The three main effects did not affect the cecal ammonia 
production (P > 0.05). Overall findings from this study revealed the potential use of 
LoPro diets containing highly digestible proteins to minimize the risk of C. perfringens 
in broilers without AGP. 
 
5.2. Introduction 
Necrotic enteritis is a common bacterial infection in current broiler flocks and has a 
great impact on poultry welfare and the economics of broiler production (Van der Sluis 
2000a). Some C. perfringens type A strains carrying the genes for α or NetB toxins are 
responsible for this economically important disease (Keyburn et al. 2008, Van 
Immerseel et al. 2008). Dietary incorporation of antibiotics in broiler rations has been 
the most common strategy employed to control the proliferation of this pathogen 
(Dahiya et al. 2006). However, with the ban on prophylactic antibiotic usage in animal 
feed industry in some countries, a higher incidence of NE is re-emerging in broiler 
chickens (Grave et al. 2004; Van Immerseel et al. 2004; Williams 2005). In this context, 
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an intense interest exists in the establishment of management and/or dietary approaches 
which substitute in-feed antibiotics to combat this enteric pathogen. Further these 
alternatives must maintain growth performance and the health and safety of broiler meat 
for human consumption (Ewing and Cole 1994).   
Clostridium perfringens is normal member of the intestinal microflora of 
chickens (Gazdzinski and Julian 1992; Branton et al. 1997) and can be isolated in high 
numbers from the intestinal tract-from the crop, through the gizzard, the small intestine 
and in the ceca of apparently healthy birds (Ficken and Wages 1997; Engberg et al. 
2002; Pedersen et al. 2003). Despite this, the mere presence of this pathogen in the GIT 
is not the only factor that required to elicit the disease NE in broiler chickens (Shane et 
al. 1984; Cowen et al. 1987; Kaldhusdal et al. 1999; Craven et al. 2001; LaRagione and 
Woodward 2003) and other nutritional and management cofactors are normally required 
to induce the infection (Dahiya et al. 2006). Nevertheless, with the withdrawal of 
antibiotics from broiler ration, diet related risk factors have attracted much attention due 
to their substantial role in the pathogenesis of NE. 
 Two major diet-related factors are associated with poultry NE. The first factor is 
cereal grains that used in poultry ration formulation. (Riddell and Kong 1992; 
Kaldhusdal and Skjerve 1996). The other factor that predisposes birds to NE is dietary 
protein (Kaldhusdal and Skjerve 1996). Previous studies have reported the marked 
effects that dietary protein source and level have on intestinal proliferation of C. 
perfringens in broiler chickens (Kaldhusdal 2000; Drew et al. 2004). Diets containing 
high concentrations of protein and high concentrations of animal-derived proteins in 
particular, increase intestinal C. perfringens numbers (Kaldhusdal 2000; Kocher 2003; 
Drew et al. 2004; Wilkie et al. 2005). However, these have used much higher inclusion 
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rates of the respective feed ingredients and protein levels than would be used in practical 
broiler rations. 
The study described in Chapter 3 demonstrated significantly inferior growth 
performance of birds fed LoPro diets formulated to contain LoDig protein supplements 
compared to those fed LoPro diets with same nutrient specifications but formulated with 
highly digestible protein sources. The nutrients available to intestinal bacteria are 
primarily derived from the indigestible portion of feeds. Thus, alterations in indigestible 
nutrients can cause changes in intestinal microbial numbers, species and species 
diversity (Drew et al. 2002; Hill et al. 2005; Dahiya et al. 2006; Pieper et al. 2008). This 
has the potential to negatively affect the health and growth performance of broilers 
(Gaskins 2001; van der Klis and Jansman 2002). Bacterial metabolism of undigested AA 
may result in the production of toxic metabolites including ammonia (Visek 1978a; 
Pond and Yen 1987), biogenic amines (Tisljar et al. 2002), phenols and indoles 
(Yokoyama et al. 1982) that can affect the turnover of enterocytes and thus the overall 
growth performance of the host (Macfarlane and Macfarlane 1995; Gaskins 2001; van 
der Klis and Jansman 2002). Based on these observations, we hypothesize that diet 
digestibility significantly affects gut C. perfringens populations and toxic metabolites, 
resulting in reduced growth performance. The purpose of this study was to examine the 
effects of ileal digestible protein level and protein digestibility in commercial type diets - 
formulated based on SID AA content - on growth performance and the intestinal 
microbial fermentation profile in broiler chickens experimentally infected with C. 
perfringens.  
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5.3. Materials and methods 
A total of 640 broiler chickens were reared in two successive batches of 320 birds under 
identical conditions at the Animal Care Unit in the Western College of Veterinary 
Medicine, University of Saskatchewan. Experimental protocols for the study were 
approved by the Animal Care Committee of the University of Saskatchewan and were 
performed in accordance with recommendations of the Canadian Council on Animal 
Care (1993).  
 
5.3.1. Birds and management 
One-day-old conventional male broiler chicks (Ross 308), obtained from a local broiler 
hatchery (Lilydale Hatchery, Wynyard, Saskatchewan, Canada) were used in both trials 
and standard management procedures were followed. The temperature was maintained at 
34 °C at placement and reduced as the birds progressed in age with a final temperature 
of 23 °C at d 35. The lighting schedule used consisted of 23 h light and 1 h dark from d 
1 to 14 and, 20 h light and 4 h dark from d15 to the end (d 35) of each trial. Feed and 
water were available to the birds on an ad libitum basis in both trials. Upon arrival to the 
research facility, 320 birds in each trial (43.89±1.06 g) were randomly allocated into 32 
floor pens in a room having thermostatically controlled heating and ventilation (10 
birds/pen). Each pen (1 m
2
) was equipped with one pan feeder, one manual drinker and 
new soft-wood shavings. A feeder lid was placed in each pen from d 1 to 5 to ensure 
chicks had adequate access to feed. The room was thoroughly cleaned, disinfected and 
rested for more than two weeks between the trials.  
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5.3.2. Experimental design 
The birds were subjected to a 2-phase feeding regimen consisting of starter (1 to 14d) 
and grower (15 to 35d) phases and fed the same diets used in the experiment described 
in Chapter 3 in a 2 x 2 x 2 factorial design. Pens were randomly assigned to one of four 
dietary treatment groups in each feeding regimen and each treatment group was 
replicated eight times.  
 
5.3.3. C. perfringens challenge procedure 
This study used an avian C. perfringens field strain isolated from a clinical case of NE in 
broiler chickens (Dr. M. Chirino, Western College of Veterinary Medicine, University of 
Saskatchewan, Saskatoon, SK). The strain was characterized using PCR technique as a 
type A toxin producer (Dumonceaux et al. 2006). The organism was cultured 
anaerobically on BBL Blood Agar Base (Becton Dickinson Co., Sparks, MD) containing 
5% sheep blood and 100 mg/L of Neomycin Sulphate (The Upjohn Co., Orangeville, 
ON, Canada) for 18 h at 37ºC, then aseptically inoculated into a sterilized preparation of 
Robertson’s cooked meat broth (Difco Laboratories, Detroit, MI), and incubated 
anaerobically overnight at 37ºC. 
 All 320 birds in trial 1 were challenged daily right after the 4 h dark period on d 
15 to 19 (inclusive), offering the inoculum in feed, as described in Chapter 4. Briefly, 
each bird in all pens received 1/3 of ADFI mixed with 2 ml of broth culture. All birds in 
trial 2 were kept unchallenged and received 1/3 of ADFI mixed with 2 ml of sterile 
cooked meat medium broth per bird. The respective feeders were top- dressed with 
culture/sterile broth mixed feed and fresh cultures were prepared daily. Culture-feed 
mixing was done immediately before offering to the birds. Bacterial counts were 
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performed on the culture daily before inoculation and the count ranged from 3.7 to 6.4 x 
10
6
 cfu/ml. 
 
5.3.4. Sample and data collection 
Birds and feeders were weighed on a pen basis at the initiation of the experiment (d 1), 
and weekly thereafter, (d 7, 14, 21, 28, and 35). Feed consumption was measured on 
each weigh day. The data were used to calculate ADG, ADFI and FCR for starter, 
grower and overall experimental periods. Birds were monitored twice a day (8:30 and 
15:30) and in the case of mortality, the weight of the dead bird/s and remaining feed in 
the respective feeder/s were recorded. At 35 d of age, all birds were euthanized by 
cervical dislocation and the contents of the ileum (from Meckel’s diverticulum to 2 cm 
proximal to the ileocecal junction) and the contents of both ceca were aseptically 
collected from each bird. One aliquot each from both locations and one additional 
aliquot only from cecum were collected and frozen at -20ºC for subsequent DNA 
extraction and, ammonia and volatile fatty acid (VFA) analysis, respectively.  
 
5.3.5. Pathological examination 
All birds were observed for any sign of clinical NE during the trial, including 
depression, diarrhea, dehydration, somnolence, ruffled feathers and reduced feed intake 
or mortality (Helmboldt and Bryant 1971; Al-Sheikhly and Truscott 1977a,b; Al-
Sheikhly and Al-Saieg 1980; Gazdzinski and Julian 1992). On d 35 prior to collecting 
digesta, intestinal lesions were scored blindly, according to the criteria described by 
Dahiya et al. (2005), using a scale from 0 to 4 (Table 4.4). 
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5.3.6. Genomic DNA extraction and purification 
The DNA extraction and purification on the collected ileal digesta samples were 
peformed based on the method described in Chapter 4.  
 
5.3.7. Bacterial enumeration 
The purified DNA was used for molecular enumeration of C. perfringens in ileal digesta 
samples. The enumeration of C. perfringens was performed using qPCR technique as 
described in Chapter 4. The qPCR counts were converted to genomes detected/g digesta 
based on the weight of digesta extracted and the dilution factors. 
 
5.3.8. Volatile fatty acid and ammonia analyses 
Upon thawing of cecal digesta samples collected for VFA analysis, 100 mg was 
transferred in duplicate into 1.8 ml Eppendorf™ centrifuge tubes. Then 20 µL of 25% 
mata – phosphoric acid was added into each Eppendorf™ tube followed by 500 µL of 1 
mM trimethyl acetic acid in acetonitrile to act as the internal standard. Finally, 830 µL of 
acetonitrile was added into each tube. Samples were vortexed for 3 seconds before 
centrifuging at 14,000 x g for 5 minutes in a Microfuge® 18 Microcentrifuge (Beckman 
Coulter™, Palo Alto, CA). The sample supernatant was pipetted (1 ml) into an 
Agilent™ GC glass vial and capped. An Agilent 6890 Series Gas Chromatography 
System (Wilmington, DE) including an Agilent 7683 Series injector (5 µl) fitted with a 
Zebron ZB-FFAP High Performance GC Capillary Column (30.0 m × 320 μm × 0.25 
μm, Phenomenex, Torrance, CA) was used to identify and quantify VFA in every 
sample. A standard curve was made from purchased standards (Nu-Chek Prep, Inc. 
Elysian, MN) and used to quantify the concentration (mM) of the individual VFA. 
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Samples were prepared daily and placed on the autosampler twice daily. Samples that 
were prepared daily, but not initially placed on the autosampler were stored in the fridge 
to minimize the loss by volatization. The concentrations of VFA were measured as 
µmol/g and the molar ratio (MR) of each VFA was calculated as a proportion to the total 
VFA concentration. 
For ammonia analysis, cecal digesta samples were thawed overnight at 4°C and 
500 mg was transferred in duplicate into 15 ml screw cap culture tubes. Upon addition 
of 10 ml of deionized water into each tube, the tubes were shaken well and stored 
overnight at 4°C. After overnight soaking, the tubes were vortexed and centrifuged at 
500 x g for 5 minutes at 4°C in an ICE MicroCL 17R Centrifuge (Thermo Electron 
Corporation, Waltham, MA). Upon sample preparation, the phenol-hypochlorite 
procedure described by Broderick and Kang (1980) was applied to quantify the 
ammonia concentration. 
 
5.3.9. Statistical analysis 
Pen was considered as the experimental unit for the growth performance variables and, 
each individual bird was considered as the experimental unit for the other variables. The 
PER was calculated as grams of weight gain per gram of protein intake, for each growth 
phase and the overall experimental period. The variables were analyzed by analysis of 
variance using the MIXED procedure of SAS (SAS Institute, Inc. Version 9.2). Means 
were reported as least-square means [± pooled standard error of the mean (SEM)] and 
were separated using the probability of difference; P < 0.05 was considered significant 
to test the hypotheses. For the performance variables, the initial BW was used as a 
covariate and the statistical model contained the following main factors and interactions 
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among them: dietary digestible protein level, protein digestibility and C. perfringens 
challenge. 
 
5.4. Results 
Neither protein level nor digestibility affected the ADG of the birds during the starter 
period (P > 0.05), and only tended to interact for the ADG (P = 0.06; Table 5.1). The 
ADG of the group to be challenged was significantly higher than that of the control 
group during the starter phase (P < 0.05). During this growth phase the interaction 
between protein level and digestibility was significant for ADFI (P < 0.05). When 
incorporated into LoPro starter diets, HiDig proteins increased ADFI of birds by 4.2% 
compared to LoDig proteins, but protein digestibility did not affect the ADFI of birds fed 
HiPro diets (data not shown). The ADFI of the prospective challenge group was 
significantly higher than that of the control group during this phase (P< 0.05). The 
protein level did not significantly affect the FCR of starters (P > 0. 05). The protein 
digestibility significantly affected the FCR during the starter phase, increacing it by 
3.1% in birds fed diets containing LoDig proteins (P < 0.05). The FCR of birds to be 
challenged was 3.1% lower than the control group during the starter phase (P < 0.05). 
During the grower phase, the main effects protein level and digestibility tended to 
interact for the ADG of birds (P = 0.06), but did not affect either ADFI or FCR (P > 
0.05).  
 Subsequent to challenge with C. perfringens, most birds became dull and 
depressed and, had abnormally wet droppings. Those symptoms subsided after a few 
days and the birds exhibited no obvious signs of morbidity by 7 to 9 d after challenge. 
The C. perfringens challenge significantly affected the ADG of birds (P < 0.05), but not 
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Table 5.1. Effect of dietary protein level, protein digestibility and Clostridium perfringens challenge on growth performance of broiler 
chickens during a 35 day growth trial. 
Main effects 
d0  
body 
weight
5
 
Starter (d0 – 14) d14 
body 
weight
5
 
Grower (d15 -35) Final 
body 
weight
5
  
Overall 
PER ADG
1
 ADFI
2
 FCR
3
 PER
4
 ADG ADFI FCR PER 
Protein level             
  Low 43.7 33.4 43.7 1.26 3.52a 513.8 89.3 143.4 1.62 3.16a 2395 3.33a 
  High 44.1 33.0 44.2 1.28 3.22b 506.8 90.6 146.1 1.59 3.05b 2432 3.13b 
Pooled SEM 0.170 0.394 0.510 0.015 0.031 4.249 0.641 1.139 0.025 0.019 20.59 0.021 
             
Protein digestibility             
  Low 44.1 33.1 43.1b 1.25b 3.34 508.3 89.6 143.1 1.60 3.02b 2398 3.18b 
  High 43.7 33.2 44.8a 1.29a 3.41 512.3 90.3 146.4 1.61 3.19a 2429 3.29a 
Pooled SEM 0.170 0.393 0.506 0.014 0.031 4.249 0.637 1.313 0.029 0.019 20.37 0.021 
             
C. perfringens challenge             
  Unchallenged 43.5 31.9b 43.2b 1.29a 3.31b 493.7 92.1a 145.4 1.56 3.15a 2455 3.21 
  Challenged
z
 44.3 34.4a 44.7a 1.25b 3.44a 526.9 87.9b 144.0 1.65 3.06b 2373 3.25 
Pooled SEM 0.170 0.339 0.494 0.014 0.031 4.249 0.902 2.085 0.047 0.019 20.50 0.019 
             
Source of variation (P – value) 
Protein level 
 0.159 0.488 0.450 0.208 <.0001 0.246 0.154 0.254 0.567 0.001 0.414 <.0001 
Protein digestibility 
 0.159 0.765 0.011 0.029 0.142 0.504 0.468 0.255 0.805 <.0001 0.252 0.001 
C. perfringens challenge 
1
2
1
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 0.001 <.0001 0.001 0.010 0.001 <.0001 0.008 0.754 0.434 0.012 0.467 0.151 
Level x Digestibility 
 0.519 0.058 0.045 0.696 0.297 0.052 0.064 0.107 0.784 0.398 0.678 0.215 
Level x Challenge 
 ND ND ND ND ND ND 0.888 0.787 0.520 0.672 0.480 0.866 
Digestibility x Challenge 
 ND ND ND ND ND ND 0.614 0.464 0.542 0.177 0.851 0.270 
Level x Digestibility x  Challenge 
 ND ND ND ND ND ND 0.367 0.216 0.604 0.740 0.648 0.141 
1
average daily gain (g/d); 
2
average daily feed intake (g/d); 
3
feed conversion ratio (g/g); 
4
PER (g/g); 
5 
d0, d14 and final body weight at 
d35d (g) 
z
birds were challenged on d14, therefore growth performance of birds to be challenged during the starter phase and challenged birds 
during the grower and the overall experimental periods 
a,b: means with different letters within a column for each main effect differ (P < 0.05)  
ND: not determined since birds were not challenged in the starter phase 
 
 
 
 
 
1
2
2
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the ADFI or FCR (P > 0. 05). The C. perfringens challenge reduced the ADG of birds 
by 4.6%. On a weekly basis, the C. perfringens challenge significantly affected the ADG 
of broilers during wk 3 and 5 (P < 0.05), but not in wk 4 (P > 0. 05; Figure 5.1). None 
of the main effects or interactions among them affected the final BW of birds (P > 0. 05; 
Table 5.1).  
 Dietary protein level during starter, grower and overall experimental periods and, 
protein digestibility during the grower and overall experimental periods, affected the 
PER of birds (P < 0.05; Table 5.1). Birds fed LoPro levels significantly increased the 
PER throughout the experiment and HiDig proteins optimized the PER during the 
grower and overall experimental periods. The PER of birds to be challenged was higher 
than that of the control group during the starter period (P < 0.05). However, the C. 
perfringens challenge significantly affected the PER (P < 0.05), which was 2.9% lower 
in challenged birds than in unchallenged birds. The overall PER of the birds was not 
affected by the challenge (P > 0. 05). In addition, the PER in both unchallenged and 
challenged birds was significantly higher for starter birds than for grower birds (P < 
0.05). 
Protein level and digestibility significantly affected both ileal C. perfringens 
counts and NE-related intestinal gross lesion score of birds (P < 0.05: Table 5.2): both 
parameters were higher in birds fed HiPro levels and LoDig proteins compared to LoPro 
levels and HiDig proteins fed counterparts, respectively. No interaction between the two 
factors was observed either for the pathogen counts or for the intestinal lesion score of 
birds (P > 0. 05). 
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Figure 5.1. Average daily gain (g/d) of broiler chickens during the grower period (Wk 
3: d15 – 21, Wk 4: d22 – 28, Wk 5: d29 – 35; SEM = 1.641). 
a,b
Means within each week with different superscripts are significantly different. 
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Table 5.2. Effect of dietary protein level and protein digestibility on ileal Clostridium 
perfringens population and intestinal gross lesion score of broiler chickens on d 35 of 
age. 
Main effects Ileal C.perfringens counts 
(log10 cfu/g) 
Intestinal gross lesion 
score
1
 
Protein level   
  Low 2.94b 1.06b 
  High 3.61a 1.59a 
Pooled SEM 0.220 0.151 
   
Protein digestibility   
  Low 3.60b 1.56b 
  High 2.95a 1.09a 
Pooled SEM 0.220 0.151 
   
Source of variation (P – value)   
  Protein level 0.039 0.019 
  Protein digestibility 0.046 0.037 
  Level x Digestibility 0.286 0.664 
1
According to the criteria described by Dahiya et al. (2005): 0-No gross lesions,  normal 
intestinal appearance; 0.5-Severely congested serosa and mesentery engorged with 
blood; 1- Thin-walled, friable intestines with small red petechiae (> 5); 2-Focal necrotic 
intestinal lesions; 3- Sizable patches of necrosis (1 to 2 cm long); 4- Diffused necrosis 
typical of field cases. 
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 The main effects of protein level, protein digestibility or C. perfringens challenge 
did not affect the microbial acetate production in the cecum (P > 0.05), but an 
interaction among the three factors tended to affect the level of acetate (P = 0.09; Table 
5.3). Only the main effect C. perfringens challenge affected the cecal propionate level (P 
< 0.05), challenged birds having 25% more propionate than unchallenged counterparts. 
The three main effects interacted for the levels of butyrate and total VFA in the cecum 
(P < 0.05). Protein digestibility affected the cecal butyrate and total VFA concentrations 
of unchallenged birds fed LoPro diets (P < 0.05), LoPro-HiDig diet fed birds having 
9.64 and 29.05 µmol more butyrate and total VFA, respectively, per g of cecal digesta 
compared to birds fed LoPro-LoDig diet. However, in birds fed LoPro-LoDig diet, C. 
perfringens  challenge significantly increased the amounts of cecal butyrate and total 
VFA by 10.02 and 29.30 µmol, respectively, per g of digesta, compared to unchallenged 
counterparts. Except for the LoPro-LoDig treatment, the amounts of cecal butyrate and 
total VFA were similar between unchallenged and challenged birds fed the other dietary 
treatments (P > 0. 05; Figure 5.2). Dietary protein level did not affect (P > 0. 05), but 
protein digestibility and C. perfringens challenge interacted for the amount of valerate 
produced in the cecum (P < 0.05). When challenged, birds fed LoDig proteins had 
71.4% more valerate, compared to birds fed HiDig proteins, but protein digestibility did 
not affect the cecal valerate level in unchallenged birds (data not shown). Only the main 
effect protein level affected the amount of isocaproate in the cecum (P < 0.05). Dietary 
HiPro level reduced cecal isocaproate concentration by 46.7% compared to LoPro level. 
The main effects did not affect the amount of cecal caproate in the birds (P > 0.05), but 
an interaction between protein level and C. perfringens challenge tended to affect the 
level of caproate (P = 0.09). None of the main effects and their interactions affected  
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Table 5.3. Effect of dietary protein level, protein digestibility and Clostridium perfringens challenge on volatile fatty acid profile, total 
volatile fatty acid concentration (μmol/g) and ammonia concentration (mmol/g) in the ceca of broiler chickens at d 35. 
Main effects Acetic Propionic Butyric 
iso 
Butyric 
iso 
Valaric 
Valaric 
iso 
Caproic 
Caproic Heptonic  Total Ammonia 
Protein level            
  Low 70.04 3.94 19.37 0.25 0.41 1.16 0.15a 0.16 0.17 95.65 435.24 
  High 74.56 3.71 16.71 0.19 0.36 1.04 0.08b 0.19 0.19 97.50 485.88 
Pooled SEM 3.51 0.27 1.01 0.02 0.03 0.08 0.03 0.03 0.02 4.58 29.26 
            
Protein digestibility            
  Low 69.78 3.77 16.60 0.21 0.36 1.31 0.13 0.15 0.20 92.98 480.60 
  High 74.82 3.88 19.47 0.23 0.41 0.90 0.10 0.19 0.16 100.17 440.52 
Pooled SEM 3.51 0.27 1.01 0.02 0.03 0.08 0.03 0.03 0.02 4.58 29.26 
            
C. perfringens challenge  
  Unchallenged 74.14 3.40b 17.59 0.20 0.40 0.97 0.10 0.16 0.17 97.14 455.03 
  Challenged 70.46 4.25a 18.49 0.24 0.37 1.23 0.13 0.19 0.18 96.02 466.10 
Pooled SEM 3.51 0.27 1.01 0.02 0.03 0.08 0.03 0.03 0.02 4.58 29.26 
            
Source of variation (P – value) 
Protein level 
 0.366 0.547 0.068 0.129 0.360 0.296 0.039 0.540 0.491 0.775 0.226 
Protein digestibility 
 0.314 0.766 0.049 0.658 0.388 0.001 0.448 0.422 0.103 0.272 0.337 
C. perfringens challenge 
 0.462 0.028 0.533 0.321 0.544 0.026 0.362 0.617 0.585 0.863 0.790 
1
2
7
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Level x Digestibility 
 0.586 0.105  0.953 0.846 0.227 0.214 0.562 0.933 0.937 0.840 0.317 
Level x Challenge 
 0.277 0.536 0.093 0.813 0.734 0.171 0.990 0.098 0.455 0.268 0.630 
Digestibility x Challenge 
 0.223 0.067 0.056 0.667 0.969 0.034 0.928 0.577 0.725 0.116 0.667 
Level x Digestibility x  Challenge 
 0.090 0.178 0.009 0.758 0.668 0.056 0.389 0.141 0.661 0.052 0.749 
 
 
 
 
 
 
1
2
8
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(A) 
 
 
(B) 
 
Figure 5.2. Effect of C. perfringens challenge on the microbial butyrate and total VFA 
production in caca of broilers fed different dietary treatments.   
 LoPro: low digestible protein level, HiPro: high digestible protein level, LoDig: low 
protein digestibility, HiDig: high protein digestibility.
 
a,b
Means for each dietary treatment within butyrate and total VFA with different 
superscripts are significantly different (A), and means for butyrate and total VFA within 
each dietary treatment with different superscripts are significantly different (B). 
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isobutyrate, isovalerate and heptonate concentrations in the cecum (P > 0.05). 
 The three main effects and their interactions did not affect the ammonia 
production in the cecum of birds (P > 0. 0.05; Table 5.3). However, HiPro level, LoDig 
proteins and C. perfringens challenge resulted numerical increases in cecal ammonia 
production.   
 The three main effects did not affect the acetate MR (Table 5.4) in the cecum of 
birds (P > 0.05), but interactions between protein level and digestibility and, protein 
digestibility and C. perfringens challenge affected that MR (P < 0.05). Compared to 
HiDig proteins, LoDig proteins in LoPro diets increased acetate MR by 3.4%. Protein 
digestibility did not affect the acetate MR in the cecum of birds fed HiPro diets. In birds 
fed LoDig proteins, C. perfringens challenge reduced the acetate MR by 5.7% compared 
to unchallenged birds, but C. perfringens challenge did not affect the acetate MR in 
birds fed HiDig proteins (data not shown). The main effect C. perfringens challenge and 
the interaction between protein level and digestibility affected the propionate MR in 
birds (P < 0.05). The MR was 25.1% higher in challenged birds than in unchallenged 
counterparts. In birds fed HiPro diets, LoDig proteins increased propionate MR by 
35.6% compared to Hidig proteins, but protein digestibility did not affect the propionate 
MR in birds fed LoPro diets (data not shown). An interaction among the main effects 
affected the butyrate MR (P < 0.05). When challenged, the MR was higher in birds fed 
LoPro diets than in birds fed HiPro diets, irrespective of protein digestibility. Among 
unchallenged treatment groups, butyrate MR was higher in birds fed LoPro-HiDig diet 
(data not shown). The main effect C. perfringens challenge affected the valerate MR (P 
< 0.05) and the interaction between protein level and digestibility tended to affect the 
MR in the cecum (P = 0.06). The C. perfringens challenge increased the valerate MR by 
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Table 5.4. Effect of dietary protein level, protein digestibility and Clostridium perfringens challenge on molar ratio (% of total) of 
volatile fatty acid in the ceca of broiler chickens at d 35. 
Main effects Acetic Propionic Butyric 
iso 
Butyric 
iso 
Valaric 
Valaric 
iso 
Caproic 
Caproic Heptonic  
Protein level          
  Low 73.44b 4.16 19.93a 0.28 0.45 1.20 0.18 0.17 0.19 
  High 76.43a 4.10 16.88b 0.21 0.40 1.10 0.10 0.22 0.20 
Pooled SEM 0.515 0.301 0.525 0.031 0.045 0.077 0.032 0.041 0.021 
          
Protein digestibility          
  Low 75.16 4.30 17.51b 0.25 0.44 1.40a 0.17 0.19 0.24 
  High 74.71 3.96 19.30a 0.23 0.42 0.90b 0.11 0.21 0.16 
Pooled SEM 0.515 0.301 0.525 0.031 0.045 0.077 0.032 0.041 0.021 
          
C. perfringens challenge  
  Unchallenged 76.33a 3.67 17.77 0.23 0.45 1.04b 0.13 0.18 0.19 
  Challenged 73.54b 4.59 19.05 0.25 0.40 1.26a 0.15 0.21 0.20 
Pooled SEM 0.515 0.301 0.525 0.031 0.045 0.077 0.032 0.041 0.021 
          
          
Source of variation (P – value)          
Protein level 0.0001 0.889 0.0001 0.124 0.430 0.383 0.088 0.394 0.662 
Protein digestibility 0.541 0.421 0.019 0.662 0.764 <.0001 0.223 0.729 0.014 
C. perfringens challenge 0.0003 0.035 0.090 0.631 0.419 0.048 0.740 0.581 0.662 
Level x Digestibility 0.009 0.039 0.541 0.949 0.370 0.063 0.761 0.820 0.868 
Level x Challenge 0.503 0.225 0.043 0.335 0.620 0.367 0.621 0.055 0.060 
1
3
1
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Digestibility x Challenge 0.033 0.626 0.147 0.234 0.355 0.234 0.421 0.957 0.200 
Level x Digestibility x Challenge 0.096 0.962 0.038 0.251 0.566 0.489 0.833 0.311 0.351 
a, b: means with different letters within a row for each main effect differ (P < 0.05) 
1
3
2
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21.2%. The protein level tended to affect the isocaproate MR (P = 0.09), but the other 
two main effects did not affect (P > 0.05). None of the main effects affected the caproate 
MR (P > 0.05), but the interaction between protein level and C. perfringens challenge 
tended to affect (P = 0.06). The main effect protein digestibility affected the heptonate 
MR in the cecum (P < 0.05) and the interaction between protein level and C. perfringens 
challenge tended to affect (P = 0.06). The LoDig proteins in the diet increased the MR 
by 50% compared to HiDig proteins.        
  
5.5. Discussion 
The previous study described in Chapter 3 reported a significant interaction between 
protein level and digestibility for ADG during the starter period of the birds fed the same 
experimental diets.  This interaction was due primarily to decreased performance in 
birds fed the LoPro-LoDig diet compared to birds fed the other three diets. The similar 
trend observed in the current experiment supports the previous findings. When proteins 
with low digestibility values are fed, comparatively higher amounts of AA may leave the 
upper GIT and thus be freely available to the microbes residing in the lower GIT. Some 
enteric bacteria acquire the ability to metabolize AA, producing toxins and other 
metabolites which may affect enterocyte turnover and growth performance of birds 
(Ewing and Cole 1994; Macfarlane and Macfarlane 1995; Gaskins 2001; van der Klis 
and Jansman 2002). This combined with reduced dietary protein would put the LoPro-
LoDig fed birds under greater stress and resulted in the decreased growth seen in both 
experiments.  
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 Birds fed LoPro-HiDig diet consumed more feed than birds fed LoPro-LoDig 
diet during the starter period of the present study. The study described in Chapter 3 
reported the same observation only during the grower period of birds, but not in the 
starter phase. Diets with HiDig proteins contained a lesser amount of CP compared to 
diets with LoDig proteins, notwithstanding the inclusion of equal amounts of digestible 
protein in feed formulation in each of the LoPro and HiPro situations. An increase in 
feed consumption was reported by Aletor et al. (2000), feeding broilers lCP – AA 
supplemented diets during the grower phase. In addition, higher amounts of nitrogen 
pass as undigested proteins to the gut microbes of birds fed diets containing LoDig 
proteins, which may result in increased hindgut fermentation (Piva et al. 1995). The 
physical distention of the hindgut as a consequence of the increased hindgut 
fermentation might result in a reduction in feed consumption of the birds (Cherbut et al. 
1988).  
 The growth performance of the birds that were challenged was superior to the 
other group during the starter phase, before the challenge occurred. However, 
subsequent to C. perfringens inoculation, the growth performance of these birds became 
inferior to the unchallenged group during the grower phase. Significantly higher initial 
BW of the group to be challenged might have led to the better growth performance 
during the starter phase, compared to the control group. The ADG of the birds was 
reduced in the first week of challenge (third week of experiment).  Nevertheless, as 
reported in Chapter 4, the C. perfringens challenge did not affect the ADG of growers 
during the fourth week, likely due to diminishing intensity of the infection. However, the 
ADG of challenged birds was reduced again during the fifth week, due to possible re-
infection caused by the ingestion of the pathogen or their spores on the litter, shed by the 
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infected birds. Reduced weight gain and increased FCR associated with impaired 
nutrient digestion and absorption due to the damage caused by C. perfringens to the 
intestinal mucosa can be linked to the substandard growth performance of challenged 
birds during the grower phase (Elswinger et al. 1992; Kaldhusdal and Hofshagen 1992; 
Kaldhusdal et al. 2001; Hofacre et al. 2003). In addition, gaining access to portal 
circulation and biliary system, C. perfringens gives rise to hepatitis and cholangio-
hepatitis in broiler chickens (Lovland and Kaldhusdal 1999, 2001; Sasaki et al. 2000). 
The subsequent damage to the liver, bile ducts and gall bladder may result in reduced 
growth performance as well. Previous studies have reported impaired overall 
performance in broiler chickens, highly infected with C. perfringens (Stutz et al. 1983; 
Stutz and Lawton 1984; Kaldhusdal and Hofshagen 1992; Dahiya et al. 2005, 2007a, b).  
 One of the factors that determines the subsequent growth rate in broilers is the 
chick quality that includes the chick weight (Wilson 1991; Tona et al. 2003, 2004). 
Accordingly, significantly higher chick weight and the resultant better growth 
performance during the starter phase of birds to be challenged might have led to the final 
BW being equal to that of their unchallenged counterparts. Even under this situation, 
although not significant, the C. perfringens challenge demonstrated a considerable effect 
on the final BW of birds under different dietary treatments (Figure 5.3), which might 
have been significant and could have created a great economic impact, if the chicks with 
similar weight would have been used in challenged and unchallenged conditions. In this 
study, the C. perfringens challenge resulted only a 1.2 g reduction in the final BW of 
birds fed LoPro-HiDig diet, compared to unchallenged counterparts, but this weight 
difference for LoPro-LoDig, HiPro-LoDig and HiPro-HiDig diets fed birds were 134.5, 
91.3 and 100.3 g, respectively. The findings of the current study clearly indicate that the  
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Figure 5.3. Effect of C. perfringens challenge on the final body weight at d35 of broilers 
fed different dietary treatments (P = 0.648; SEM = 39.51)   
 LoPro: low digestible protein level, HiPro: high digestible protein level, LoDig: low 
protein digestibility, HiDig: high protein digestibility. 
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impact of C. perfringens on broiler growth performance can be reduced to a great extent 
by using LoPro diets containing high quality protein supplements.   
 The efficiency of dietary protein utilization is generally reflected by the PER 
(Kamran et al. 2008). In the present study, the PER was higher in birds fed LoPro diets 
compared to birds fed HiPro diets during starter, grower and overall experimental 
periods. This finding was supported by previous studies (Cheng et al. 1997; Aletor et al. 
2000) as well as the study described in Chapter 3, reporting a significant increase in PER 
with the reduction of dietary protein content. Increasing dietary protein level by adding 
non essential AA to lCP diets, Aletor et al. (2000) reported a reduction in PER compared 
to AA un-supplementation. However, lowering the CP content but maintaining a 
constant ME:CP ratio, Kamran et al. (2008) demonstrated a linear reduction in PER in 
broiler chickens during the grower, finisher and entire experimental periods. This 
observation can be attributed to the linear increase in feed consumption with the 
lowering ME:CP ratio, which in turn increased protein intake of birds during those 
growth phases. 
Compared to LoDig protein supplements, HiDig protein supplements in broiler 
rations optimized the protein utilization, as reflected by the PER, in the present study. 
The previous study described in Chapter 3 with the same dietary treatments reported the 
same observations only during the grower and finisher periods, but not in the starter 
phase. As previously discussed, undigested proteins originated from LoDig protein 
sources are subjected to microbial metabolism in the hind gut and the consequential 
metabolites may negatively affect the growth of birds (Ewing and Cole 1994; 
Macfarlane and Macfarlane 1995; Gaskins 2001; van der Klis and Jansman 2002). As a 
result, the PER in birds fed diets containing LoDig proteins was decreased, despite the 
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similar protein intake. In addition, in unchallenged birds the PER was higher during the 
starter period compared to grower period. This observation was supported by Johnson 
and Parsons (1997), Kamran et al. (2008) and data from the study described in Chapter 
3. Increasing demand for nutrients for maintenance with increasing age is a plausible 
explanation for this observation. 
Similar to the other growth performance parameters, the PER as well, was 
superior in birds to be challenged during the starter period compared to the control 
group. Nevertheless, C. perfringens challenge at the beginning of the grower period 
reduced the PER of the challenged group. Damage caused by C. perfringens to the GIT 
and associated organs adversely affects the growth performance of birds (Elswinger et 
al. 1992; Kaldhusdal and Hofshagen 1992; Kaldhusdal et al. 2001; Lovland and 
Kaldhusdal 1999, 2001; Hofacre et al. 2003). The ADFI, hence the CP intake, was 
similar between the challenged and unchallenged birds during the grower period, so the 
weight gain suppressed by the pathogen reduced the PER of challenged birds. However, 
the PER was similar for challenged and unchallenged birds at the end of the experiment 
on account of the superior PER of challenged birds before challenging.  
Overall, as previously suggested in Chapter 3, high quality protein supplements 
should be incorporated into broiler diets and essential AA should be supplemented in 
quantities not more than required for optimum performance, to optimize the utilization 
of dietary protein.  
 Based on the findings of previous studies, the distinct impact of the source and 
level of dietary protein have on C. perfringens proliferation in the GIT of broiler 
chickens is evident (Kaldhusdal 2000; Drew et al. 2004). Studies have demonstrated an 
over-proliferation C. perfringens in the small intestine of broiler chickens, subsequent to 
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an increased consumption of protein or a specific AA and, predisposing of birds fed 
higher amounts of proteins to NE (Titball et al. 1999; Drew et al. 2004; Kaldhusdal 
2000; Kocher 2003; Wilkie et al. 2005). Although sufficient evidence exists to support 
the mechanisms behind the effects of other dietary factors on the proliferation of C. 
perfringens and development of NE, there is a scarcity of information to describe the 
mechanisms associated with the high prevalence of NE in broilers fed HiPro levels. 
Genetic makeup of broiler chickens determines the capacity of nutrient digestion and 
absorption and amounts beyond that level escapes the absorptive area of the GIT without 
being utilized. Accordingly, as previously described, feeding broilers with diets 
containing higher levels of proteins may increase the flow of unused protein to the latter 
part of the GIT and acting as a good source of nutrients for enteric pathogens, this 
portion of dietary protein may increase the proliferation of C. perfringens. The findings 
of the present study support this hypothesis with significantly higher C. perfringens 
numbers in the ileal digesta of broilers fed HiPro diets. In addition, when broilers are fed 
poorly digestible proteins, relatively higher amounts of undigested AA are present in the 
GIT (Lan et al. 2004; McDevitt et al. 2006) where they are available to the pathogenic 
microbes residing in the lower GIT. This hypothesis too, in accordance with the results 
of the current study, in which birds fed diets with LoDig protein supplements had higher 
ileal C. perfringens counts compared to HiDig proteins fed counterparts.   
In view of the cost, complications and requirement of specialized training and 
equipments associated with the procedures for precise identification of bacterial genera 
and species, measurement of bacterial metabolites and end products of fermentation can 
be used to evaluate the overall shifts in bacterial activity in the GIT. The VFA are the 
major end products of microbial fermentation in the GIT (Ricke at al. 2004), thus 
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measuring VFA levels in digesta is used as a tool of evaluating changes in the bacterial 
activity in the GIT of broilers (Corrier et al. 1990; Choct et al. 1996, 1999; Vahjen et al. 
1998; Yasar and Forbes 1999; Kocher et al. 2000). Ceca are the main site of microbial 
fermentation in the avian GIT because these chambers provide a relatively stable 
environment and harbor the largest as well as the most complex bacterial community in 
the GIT of poultry (Mead 1997). In addition, shorter digesta transit time in the upper 
GIT limits the microbial fermentation hence VFA concentration is normally low in the 
small intestine compared to the cecum of poultry (Rehman et al. 2007). Despite the 
highly efficient digestion and nutrient absorption process of the upper GIT, a constant 
supply of nutrients to the lower GIT still exists in the form of undigested dietary 
components, desquamated gut mucosal cells and host enzymes. Hence, the main energy 
sources available for cecal microbes are complex carbohydrates and undigested proteins 
(Piva et al. 1995; Józefiak et al. 2004). In the absence of simple sugars, inducible 
enzymes produced by the microbes facilitate utilization of dietary components not 
digested by the host (Bugaut 1987). In general, complex carbohydrates are fermented by 
the resident microflora in the cecum to VFA (Józefiak et al. 2004).    
 In the present study, the amount of microbial acetate produced in the caca of 
birds challenged with C. perfringens was similar among all treatment groups, but in 
unchallenged group, birds fed HiPro-HiDig diet had more acetate than LoPro-LoDig 
diet fed birds. However, the lowest acetate MR was reported by unchallenged birds fed 
LoPro-HiDig diet and challenged birds fed LoPro diets. The C. perfringens challenge 
increased the amount and the MR of cecal propionate. In addition, HiDig protein 
supplements reduced the propionate MR in birds fed HiPro diets. The low cecal MR of 
acetate and propionate in birds fed LoPro diets or HiDig proteins can be attributed to a 
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number of factors; proportionately lower production of these VFA, higher uptake by the 
host or utilization as energy sources by cecal microbes. Moreover, a possibility of 
utilizing some of these VFA by certain microbes as growth substrates cannot be 
excluded, because metabolic end products produced by one organism or species can 
serve as growth substrates for another. In fact, previous reports indicated the utilization 
of acetate by butyrate – producing microbes (Barcenilla et al. 2000) and lactobacilli 
(Meimandipour et al. 2009) for their metabolic activities.  
 In unchallenged birds fed LoPro diets, LoDig proteins reduced the cecal butyrate 
concentration compared to HiDig proteins. Nevertheless, birds fed LoPro diet containing 
LoDig proteins reported the highest amount of cecal butyrate when challenged with C. 
perfringens. This observation was same for the total VFA content in the cecum as well. 
The butyrate MR was higher in unchallenged birds fed LoPro-LoDig diet and challenged 
birds fed LoPro diets. Currently, butyrate attracts more attention than other VFA due to 
its beneficial effects on the GI epithelial cells (Cavaglieri et al. 2003). Lactate is a major 
precursor of butyrate synthesis (Bjerrum et al. 2006; Meimandipour et al. 2009) 
therefore an increase in the number of lactic acid bacteria is correlated with the increase 
in the butyrate synthesis (Duncan et al. 2004). Nevertheless, a negative correlation has 
been reported between presence of Lactobacillus and pathogenecity and/or proliferation 
of C. perfringens in the GIT of broiler chickens.  For instance, Fukata et al. (1991) 
observed a lower intensity in pathogenecity of C. perfringens in chickens fed a 
monoflora of Lactobacillus acidophilus. In addition, a significant decrease in C. 
perfringens numbers was reported with increasing numbers of Lactobacilli in the cecum 
of broilers (Dahiya et al. 2007a). However, challenged birds fed LoPro-LoDig diet 
demonstrated the numerically worst growth performance in this study and that might 
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partly be due to the substantial damage caused by the pathogen to the intestinal mucosa. 
This damage may have limited the uptake and utilization of VFA by the GIT and that 
can be attributed to the higher butyrate and total VFA levels in challenged birds fed that 
particular diet, compared to unchallenged birds.   
    However, when carbohydrate sources are limited, carbohydrate: nitrogen ratio 
of the cecum decreases resulting in more proteolytic fermentation (Piva et al. 1995). 
Accordingly, a portion of the intestinal VFA, mainly branched – chain VFA, is protein 
derived and produced as a result of fermentation of branched – chain AA (valine, leucine 
and isoleucine:  Macfarlane et al. 1992). However, a minimal proteolytic fermentation 
had taken place in the ceca of birds in the current study, as reflected by very low 
concentrations and MR of branched – chain VFA such as isobutyrate, isovalerate and 
isocaproate. It appears that cecal microbes utilized preferably carbohydrate substrates for 
fermentation resulting in a lower concentration of branch-chain VFA with higher 
proportion of straight chain VFA. This is beneficial to the host in terms of gut health and 
overall performance, because a proteolytic fermentation produces such potentially toxic 
metabolites as ammonia, biogenic amines, volatile phenols and indoles in addition to 
VFA (Yokoyama et al. 1982; Russell et al. 1983; Macfarlane et al. 1992). In this 
context, carbohydrate fermentation is preferred over proteolytic activity of microbes in 
the GIT.  
In general, ammonia concentration is higher in the cecum compared to other 
segments of avian GIT (Isshiki 1980). Amino acids from both dietary and endogenous 
proteins are the main source of ammonia in the lower GIT (Wrong and Vince 1984). 
Accordingly, the concentration of ammonia in the cecum reflects the amount of AA 
reaching the lower GIT. In the present study, in the cecum of birds fed LoPro and HiDig 
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protein supplements the ammonia concentration was numerically lower by 10 and 8%, 
compared to ammonia in birds fed HiPro and LoDig proteins, respectively. This 
observation suggests that lower amounts of proteins escaped the digestion and 
absorption process of the upper GIT of broilers fed low dietary digestible proteins and 
highly digestible protein sources. In addition, the C. perfringens challenge of the birds 
resulted a numerical increase in cecal ammonia by 2.4%.  In fact, Clostridium is among 
the few candidates who are able to metabolize proteins in the cecum, producing 
ammonia as an end product (Macfarlane et al. 1992). Therefore these findings have 
shown that feeding broilers with LoPro diets containing highly digestible proteins can 
improve the gut health by reducing effects of enteric pathogens. 
 In conclusion, data from this investigation revealed the capacity of LoPro diets 
with highly digestible protein supplements to minimize the C. perfringens challenge 
related growth suppression of broiler chickens. The key beneficial effects of that 
particular dietary approach were likely due to limited nutrient availability to the 
pathogen as a consequence of enhanced nutrient utilization by the host and a possibility 
for formation of host friendly intestinal ecosystem. The overall results of this study may 
support our efforts in the development of nutritional strategies to minimize the impact of 
C. perfringens on broiler production in the absence of AGP. 
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6. ORAL Clostridium perfringens CHALLENGE AFFECTS THE METHIONINE 
REQUIREMENTS OF BROILER CHICKENS 
 
6.1 Abstract 
Bacterial overgrowth of opportunistic pathogens often does not elicit clinical disease. 
However, it may result in changes in nutrient utilization altering the requirement for 
nutrients including AA. The effect of C. perfringens challenge of broiler chickens on the 
requirement for methionine was determined in a 21d growth trial. Broiler chickens (288) 
were randomly assigned to two rooms and fed a medicated commercial starter diet from 
d0-6. From d7-21, the birds were fed seven different diets: a methionine deficient basal 
diet (230 g/kg CP and 2.7 g/kg standardized ileal digestible methionine), of diets 
fortified with equi-sulfurous amounts of DLM (1.6, 3.2 or 4.8 g/kg) or HMB (1.8, 3.6 or 
5.5 g/kg).  On d7-20, the birds in one room were challenged using an overnight broth 
culture of C. perfringens, offered 2 ml per bird in 1/3 of ADFI, while the birds in the 
other room received feed mixed with sterile broth. Quadratic regressions were fitted to 
growth, feed intake and feed conversions, and methionine requirement was calculated as 
the inflection point of the regression line. The methionine requirement of the birds fed 
DLM was higher in infected birds compared to uninfected birds for ADG (6.03 and 5.07 
g/kg; P < 0.05) while the infected and uninfected HMB fed birds had requirements that 
were not significantly different than the other two groups (5.30 and 5.39 g/kg). The 
methionine requirement for optimum FCR was significantly higher in infected birds than 
uninfected birds for both the DLM-fed birds (6.27 vs 5.41 g/kg) and the HMB-fed birds 
(6.50 and 5.94 g/kg). Further, the DLM fed birds had significantly lower methionine 
requirements for maximum FCR than the HMB fed bird in both infected and uninfected 
groups. The methionine requirements for maximum ADFI were not significantly 
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different between groups. Cecal C. perfringens populations and intestinal lesion scores 
were not significantly affected by either methionine source or level. C. perfringens 
infection has a significant effect on methionine requirement and may be responsible for 
the reduced growth performance of birds with subclinical NE. 
 
6.2. Introduction 
Necrotic enteritis is a potentially fatal bacterial infection of poultry and all poultry 
producing regions of the world have reported it as an economically important disease 
(Van Immerseel et al. 2004). The disease is associated with C. perfringens type A 
strains, carrying the genes for α or NetB toxins (Keyburn et al. 2008; Van Immerseel et 
al. 2008). The approximate annual global loss due to this disease has been estimated as 
US $2 billion (Van der Sluis 2000b). With the legal restrictions on the utilization of 
AGP in animal feed industry in some poultry producing countries, this disease is re-
emerging in broiler chickens (Grave et al. 2004; Van Immerseel et al. 2004; Williams 
2005). In this scenario, there is an earnest interest in finding alternative management as 
well as nutritional strategies to antibiotics to combat the occurrence and intensity of NE 
in poultry.       
Dietary protein plays a crucial role in the development of NE in broiler chickens. 
The marked effect of the source and level of dietary protein on counts of C. perfringens 
in intestinal contents of broiler chickens is well documented (Kaldhusdal 2000; Drew et 
al. 2004). Studies have revealed that HiPro diets, in particular diets containing high level 
of animal-derived proteins, predispose broilers to NE (Kaldhusdal 2000; Kocher 2003; 
Drew et al. 2004; Wilkie et al. 2005). 
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In addition to dietary proteins, evidence exists to suggest a correlation between 
certain AA and C. perfringens growth and/or α toxin production. The presence of certain 
AA in the GIT triggers C. perfringens growth and α toxin production. Accordingly, 
increased levels of protein and/or a particular AA in the small intestine of broiler 
chickens can induce the over-proliferation of this organism (Titball et al. 1999). Several 
studies demonstrated the stimulatory effect of dietary glycine on the proliferation of this 
pathogen in the GIT of broiler chickens and thereby increasing the possibility of NE 
(Ispolatovskaya 1971; Nakamura et al. 1978; Dahiya et al. 2005; Wilkie et al. 2005). C. 
perfringens has demonstrated the requirement of peptides with glycine for the synthesis 
of α toxin (Nakamura et al. 1978; Stevens and Rood 2000). In contrast to the role of 
glycine in C. perfringens proliferation, methionine is required for sporulation and is 
highly stimulatory for growth, despite not being an essential nutrient for C. perfringens 
(Muhammed et al. 1975). However, in vitro experiments conducted in our laboratory 
observed a significant suppression of C. perfringens proliferation upon incubation of a 
mixed bacterial culture for a period of 24-h in minimal salt media supplemented with 
DLM at a higher concentration (10 mg/ml), compared to the unsupplemented media 
(Wilkie et al. 2005). Moreover, performing an in vivo study using the two commercially 
available methionine forms, DLM and HMB, Dahiya et al. (2007b) observed a 
significant decrease in C. perfringens numbers in the GIT of broilers fed relatively high 
concentrations of methionine. 
Methionine is a limiting AA in commercial poultry feeds and is normally 
supplemented using dry DLM with approximately 99% methionine activity or dry or 
liquid HMB, commonly available as a product containing 88% methionine activity. For 
over four decades there has been debate in the scientific literature regarding the 
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nutritional effectiveness (Thomas et al. 1991; Van Weerden et al. 1992; Esteve-Garcia 
and Austic 1993; Huyghebaert 1993; Rostagno and Barbosa 1995; Schutte and de Jong 
1996; Esteve-Garcia and Llaurado 1997; Wallis, 1999; Lemme et al. 2002) and the 
appropriate statistical methodology to evaluate the precise bioefficacy estimates (Littell 
et al. 1997; Kratzer and Littell 2006; Sauer et al. 2008) of DLM and HMB. The 
objective of current study was to evaluate the methionine requirement for optimum 
growth in broiler chickens fed diets supplemented with DLM or MHA under C. 
perfringens infected and uninfected situations.    
 
6.3. Materials and methods 
Experimental protocols for the study was approved by the Animal Care Committee of 
the University of Saskatchewan and was performed in accordance with 
recommendations of the Canadian Council on Animal Care as specified in the guide to 
the Care and Use of Experimental Animals (Canadian Council on Animal Care 1993). 
 
6.3.1. Birds and management 
One-day-old male Ross 308 broiler chicks (288), obtained from a local broiler hatchery 
(Lilydale Hatchery, Wynyard, Saskatchewan, Canada) were used in this study. Upon 
arrival to the research facility, birds were randomly allocated into 24 battery cages (12 
birds/cage). On d 1-7, birds were fed the same corn/soybean meal-based starter crumble 
diet (3,200 kcal/kg of ME; 1.2% Lys) described in chapter 3 (Table 3.1: Federated Coop 
Feeds, Saskatoon, Saskatchewan, Canada). At the end of the pre-experimental period (d 
7), the birds were weighed (142.85 ± 14.35 g) and randomly distributed in 48 battery 
cages in two rooms (24 cages/room; 6 birds/cage). The battery cages were arranged in 
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six tiers with wire floors plus fecal collection trays and were equipped with external feed 
and water troughs. Temperature was maintained at 34 °C at placement and reduced as 
the birds progressed in age with a final temperature of 27 °C at d 21. The lighting 
schedule used was intended not to restrict early growth and consisted of 23 h light and 1 
h dark from d 1 to 7 and, 20 h light and 4 h dark from d 8 to the end (d 21) of 
experiment. Feed and water were available to the birds for ad libitum consumption, 
throughout the experiment. 
 
6.3.2. Dietary treatments 
On d 7, three cages of six birds each were assigned in a completely randomized design 
to one of the seven different experimental diets in mash form. The ideal protein-
balanced, isocaloric diets were formulated based on SID AA content, calculated using 
QuickChick 1.0 program (Evonik-Degussa GmbH, Hanau, Germany). The birds were 
fed diets supplemented with either DLM (at 0, 0.16, 0.32, and 0.48%) or HMB (at 0, 
0.18, 0.36, and 0.55%) thus providing four corresponding equimolar levels of each 
methionine source (Table 6.1). The control diet with no added methionine was 
formulated to contain 3100 kcal/ kg of ME, 23% CP, and 1.2, 0.27 and 0.35% SID 
lysine, methionine and cystine, respectively. Accordingly, the control diet contained 
only 50% of SID methionine required in d 8 – 21 period. The control diet was then 
supplemented with either DLM or HMB to achieve four equimolar levels of each 
methionine source (0, 0.16, 0.32, and 0.48%). The supplementation of methionine 
precursors was made at the expense of Celite (Celite 545, Celite Corporation, World 
Minerals Co., Lompoc, CA, USA). Except for methionine, the diets met or exceeded the 
NRC (1994) energy and nutrient requirements for broiler chickens for all other nutrients. 
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Table 6.1. Ingredient and nutrient composition of experimental diets to be fed from d8 to 21 of age (% as-is basis). 
Ingredient (%) Control 
DL-Methionine  DL-Hydroxy Methionine 
0.16  0.32 0.48  0.18  0.36 0.55 
  Wheat 58.00 58.00 58.00 58.00  58.00 58.00 58.00 
  Field Pea 14.50 14.50 14.50 14.50  14.50 14.50 14.50 
  Soybean meal 12.00 12.00 12.00 12.00  12.00 12.00 12.00 
  Canola meal 0.35 0.35 0.35 0.35  0.35 0.35 0.35 
  Wheat DDGS
1
 0.39 0.39 0.39 0.39  0.39 0.39 0.39 
  Meat and bone meal 6.00 6.00 6.00 6.00  6.00 6.00 6.00 
  Fish meal 0.42 0.42 0.42 0.42  0.42 0.42 0.42 
  Blood meal 0.14 0.14 0.14 0.14  0.14 0.14 0.14 
  Dried casein 0.04 0.04 0.04 0.04  0.04 0.04 0.04 
  Canola oil 3.49 3.49 3.49 3.49  3.49 3.49 3.49 
  Dicalcium phosphate 0.81 0.81 0.81 0.81  0.81 0.81 0.81 
  Calcium carbonate 0.28 0.28 0.28 0.28  0.28 0.28 0.28 
  NaCl 0.35 0.35 0.35 0.35  0.35 0.35 0.35 
  Vit/Min premix
2
 0.50 0.50 0.50 0.50  0.50 0.50 0.50 
  Choline chloride 0.10 0.10 0.10 0.10  0.10 0.10 0.10 
  L-Lysine.HCL 0.32 0.32 0.32 0.32  0.32 0.32 0.32 
  L-Threonine 0.08 0.08 0.08 0.08  0.08 0.08 0.08 
  Isoleucine 0.07 0.07 0.07 0.07  0.07 0.07 0.07 
  Valine 0.09 0.09 0.09 0.09  0.09 0.09 0.09 
  Glycine 0.02 0.02 0.02 0.02  0.02 0.02 0.02 
  DL-Methionine 0.00 0.16 0.32 0.48  0.00 0.00 0.00 
1
4
9
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  DL-Hydroxy Methionine 0.00 0.00 0.00 0.00  0.18 0.36 0.55 
  Xylanase
3
 0.05 0.05 0.05 0.05  0.05 0.05 0.05 
  Celite 2.00 1.84 1.68 1.52  1.82 1.64 1.45 
         
Energy and nutrient (%)         
  ME (kcal/kg) 3100 3100 3100 3100  3100 3100 3100 
  Total protein 23.00 23.00 23.00 23.00  23.00 23.00 23.00 
  AID protein 19.00 19.00 19.00 19.00  19.00 19.00 19.00 
  AID Glycine 0.90 0.90 0.90 0.90  0.90 0.90 0.90 
  Calcium 0.94 0.94 0.94 0.94  0.94 0.94 0.94 
  Available Phosphorus 0.42 0.42 0.42 0.42  0.42 0.42 0.42 
  Linoleic acid 2.09 2.09 2.09 2.09  2.09 2.09 2.09 
  Sodium 0.20 0.20 0.20 0.20  0.20 0.20 0.20 
SID Lysine 1.20 1.20 1.20 1.20  1.20 1.20 1.20 
SID Methionine 0.27 0.43 0.59 0.75  0.43 0.59 0.75 
SID Cys 0.35 0.35 0.35 0.35  0.35 0.35 0.35 
SID Met+Cys 0.62 0.78 0.94 1.10  0.78 0.94 1.10 
SID Threonine 0.76 0.76 0.76 0.76  0.76 0.76 0.76 
SID Tryptophan 0.19 0.19 0.19 0.19  0.19 0.19 0.19 
SID Arginine 1.26 1.26 1.26 1.26  1.26 1.26 1.26 
SID Valine 0.95 0.95 0.95 0.95  0.95 0.95 0.95 
SID Isoleucine 0.82 0.82 0.82 0.82  0.82 0.82 0.82 
SID Leucine 1.29 1.29 1.29 1.29  1.29 1.29 1.29 
1
Wheat distiller’s dried grains with solubles 
1
5
0
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2
Supplied per kilogram of diet: vitamin A, 11,000 IU; cholecalciferol, 2,200 IU; vitamin E, 30 IU; vitamin K, 0.5 mg; vitamin B12, 
0.02 mg; thiamine, 1.5 mg; riboflavin, 6 mg; folic acid, 0.6 mg; biotin, 0.15 mg; niacin, 60 mg; pyridoxine, 5 mg; pantothenic acid, 
0.02 mg; chloride, 788 mg; sodium, 511 mg; iron, 80 mg; manganese, 21.8 mg; selenium, 0.1 mg; iodine, 0.35 mg; zinc, 100 mg. 
3
Xylanase 5000 U/g; Protease 1600 U/g (Halchemix Canada Inc.)
1
5
1
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6.3.3. C. perfringens challenge procedure 
For this study an avian C. perfringens field strain isolated from a clinical case of NE in 
broiler chickens was used (Dr. M. Chirino, Western College of Veterinary Medicine, 
University of Saskatchewan, Saskatoon, SK). The particular strain was characterized 
using PCR technique as a type A toxin producer (Dumonceaux et al. 2006). The 
organism was cultured anaerobically on BBL Blood Agar Base (Becton Dickinson Co., 
Sparks, MD) containing 5% sheep blood and 100 mg/L of Neomycin Sulphate (The 
Upjohn Co., Orangeville, ON, Canada) for 18 h at 37ºC, then aseptically inoculated into 
a sterilized preparation of Robertson’s cooked meat broth (Difco Laboratories, Detroit, 
MI), and incubated anaerobically and statically for 8 h at 37ºC. 
 All 144 birds in one room were challenged right after the 4 h dark period on d 7 
to 20 (inclusive), offering the inoculum in feed, as per the experimental model described 
in Chapter 4 with slight modifications. Briefly, each bird in that particular room received 
feed equivelent to 1/3 of ADFI mixed with 2 ml of broth culture. Similarly, each bird in 
the other room (unchellenged) received feed equivelent to 1/3 of ADFI mixed with 2 ml 
of sterile cooked meat medium broth. The respective feeders were top-dressed with 
culture/sterile broth mixed feed and fresh cultures were prepared daily. Culture-feed 
mixing was done immediately before offering to the birds. Bacterial counts were 
performed on the culture daily before inoculation and the count ranged from 4.46 x 10
4
 
to 6.87 x 10
6
 cfu/ml. 
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6.3.4. Experimental design 
Birds in six randomly selected cages in each room received the control diet whereas 
each experimental diet was offered to birds in three randomly selected cages in each 
room. Accordingly, each methionine source had three cages each fed the control diet and 
the three different methionine levels, to be considered in the statistical analysis. 
 
6.3.5. Sample and data collection 
Birds and feeders were weighed on a cage basis at the initiation (d 7) and termination (d 
21) of the experiment. The data were used to calculate ADG, ADFI and FCR for the 
overall experimental period. Birds were monitored twice a day (8:30 and 15:30) and in 
the case of mortality, the weight of the dead bird/s and remaining feed in the respective 
feeder/s were recorded immediately, in order to consider in calculations. At 21 d of age, 
all birds were euthanized by cervical dislocation and the contents of both ceca were 
aseptically collected from each bird. One aliquot from both ceca was frozen at -20ºC for 
subsequent DNA extraction. 
 
6.3.6. Pathological examination 
All birds were kept under constant observation for any sign of NE, which include 
depression, diarrhea, dehydration, somnolence, ruffled feathers and reduced feed intake 
or mortality (Helmboldt and Bryant 1971; Al-Sheikhly and Truscott 1977a,b; Al-
Sheikhly and Al-Saieg 1980; Gazdzinski and Julian 1992). As described above, birds 
were killed by cervical dislocation on d 21 of each trial and their intestinal tracts were 
removed immediately. Prior to digesta collection, intestinal lesions were scored blindly, 
according to the criteria described by Dahiya et al. (2005), using a scale from 0 to 4. 
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6.3.7. Genomic DNA extraction and purification 
The DNA extraction and purification on the collected cecal digesta samples were 
performed based on the method described in Chapter 4. 
 
6.3.8. Bacterial enumeration 
The purified DNA was used for molecular enumeration of C. perfringens in cecal 
digesta samples. The enumeration of C. perfringens was performed using qPCR 
technique as described in Chapter 4. The qPCR counts were converted to genomes 
detected/g digesta based on the weight of digesta extracted and the dilution factors. 
 
6.3.9. Statistical analysis 
The 5% level of significance was used for all statistical analyses. The experiment was 
analyzed by fitting quadratic regression models to the data using the regression 
procedure of SPSS (version 18.0, SPSS INC., Chicago IL). All the effects were 
considered as fixed, and the interactions between the main effects were used in the 
model, with pen as the experimental unit. Requirements for methionine were calculated 
as the inflection point of regression equations. Differences between requirements were 
calculated using Tukey’s honestly significant difference.  
 
6.4. Results 
The majority of challenged birds became dull and depressed, and excreted abnormally 
wet droppings upon initiation of challenging with C. perfringens. Cecal C. perfringens 
populations and intestinal lesion scores were not significantly affected by either 
methionine source or level (P > 0.05: Table 6.2). The methionine requirement of the 
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Table 6.2. Effect of different methionine sources and levels on intestinal lesion score 
and Clostridium perfringens populations in the ceca of broiler chickens on d 21 of age. 
Main effects Intestinal lesion score
1
 C.  perfringens counts 
(log10 cfu/g) 
Methionine source   
   DL-methionine 1.04 2.76 
   HMB
2
 1.19 3.09 
SEM 0.174 0.386 
   
Methionine level (%)
3
   
   0.27 1.08 2.85 
   0.43 0.83 2.41 
   0.59 1.38 3.28 
   0.75 1.17 3.16 
SEM 0.246 0.545 
   
Source of variation (P – value) 
      Methionine source 0.557 0.553 
      Methionine level 0.485 0.677 
      Source x Level 0.437 0.353 
1
According to the criteria described by Dahiya et al. (2005): 0-No gross lesions,  normal 
intestinal appearance; 0.5-Severely congested serosa and mesentery engorged with 
blood; 1- Thin-walled, friable intestines with small red petechiae (> 5); 2-Focal necrotic 
intestinal lesions; 3- Sizable patches of necrosis (1 to 2 cm long); 4- Diffused necrosis 
typical of field cases.
 
2
HMB = 2-hydroxy-4-methylthiobutanoic acid. 
3
Standardized ileal digestible methionine 
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birds fed DLM was higher in infected birds compared to uninfected birds for maximum 
ADG (6.03 and 5.07 g/kg; P < 0.05) while the infected and uninfected HMB fed birds 
had requirements that were not significantly different than the other two groups (5.30 
and 5.39 g/kg; P > 0.05: Table 6.3, Figure 6.1). The methionine requirement for 
optimum FCR was significantly higher in infected birds than in uninfected birds for both 
the DLM (6.27 vs 5.41 g/kg; P < 0.05) and the HMB (6.50 vs 5.94 g/kg; P < 0.05) fed 
birds. Further, the DLM fed birds had significantly lower methionine requirements for 
optimum FCR than the HMB fed bird in both infected and uninfected situations (P < 
0.05). The methionine requirements for maximum ADFI were not significantly different 
between treatment groups (P > 0.05). 
 
6.5. Discussion 
The methionine requirement for the maximum broiler performance is variable and 
ranges from 1.8-5.7 g/kg (NRC 1994; Klain et al. 1960; Waldroup et al. 1979). This 
variability is due to environmental conditions and interaction between methionine and 
other nutrients. The requirements in the present study were within this range for BW 
gain, feed intake and feed conversion. The methionine requirement for maximum feed 
conversion is generally higher that for gain (Schutte and de Jong 1996; Tillman and 
Pesti 1985) and this agrees with the results of the present study.   
Over the last several decades a large body of research has been performed to 
assess the relative bioefficacy of DLM and HMB. A recent review of this research by 
Jansman et al. (2003) reported that bioefficacy of HMB relative to DLM ranged from 
53-98% in broiler chickens with a mean value of 77% for BW gain and 76% for FCR. In  
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Table 6.3. The effect of methionine source and C. perfringens infection on the quadratic 
regression coefficients and calculated methionine requirements for ADG, ADFI and 
FCR in broiler chickens. 
   Regression Coefficients
1
   Calculated 
Parameter Treatment b0 b1 b2 r
2
 P-value Requirement 
ADG DLM
z
 Uninfected -36.78 19.94 -1.163 0.61 0.03 5.07a 
 DLM Infected -20.61 15.28 -0.802 0.74 0.03 6.03b 
 HMB
y
 Uninfected -32.71 18.78 -1.067 0.61 0.07 5.30ab 
 HMB Infected -42.73 21.59 -1.214 0.65 0.04 5.39ab 
ADFI
2 
 
DLM Uninfected 47.71 7.55 -0.464 0.33 0.90 4.64 
 DLM Infected 52.78 6.93 -0.376 0.11 0.59 5.72 
 HMB Uninfected -19.78 23.26 -1.327 0.49 0.33 5.26 
 HMB Infected -27.51 26.00 -1.503 0.69 0.06 5.15 
FCR 
 
DLM Uninfected 2.50 -0.34 0.032 0.63 0.02 5.41a 
 DLM Infected 2.46 -0.27 0.022 0.40 0.08 6.27c 
 HMB Uninfected 1.92 -0.13 0.009 0.61 0.13 5.94b 
 HMB Infected 1.99 -0.20 0.010 0.37 0.08 6.50d 
1
where regression equation is in the form: y = b0 + b1x +b2x
2 
z
DLM- DL methionine,
 y
HMB - 2-hydroxy-4-methylthiobutanoic acid 
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Figure 6.1. The effect of methionine source and C. perfringens inoculation on the 
requirement of broiler chickens for methionine. 
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the present study, the bioefficacy of HMB relative to DLM was 96% for ADG, 88% for 
ADFI and 74% for FCR. The high bioefficacy of HMB for ADG and ADFI may be a 
result of the small number of experimental units.  
 As previously observed with male (Bunchasak and Keawarun 2006) and female 
(Matsushita et al. 2007) broiler chickens, the methionine source did not affect the growth 
rate of uninfected birds in the current study. However, when infected, birds fed DLM 
needed 11% more methionine for maximum growth than uninfected counterparts. This 
indicates that C. perfringens infection elevates the methionine demand required for 
maximal growth in broiler chickens fed DLM supplemented diets. The growth 
performance, pathological observations and C. perfringens numbers of challenged birds 
indicate a subclinical form of NE, as indicated by Lovland and Kaldhusdal (2001). In the 
subclinical form of NE, nutrient digestion and absorption (including methionine) get 
impaired due to the damage caused by C. perfringens to the intestinal mucosa (Elwinger 
et al. 1992; Hofshagen and Kaldhusdal 1992; Lovland and Kaldhusdal 1999; Kaldhusdal 
et al. 2001; Hofacre et al. 2003). In addition, the intestinal epithelium processes 
absorbed AA prior to entry into the portal circulation, thereby determining the systemic 
availability of those AA (Brosnan 2003). Accordingly, the damaged intestinal 
epithelium of C. perfringens challenged birds may have affected the absorption and 
availability of methionine, limiting the absorptive and metabolic capacity, whereas no 
such limitation on methionine absorption and availability might have taken place at 
levels used in the present study in unchallenged birds with an intact intestinal 
epithelium. On the other hand, enteric infections in general increase the thickness of the 
intestinal wall which in turn reduces nutrient absorption (Thomke and Elwinger 1998). 
Methionine is usually considered as the first limiting AA in commercial broiler diets. 
  
160 
 
Therefore, the limited absorption of methionine might have limited the growth of the 
challenged birds while the growth of the unchallenged birds ascended with the 
increasing methionine level in the diet. In addition, the epithelial damage caused by the 
pathogen and associated metabolites elevates the methionine requirement since the 
healing process involves the use of nutrients to repair the damaged cells (Apajalahti et 
al. 2004). Moreover, intestinal tissue damage will lead to inflammatory and immune 
responses to promote the healing of damaged cells and to avoid the entry of enteric 
pathogen into the host tissues. AA deal with a number of metabolic or cellular responses 
as obligatory precursors with immune activation, acute phase protein production and the 
activation of peroxidative defenses (Reeds and Jahoor 2001). Accordingly, reduced 
absorption as well as enhanced utilization in processes other than production might have 
increased dietary methionine level required for growth.     
However, dietary inclusion of HMB made no significant difference in the 
methionine requirement for optimum ADG in infected and uninfected birds. Reports 
exist on the competition between the host and intestinal bacteria for nutrients. Both 
sources provide L-methionine activity to monogastric species in the same way, but the 
compounds are chemically different in that the asymmetric alpha carbon has an amino 
group in DLM and hydroxyl group in HMB (Leeson and Summers 2008). Hence, the 
chemically different nature of the two methionine sources might have affected bacterial 
utilization of this nutrient. Evaluating the ability of three bacterial species (Lactobacillus 
plantarum, Leuconostoc mesenteroides and Lactobacillus casei) to utilize HMB for 
growth, Hegedus et al. (1993) reported that none of these bacteria could utilize HMB 
although they all could use methionine. This suggests a group of limited number of 
bacterial species may be responsible for the uptake and metabolism of HMB and C. 
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perfringens may not be one of them. In addition, feeding the two methionine sources at 
levels to meet the TSAA requirement of broilers, Matsushita et al. (2007) reported 
significantly lower plasma levels of acute phase proteins in birds fed HMB than the 
levels in birds fed DLM. The authors attributed this observation to the greater anti-
inflammatory and anti-stress properties of HMB compared to DLM. This suggests lower 
utilization of dietary methionine in inflammatory responses of broilers fed HMB saving 
more for growth. Similarly, Zhang and Guo (2008) reported an increased innate and 
humoral immunocompetence in broiler chickens fed diets supplemented with HMB. 
Accordingly, as observed in the current study, C. perfringens infection per se does not 
elevate the methionine requirement for maximum growth when supplemented as HMB. 
When infected, methionine required for optimal FCR was higher than in 
uninfected birds. As previously discussed, infections in general increase the nutrient 
demand by spending nutrients on the pathogen combat process, which otherwise 
available for the production purposes. In addition, the capacity of nutrient absorption 
plunges with infections like NE due to the damage caused by C. perfringens to the 
intestinal epithelium (Elwinger et al. 1992; Hofshagen and Kaldhusdal 1992; Lovland 
and Kaldhusdal 1999; Kaldhusdal et al. 2001; Hofacre et al. 2003). Moreover, previous 
reports explain how synergisms, antagonisms and vital interactions between nutrition 
and immunity can influence the growth and production performance of broiler chickens. 
Some studies observed higher requirements of dietary essential AA than the NRC 
recommended levels to achieve optimal immunocompetence in broilers (Kidd et al. 
2001; Quentin et al. 2005). In fact, the NRC (1994) specifications have generally been 
created on the requirements of normal healthy birds raised in optimum management 
conditions, however birds in real industrial settings are usually under constant immune 
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challenge. Tsiagbe et al. (1987) reported higher requirement of methionine for maximum 
antibody titers than for growth of broilers. Methionine is considered to be a vital AA in 
both humoral and cell-mediated immunity (Swain and Johri 2000; Shini et al. 2005) 
owing to its ability to modulate the synthesis of glutathione, an essential intracellular 
antioxidant which provide protection against oxidative stress and subsequent 
inflammatory processes (Le Floc’h et al. 2004; Wu et al. 2004). Orally challenging 
broilers - fed graded level of methionine - with infectious bursal disease virus, 
Maroufyan et al. (2010) observed a positive correlation between the methionine level 
and antibody titer for that specific virus on 7d post challenge. These findings suggest a 
higher requirement of dietary methionine in broilers under immune challenge.  
When the diets were supplemented with HMB, birds needed 6 and 2% more 
methionine for the optimum FCR than birds fed DLM supplemented diets in uninfected 
and infected situations, respectively. The chemical difference in the two compounds 
results in considerable variations vis-à-vis mechanism and site of absorption (Knight and 
Dibner 1984), transport within the body (Lobley et al. 2006; Wester et al. 2006) and 
metabolism and conversion by the body tissues (Dibner 2003). No explanation is 
available for the variability in the bioefficacy estimates of HMB relative to DLM, even 
after extensive research from different laboratories. According to some reports HMB 
absorption in the avian GIT is lower than DLM absorption (Lingens and Molnar 1996; 
Maenz and Engele-Schaan 1996a,b; Drew et al. 2003). Moreover, some researchers 
reported less efficient absorption of HMB oligomers in poultry (Saunderson 1991; Van 
Weerden et al. 1992). Therefore, the less efficient absorption of HMB may have 
increased the dietary methionine requirement for optimum protein accretion.   
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In the present study, methionine supplementation did not suppress the growth of 
C. perfringens, as observed in in-vitro (Wilkie 2006) and in-vivo (Dahiya et al. 2007b) 
studies. Conversely, supplementary methionine did not promote the pathogen growth as 
reported by Muhammed et al. (1975), who demonstrated a stimulatory effect of 
methionine on the proliferation and sporulation of C. perfringens. Instead, the pathogen 
proliferation was similar in the current study, in the ceca of birds fed unsupplemented 
control diet and diets with increasing levels of methionine. Nevertheless, compared to 
the high methionine levels examined in those studies, marginally deficient or excess 
levels were included in the experimental diets of the current study which may be not 
enough to exert an effect on the C. perfringens growth in the GIT of birds. However, 
both methionine sources equally supported the pathogen proliferation as observed by 
Dahiya et al. (2007b). Similar to Dahiya et al. (2007b), the NE-specific intestinal lesion 
score was not affected by either methionine source or level, but demonstrated a 
correlation with the pathogen counts. 
The results of the present investigation indicate that C. perfringens infection 
increases the methionine requirement for maximal growth in broiler chickens when fed 
diets supplemented with DLM but not with HMB. The methionine requirement for 
optimal FCR is higher in infected than in uninfected birds and when the diets were 
supplemented with HMB, the methionine requirement for optimum FCR is higher than 
DLM supplemented diets in both uninfected and infected situations. Different beneficial 
effects of the two methionine sources suggest more favorable responses when the 
products are being used in combination, so more research in this area is warranted. 
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7. GENERAL DISCUSSION 
Necrotic enteritis is a bacterial infection of poultry caused by some strains of C. 
perfringens and often left untreated in broiler chickens due to complexity in its detection 
in farm flocks.  It can lead to significant economic losses due to high mortality or 
substandard growth performance in chickens with sub-clinical NE. Currently, the only 
reliable and successful preventative measure against this disease is the incorporation of 
antibiotics into broiler feeds. However, with the removal of AGP and coccidiostats from 
animal feed formulations, outbreaks of NE have drastically gone up, particularly in 
poultry producing countries in the European Union. This suggests the need for 
alternative methods of prophylaxis, hence a considerable amount of money and time are 
being spent throughout the world at present to develop cost-effective alternatives to 
AGP to combat this disease. Nevertheless, the antibiotic-free approaches developed so 
far to control C. perfringens in poultry are less than satisfactory. Much attention has paid 
on dietary and management practices in developing non-antibiotic approaches to control 
NE in broiler chickens. 
The necessity of a well controlled and repeatable disease model for NE has ever 
been there, because no generally accepted robust and reproducible disease model has 
been established so far to induce the disease experimentally to investigate potential non-
antibiotic approaches. Numerous efforts made to reproduce NE experimentally in 
different labs has resulted in markedly inconsistent results. Almost all current models 
depend on a multiorganism challenge using different Eimeria species in combination 
with C. perfringens, for the experimental induction of NE. The model used in this 
project was developed to be used in birds raised on the floor (litter) and tested with 
experimental as well as commercial type of diets comparing different challenging modes 
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without a concurrent coccidial infection. A more realistic approach was employed to 
mimic the normal way of infection, but to what degree this model would be successful in 
inducing the infection in a commercial setup is still uncertain. The implementation of 
this model in subsequent experiments did not elicit the clinical disease as seen in field 
outbreaks, but was able to produce sub-clinical version of NE in birds, ensuring very 
effective intestinal colonization of the pathogen. In addition, this model does not 
devastate the intestine of birds with coccidial pathogens interfering macroscopic and 
microscopic pathological evaluation and other findings. The absence of coccidial co-
infection makes it easier in employing this method and in result interpretation. However, 
a microscopic lesion evaluation in the intestinal tissues was not performed but could 
have been done to enhance the validity of the challenge model.  
The primary source of nutrients available to intestinal bacteria is that derived 
from the indigestible portion of feed. Thus, an alteration in intestinal microbial 
ecosystem can be expected with a modification in indigestible nutrients in the diet. C. 
perfringens is incapable of synthesizing not less than 13 out of 20 indispensable AA, 
hence heavily depends on proteins derived from the diet. The overwhelming impact of 
dietary protein level, protein digestibility and AA composition has on the occurrence and 
intensity of NE by triggering the C. perfringens proliferation and/or α toxin production 
and secretion is well documented in the literature. This indicates that one of the most 
efficient ways to control this pathogen without in-feed antibiotics is through appropriate 
feed formulation, particularly manipulating the protein level, quality (in terms of 
digestibility) and AA profile. In this context, use of LoPro diets can be speculated as a 
promising nutritional approach to control the proliferation of C. perfringens in broiler 
chickens, in the absence of AGP. However, based on available information the growth 
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and carcass performance seems to be impaired when broilers are fed LoPro diets even if 
formulated to meet all known nutrient requirements. Accordingly, one of the 
experiments (Chapter 3) conducted under this project was designed to evaluate the 
growth and production performance of broilers fed diets containing low and high ileal 
digestible protein levels, formulated with highly and poorly digestible protein 
supplements but equal amounts of nutrients. Based on the results of that experiment, the 
birds fed LoPro diets demonstrated inferior performance only when poorly digestible 
protein supplements were included in the diet. Birds fed LoPro diets with highly 
digestible protein supplements demonstrated equal performance as in birds fed HiPro 
diets. Hence, the findings of this experiment revealed that the negative effects of LoPro 
diets could be overcome with the inclusion of highly digestible protein supplements in 
broiler ration formulation. Nevertheless, this feeding strategy still has some limitations 
from the production point of view. Feeding LoPro diets is not an appropriate practice if 
maximal breast meat yield is the key intent of broiler production. In addition, compared 
to poorly digestible protein supplements, incorporation of highly digestible protein 
supplements into isoenergetic diets elevates the energy: protein ratio of the diet which 
increases the carcass fat accumulation. The precise energy: protein ratio for the optimum 
carcass quality could have been evaluated formulating diets with a series of ME levels, 
but higher numbers of dietary treatments, animals and experimental units in the same 
trial would have made the experiment more complicated and practically more difficult to 
deal with. Hence, more research in this area is warranted.   
The study conducted to investigate the effect of dietary protein level and 
digestibility on C. perfringens proliferation and subsequent growth performance of 
broiler chickens (Chapter 5) demonstrated that the pathogen proliferation and associated 
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growth suppression of birds fed LoPro diets could be minimized with the inclusion of 
highly digestible protein supplements in such diets. In addition, this investigation 
revealed the ability of that particular dietary approach to create a host friendly intestinal 
ecosystem, with the formation of beneficial VFA and less ammonia. Nevertheless, one 
of the crucial constraints in this type of experiment is the inability to use the same set of 
ingredients to formulate the diets with different protein and digestibility levels, 
maintaining the same nutrient specifications. This makes it difficult to distinguish the 
nutrient effects from ingredient effects. In addition, each diet was made as one batch to 
be used in the respective experiments and stored in a cool room facility until being used 
in each experiment. However, the loss of nutritional characteristics of some ingredients, 
vitamins for instance, with time is inevitable, even if stored properly. Accordingly, the 
diets fed in the last experiment might nutritionally be somewhat different from those fed 
in the first experiment. In the study described in Chapter 3, the execution of C. 
perfringens challenged and unchallenged experiments at separate times in the same 
room ruled out the environment effect, but brought some confounding factors in. One 
such factor was the birds in the two groups might not receive exactly the same dietary 
treatments, as described previously. In addition, birds used in the two experiments were 
received at two different times from two different progenies with significantly different 
chick weights. Therefore, chick quality in the two groups might not be the same, which 
is considered as one of the critical factors that determines the subsequent growth 
performance of broiler chickens. In this scenario, the significantly higher chick weight 
of birds to be challenged apparently resulted in superior growth performance in that 
group up to the point of challenging, which in turn reduced the impact of the challenge, 
giving only numerically different final BW compared to the unchallenged counterparts.   
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The study conducted to evaluate methionine requirement for optimum growth 
performance in broiler chickens fed diets supplemented with DLM or HMB under C. 
perfringens infected and uninfected situations (Chapter 6) revealed that C. perfringens 
infection increases the dietary methionine requirement for maximal growth only when 
supplemented with DLM but not with HMB. However, different chemical nature and 
associated differences in absorption, metabolism and transport suggest different 
beneficial effects of the two compounds. Accordingly, the potential additive effect of the 
two methionine sources in combination would be more advantageous, so further 
research in this area would definitely add some interesting information to the current 
study. 
The use of antibiotics in livestock industry is still in debate. However, these 
studies suggest that diet formulation, and ingredient quality can be manipulated to 
reduce the impact of C. perfringens on broiler production. Nevertheless, complete 
elimination of dietary predisposing factors remains a substantial challenge in broiler 
production. Further research investigating the effects of not only dietary protein, but also 
of other dietary components such as starch, fibre, lipid and minerals on C. perfringens 
are required. 
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